1
|
Zhang J, Jiang T, Chan LC, Lau SH, Wang W, Teng X, Chan PK, Cai J, Wen C. Radiomics analysis of patellofemoral joint improves knee replacement risk prediction: Data from the Multicenter Osteoarthritis Study (MOST). Osteoarthr Cartil Open 2024; 6:100448. [PMID: 38440779 PMCID: PMC10910336 DOI: 10.1016/j.ocarto.2024.100448] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/18/2023] [Accepted: 02/20/2024] [Indexed: 03/06/2024] Open
Abstract
Objective Knee replacement (KR) is the last-resort treatment for knee osteoarthritis. Although radiographic evidence of tibiofemoral joint has been widely adopted for prognostication, patellofemoral joint has gained little attention and may hold additional value for further improvements. We aimed to quantitatively analyse patellofemoral joint through radiomics analysis of lateral view radiographs for improved KR risk prediction. Design From the Multicenter Osteoarthritis Study dataset, we retrospectively retrieved the initial-visit lateral left knee radiographs of 2943 patients aged 50 to 79. They were split into training and test cohorts at a 2:1 ratio. A comprehensive set of radiomic features were extracted within the best-performing subregion of patellofemoral joint and combined into a radiomics score (RadScore). A KR risk score, derived from Kellgren-Lawrence grade (KLG) of tibiofemoral joint and RadScore of patellofemoral joint, was developed by multivariate Cox regression and assessed using time-dependent area under receiver operating characteristic curve (AUC). Results While patellofemoral osteoarthritis (PFOA) was insignificant during multivariate analysis, RadScore was identified as an independent risk factor (multivariate Cox p-value < 0.001) for KR. The subgroup analysis revealed that RadScore was particularly effective in predicting rapid progressor (KR occurrence before 30 months) among early- (KLG < 2) and mid-stage (KLG = 2) patients. Combining two joints radiographic information, the AUC reached 0.89/0.87 for predicting 60-month KR occurrence. Conclusions The RadScore of the patellofemoral joint on lateral radiographs emerges as an independent prognostic factor for improving KR prognosis prediction. The KR risk score could be instrumental in managing progressive knee osteoarthritis interventions.
Collapse
Affiliation(s)
- Jiang Zhang
- Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong, China
| | - Tianshu Jiang
- Department of Biomedical Engineering, The Hong Kong Polytechnic University, Hong Kong, China
| | - Lok-Chun Chan
- Department of Biomedical Engineering, The Hong Kong Polytechnic University, Hong Kong, China
| | - Sing-Hin Lau
- Department of Biomedical Engineering, The Hong Kong Polytechnic University, Hong Kong, China
| | - Wei Wang
- Department of Biomedical Engineering, The Hong Kong Polytechnic University, Hong Kong, China
| | - Xinzhi Teng
- Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong, China
| | - Ping-Keung Chan
- Department of Orthopaedics and Traumatology, The University of Hong Kong, Hong Kong, China
| | - Jing Cai
- Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong, China
- Research Institute for Smart Ageing, The Hong Kong Polytechnic University, Hong Kong, China
| | - Chunyi Wen
- Department of Biomedical Engineering, The Hong Kong Polytechnic University, Hong Kong, China
- Research Institute for Smart Ageing, The Hong Kong Polytechnic University, Hong Kong, China
| |
Collapse
|
2
|
Sun S, Liu Y, He C, Hu W, Liu W, Huang X, Wu J, Xie F, Chen C, Wang J, Lin Y, Zhu W, Yan G, Cai J, Li S. Combining NanoKnife with M1 oncolytic virus enhances anticancer activity in pancreatic cancer [Cancer Lett. 502 (2021) 9-24]. Cancer Lett 2024; 589:216697. [PMID: 38350772 DOI: 10.1016/j.canlet.2024.216697] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/15/2024]
Affiliation(s)
- Shuxin Sun
- Department of Pancreatobiliary Surgery, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, PR China; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, PR China
| | - Yang Liu
- Department of Pharmacology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong, PR China
| | - Chaobin He
- Department of Pancreatobiliary Surgery, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, PR China; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, PR China
| | - Wanming Hu
- Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, PR China; Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, PR China
| | - Wenfeng Liu
- Department of Pharmacology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong, PR China
| | - Xin Huang
- Department of Pancreatobiliary Surgery, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, PR China; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, PR China
| | - Jiali Wu
- Department of Pancreatobiliary Surgery, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, PR China; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, PR China
| | - Fengxiao Xie
- Department of Pancreatobiliary Surgery, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, PR China; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, PR China
| | - Chen Chen
- Department of Pharmacology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong, PR China
| | - Jun Wang
- Department of Pancreatobiliary Surgery, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, PR China; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, PR China
| | - Yuan Lin
- Department of Pharmacology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong, PR China
| | - Wenbo Zhu
- Department of Pharmacology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong, PR China
| | - Guangmei Yan
- Department of Pharmacology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong, PR China
| | - Jing Cai
- Department of Pharmacology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong, PR China.
| | - Shengping Li
- Department of Pancreatobiliary Surgery, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, PR China; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, PR China.
| |
Collapse
|
3
|
Wang K, Cai J, Yu JK, Li XW, Zhai GM, Wu GQ. We Reduced the Incidence of Postoperative Complications in Neonatal Ostomy Patients by Using Simple Devices. J Laparoendosc Adv Surg Tech A 2024. [PMID: 38634643 DOI: 10.1089/lap.2023.0046] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/19/2024] Open
Abstract
Background: Complications frequently occur after neonatal enterostomy. Enterostomy formation is a common outcome following an emergency neonatal laparotomy. This study investigated whether the incidence of complications after enterostomy could be decreased with a drainage device (composed of foreskin cerclage staple, a condom, and a 0-Mersilk braided nonabsorbable suture) fixed in the proximal ostomy bowel tube to improve proximal enterostomy in newborns. Methods: This study was a retrospective case note review of the incidence of emergency neonatal enterostomy incidence over a 3-year period (2/2016-2/2019) at the authors' center. A single surgeon conducted all surgeries. The incidence of intraoperative and postoperative complications was compared between modified and traditional surgery groups. Results: All 47 surgeries were successfully completed (32 boys and 15 girls; sex ratio: 2.13:1). The mean (±SD) birth weight, gestational period, and daily age were 2.64 ± 0.81 kg 35.62 ± 3.76 weeks and 3.49 ± 5.61 days, respectively. The patients were divided into modified surgery groups (20 cases) and traditional surgery groups (27 cases). The modified surgery group had significantly lower rates of total complications, unplanned reoperations, wound-related complications, and stoma-related complications than the traditional group (p <0.05). Conclusions: The preliminary observations suggested that the simple drainage device was a safe and effective operation device that reduced the risk of stoma-related complications.
Collapse
Affiliation(s)
- Kun Wang
- Dongguan Maternal and Child Health Care Hospital, Dongguan, China
| | - Jing Cai
- Dongguan Maternal and Child Health Care Hospital, Dongguan, China
| | - Jia Kang Yu
- Department of Pediatric Surgery, Guangzhou Women and Children's Medical Center, Guangzhou, China
| | - Xiao Wei Li
- Dongguan Maternal and Child Health Care Hospital, Dongguan, China
| | - Guo Min Zhai
- Dongguan Maternal and Child Health Care Hospital, Dongguan, China
| | - Gang Quan Wu
- Dongguan Maternal and Child Health Care Hospital, Dongguan, China
| |
Collapse
|
4
|
Liu P, Xie L, Wu Q, Huang L, Liu X, Li W, Cai J, Wang Z, Yang P, Cai L. TIE1 promotes cervical cancer progression via Basigin-matrix metalloproteinase axis. Int J Biol Sci 2024; 20:2297-2309. [PMID: 38617545 PMCID: PMC11008262 DOI: 10.7150/ijbs.93667] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/27/2023] [Accepted: 03/23/2024] [Indexed: 04/16/2024] Open
Abstract
Background: Tyrosine kinase with immunoglobulin and EGF-like domains 1 (TIE1) is known as an orphan receptor prominently expressed in endothelial cells and participates in angiogenesis by regulating TIE2 activity. Our previous study demonstrated elevated TIE1 expression in cervical cancer cells. However, the role of TIE1 in cervical cancer progression, metastasis and treatment remains elusive. Methods: Immunohistochemistry staining for TIE1 and Basigin was performed in 135 human cervical cancer tissues. Overexpressing vectors and siRNAs were used to manipulate gene expression in tumor cells. Colony formation, wound healing, and transwell assays were used to assess cervical cancer cell proliferation and migration in vitro. Subcutaneous xenograft tumor and lung metastasis mouse models were established to examine tumor growth and metastasis. Co-Immunoprecipitation and Mass Spectrometry were applied to explore the proteins binding to TIE1. Immunoprecipitation and immunofluorescence staining were used to verify the interaction between TIE1 and Basigin. Cycloheximide chase assay and MG132 treatment were conducted to analyze protein stability. Results: High TIE1 expression was associated with poor survival in cervical cancer patients. TIE1 overexpression promoted the proliferation, migration and invasion of cervical cancer cells in vitro, as well as tumor growth and metastasis in vivo. In addition, Basigin, a transmembrane glycoprotein, was identified as a TIE1 binding protein, suggesting a pivotal role in matrix metalloproteinase regulation, angiogenesis, cell adhesion, and immune responses. Knockdown of Basigin or treatment with the Basigin inhibitor AC-73 reversed the tumor-promoting effect of TIE1 in vitro and in vivo. Furthermore, we found that TIE1 was able to interact with and stabilize the Basigin protein and stimulate the Basigin-matrix metalloproteinase axis. Conclusion: TIE1 expression in cervical cells exerts a tumor-promoting effect, which is at least in part dependent on its interaction with Basigin. These findings have revealed a TIE2-independent mechanism of TIE1, which may provide a new biomarker for cervical cancer progression, and a potential therapeutic target for the treatment of cervical cancer patients.
Collapse
Affiliation(s)
- Pan Liu
- Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
| | - Lisha Xie
- Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
| | - Qiulei Wu
- Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
| | - Lin Huang
- Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
| | - Xiaoli Liu
- Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
| | - Wenhan Li
- Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
| | - Jing Cai
- Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
| | - Zehua Wang
- Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
| | - Ping Yang
- Department of Obstetrics and Gynecology, First Affiliated Hospital, School of Medicine, Shihezi University, Shihezi 832003, China
| | - Liqiong Cai
- Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
| |
Collapse
|
5
|
Tang Q, Yuan Y, Li L, Xu Y, Ji W, Xiao S, Han Y, Miao W, Cai J, You P, Chen M, Ding S, Li Z, Qi Z, Hou W, Luo H. Comprehensive analysis reveals that LTBR is a immune-related biomarker for glioma. Comput Biol Med 2024; 174:108457. [PMID: 38599071 DOI: 10.1016/j.compbiomed.2024.108457] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/22/2023] [Revised: 04/02/2024] [Accepted: 04/07/2024] [Indexed: 04/12/2024]
Abstract
Glioma is a common malignant brain tumor with great heterogeneity and huge difference in clinical outcomes. Although lymphotoxin (LT) beta receptor (LTBR) has been linked to immune system and response development for decades, the expression and function in glioma have not been investigated. To confirm the expression profile of LTBR, integrated RNA-seq data from glioma and normal brain tissues were analyzed. Functional enrichment analysis, TMEscore analysis, immune infiltration, the correlation of LTBR with immune checkpoints and ferroptosis, and scRNAseq data analysis in gliomas were in turn performed, which pointed out that LTBR was pertinent to immune functions of macrophages in gliomas. In addition, after being trained and validated in the tissue samples of the integrated dataset, an LTBR DNA methylation-based prediction model succeeded to distinguish gliomas from non-gliomas, as well as the grades of glioma. Moreover, by virtue of the candidate LTBR CpG sites, a prognostic risk-score model was finally constructed to guide the chemotherapy, radiotherapy, and immunotherapy for glioma patients. Taken together, LTBR is closely correlated with immune functions in gliomas, and LTBR DNA methylation could serve as a biomarker for diagnosis and prognosis of gliomas.
Collapse
Affiliation(s)
- Qisheng Tang
- Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, State Key Laboratory of Medical Neurobiology, MOE Frontiers Center for Brain Science and Institutes of Brain Science, Fudan University, Shanghai, 200040, China
| | - Yifan Yuan
- Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, State Key Laboratory of Medical Neurobiology, MOE Frontiers Center for Brain Science and Institutes of Brain Science, Fudan University, Shanghai, 200040, China
| | - Lingjuan Li
- Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, State Key Laboratory of Medical Neurobiology, MOE Frontiers Center for Brain Science and Institutes of Brain Science, Fudan University, Shanghai, 200040, China
| | - Yue Xu
- Key Laboratory of Shaanxi Province for Craniofacial Precision Medicine Research, Department of General Dentistry, College of Stomatology, Xi'an Jiaotong University, Xi'an, 710004, Shaanxi Province, China
| | - Wei Ji
- Department of Anesthesiology, Yantai Affiliated Hospital of Binzhou Medical University, Yantai, 264000, Shandong Province, China
| | - Siyu Xiao
- Department of Rehabilitation, Gongan Hospital of Traditional Chinese Medicine Affiliated to Hubei University of Chinese Medicine, Jingzhou, 434300, Hubei Province, China
| | - Yi Han
- Naval Medical Center of PLA, Naval Medical University, Shanghai, 200052, China
| | - Wenrong Miao
- Naval Medical Center of PLA, Naval Medical University, Shanghai, 200052, China
| | - Jing Cai
- Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, State Key Laboratory of Medical Neurobiology, MOE Frontiers Center for Brain Science and Institutes of Brain Science, Fudan University, Shanghai, 200040, China
| | - Pu You
- Shanghai QuietD Biotechnology Co., Ltd., Shanghai, 201210, China
| | - Ming Chen
- Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, State Key Laboratory of Medical Neurobiology, MOE Frontiers Center for Brain Science and Institutes of Brain Science, Fudan University, Shanghai, 200040, China
| | - Saineng Ding
- Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, State Key Laboratory of Medical Neurobiology, MOE Frontiers Center for Brain Science and Institutes of Brain Science, Fudan University, Shanghai, 200040, China
| | - Zhen Li
- Shanghai QuietD Biotechnology Co., Ltd., Shanghai, 201210, China.
| | - Zengxin Qi
- Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, State Key Laboratory of Medical Neurobiology, MOE Frontiers Center for Brain Science and Institutes of Brain Science, Fudan University, Shanghai, 200040, China.
| | - Weiliang Hou
- Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, State Key Laboratory of Medical Neurobiology, MOE Frontiers Center for Brain Science and Institutes of Brain Science, Fudan University, Shanghai, 200040, China.
| | - Hao Luo
- Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, State Key Laboratory of Medical Neurobiology, MOE Frontiers Center for Brain Science and Institutes of Brain Science, Fudan University, Shanghai, 200040, China.
| |
Collapse
|
6
|
Liu X, Zhang W, Zhang Y, Yang J, Zeng P, Tian Z, Sun W, Cai J. Chromosome-scale genomes of Quercus sichourensis and Quercus rex provide insights into the evolution and adaptation of Fagaceae. J Genet Genomics 2024:S1673-8527(24)00065-1. [PMID: 38575109 DOI: 10.1016/j.jgg.2024.03.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/26/2023] [Revised: 03/25/2024] [Accepted: 03/28/2024] [Indexed: 04/06/2024]
Abstract
The Fagaceae, a plant family with a wide distribution and diverse adaptability, has garnered significant interest as a subject of study in plant speciation and adaptation. Meanwhile, certain Fagaceae species are regarded as highly valuable wood resources due to the exceptional quality of their wood. In this study, we present two high-quality, chromosome-scale genome sequences for Quercus sichourensis (848.75 Mb) and Quercus rex (883.46 Mb). Comparative genomics analysis reveals that the difference in the number of plant disease resistance genes and the nonsynonymous and synonymous substitution ratio (Ka/Ks) of protein-coding genes among Fagaceae species are related to different environmental adaptations. Interestingly, most genes related to starch synthesis in the investigated Quercoideae species are located on a single chromosome, as compared to the outgroup species, Fagus sylvatica. Furthermore, resequencing and population analysis of Q. sichourensis and Q. rex reveal that Q. sichourensis has lower genetic diversity and higher deleterious mutations compared to Q. rex. The high-quality, chromosome-level genomes and the population genomic analysis of the critically endangered Q. sichourensis and Q. rex will provide an invaluable resource as well as insights for future study in these two species, even the genus Quercus, to facilitate their conservation.
Collapse
Affiliation(s)
- Xue Liu
- School of Ecology and Environment, Northwestern Polytechnical University, Xi'an, Shaanxi 710072, China
| | - Weixiong Zhang
- School of Ecology and Environment, Northwestern Polytechnical University, Xi'an, Shaanxi 710072, China
| | - Yongting Zhang
- School of Ecology and Environment, Northwestern Polytechnical University, Xi'an, Shaanxi 710072, China
| | - Jing Yang
- Yunnan Key Laboratory for Integrative Conservation of Plant Species with Extremely Small Populations, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming, Yunnan 650201, China
| | - Peng Zeng
- School of Ecology and Environment, Northwestern Polytechnical University, Xi'an, Shaanxi 710072, China
| | - Zunzhe Tian
- School of Ecology and Environment, Northwestern Polytechnical University, Xi'an, Shaanxi 710072, China
| | - Weibang Sun
- Yunnan Key Laboratory for Integrative Conservation of Plant Species with Extremely Small Populations, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming, Yunnan 650201, China.
| | - Jing Cai
- School of Ecology and Environment, Northwestern Polytechnical University, Xi'an, Shaanxi 710072, China.
| |
Collapse
|
7
|
Cai J, Lu B, Chen H, Lu M, Zhang Y, Luo C, You L, Dai M, Zhao Y. The impacts of exposure to risk factors during youth on the increasing global trend of early-onset pancreatic cancer. Public Health 2024; 229:65-72. [PMID: 38402665 DOI: 10.1016/j.puhe.2023.11.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/04/2023] [Revised: 10/18/2023] [Accepted: 11/05/2023] [Indexed: 02/27/2024]
Abstract
OBJECTIVES An increasing trend of pancreatic cancer in young adults has emerged in some countries. This study aimed to investigate global trends of pancreatic cancer in young adults and explore the impact of exposure to risk factors on pancreatic cancer incidence during youth. METHODS Global and national data on pancreatic cancer incidence, disability-adjusted life-years, attributive mortality, and summary exposure values of risk factors were retrieved from the Global Burden of Disease 2019. The average annual percent change (AAPC) of incidence and mortality was calculated. Additionally, generalized additive models were applied to explore the non-linear associations between the levels and changes in the Human Development Index and AAPC. RESULTS Global pancreatic cancer incidence increased during various periods from 1990 to 2019, particularly in adults aged <45 years from 2010 to 2019, at an average annual increase rate of 0.7% (95% confidence interval: 0.4-1.0%). The AAPC of early-onset pancreatic cancer incidence from 2010 to 2019 was negatively correlated with Human Development Index levels in both 2010 and 2019 but positively correlated with Human Development Index acceleration. Significant increases in early-onset pancreatic cancer incidence were observed over this period in 32 of 88 countries, primarily in South America, North America, Oceania, and Africa. Early-onset pancreatic cancer mortality attributed to high body mass index and fasting plasma glucose increased, while that attributed to tobacco use declined. CONCLUSIONS An increasing trend has emerged in the global incidence and burden of early-onset pancreatic cancer over the last few decades. This rise may partly be attributed to global epidemics of high body mass index and fasting plasma glucose.
Collapse
Affiliation(s)
- J Cai
- Department of Hospital Infection Control, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China; Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China
| | - B Lu
- Medical Research Center, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China; Department of Cancer Epidemiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China
| | - H Chen
- Medical Research Center, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China
| | - M Lu
- Medical Research Center, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China
| | - Y Zhang
- Medical Research Center, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China; Department of Cancer Epidemiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China
| | - C Luo
- Medical Research Center, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China; Department of Cancer Epidemiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China
| | - L You
- Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China
| | - M Dai
- Department of Cancer Epidemiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
| | - Y Zhao
- Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China.
| |
Collapse
|
8
|
Gao L, Wei Z, Ying F, Huang L, Zhang J, Sun S, Wang Z, Cai J, Zhang Y. Glutamine metabolism prognostic index predicts tumour microenvironment characteristics and therapeutic efficacy in ovarian cancer. J Cell Mol Med 2024; 28:e18198. [PMID: 38506093 PMCID: PMC10951877 DOI: 10.1111/jcmm.18198] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/07/2023] [Revised: 01/17/2024] [Accepted: 02/09/2024] [Indexed: 03/21/2024] Open
Abstract
Mounting evidence has highlighted the multifunctional characteristics of glutamine metabolism (GM) in cancer initiation, progression and therapeutic regimens. However, the overall role of GM in the tumour microenvironment (TME), clinical stratification and therapeutic efficacy in patients with ovarian cancer (OC) has not been fully elucidated. Here, three distinct GM clusters were identified and exhibited different prognostic values, biological functions and immune infiltration in TME. Subsequently, glutamine metabolism prognostic index (GMPI) was constructed as a new scoring model to quantify the GM subtypes and was verified as an independent predictor of OC. Patients with low-GMPI exhibited favourable survival outcomes, lower enrichment of several oncogenic pathways, less immunosuppressive cell infiltration and better immunotherapy responses. Single-cell sequencing analysis revealed a unique evolutionary trajectory of OC cells from high-GMPI to low-GMPI, and OC cells with different GMPI might communicate with distinct cell populations through ligand-receptor interactions. Critically, the therapeutic efficacy of several drug candidates was validated based on patient-derived organoids (PDOs). The proposed GMPI could serve as a reliable signature for predicting patient prognosis and contribute to optimising therapeutic strategies for OC.
Collapse
Affiliation(s)
- Lingling Gao
- Department of Obstetrics and Gynecology, Union HospitalTongji Medical College, Huazhong University of Science and TechnologyWuhanChina
| | - Zheng Wei
- Department of Obstetrics and GynecologyThird Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi HospitalTaiyuanChina
| | - Feiquan Ying
- Department of Obstetrics and Gynecology, Union HospitalTongji Medical College, Huazhong University of Science and TechnologyWuhanChina
| | - Lin Huang
- Department of Obstetrics and Gynecology, Union HospitalTongji Medical College, Huazhong University of Science and TechnologyWuhanChina
| | - Jingni Zhang
- Department of Obstetrics and Gynecology, Union HospitalTongji Medical College, Huazhong University of Science and TechnologyWuhanChina
| | - Si Sun
- Department of Obstetrics and Gynecology, Union HospitalTongji Medical College, Huazhong University of Science and TechnologyWuhanChina
| | - Zehua Wang
- Department of Obstetrics and Gynecology, Union HospitalTongji Medical College, Huazhong University of Science and TechnologyWuhanChina
| | - Jing Cai
- Department of Obstetrics and Gynecology, Union HospitalTongji Medical College, Huazhong University of Science and TechnologyWuhanChina
| | - Yuan Zhang
- Department of Obstetrics and Gynecology, Union HospitalTongji Medical College, Huazhong University of Science and TechnologyWuhanChina
| |
Collapse
|
9
|
Du L, Cai J, Yu J, Chen X, Yang X, Xu X, Zhang X. Relations Between Posttraumatic Growth and Fear of Progression Among Young and Middle-Aged Primary Brain Tumor Patients: The Parallel Mediating Role of Perceived Social Support and Illness Uncertainty. World Neurosurg 2024; 184:e794-e802. [PMID: 38364895 DOI: 10.1016/j.wneu.2024.02.048] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/23/2024] [Revised: 02/07/2024] [Accepted: 02/08/2024] [Indexed: 02/18/2024]
Abstract
OBJECTIVE This study aimed to investigate the mediating role of perceived social support and illness uncertainty in posttraumatic growth (PTG) and fear of progression (FoP) among young and middle-aged primary brain tumor (PBT) patients. METHODS A total of 252 young and middle-aged benign PBT patients were investigated. Data were collected by using self-designed general and disease-related data questionnaires, PTG Inventory, FoP Questinaire-Short Form, Mischel Uncertainty in Illness Scale, and Perceived Social Support Scale. Parallel mediation effect models were used to explore the relationship between PTG and FoP mediation effects. Bootstrap analysis was conducted to examine the mediation effect of PTG on FoP. RESULTS The total FoP and PTG scores were 35.15 ± 4.85 and 55.04 ± 7.86. Furthermore, mediation effect analyses revealed that perceived social support and illness uncertainty were partially associated with the mediated relationship between PTG and FoP. (std.β = -0.026, P-value = 0.001, std. β = -0.393, P value <0.001, respectively). CONCLUSIONS Illness uncertainty and perceived social support were identified as partially parallel mediators between PTG and FoP. Thus, we should ensure adequate social support and improve the enthusiasm and input of family members for better patient recovery. Strengthening the nursing support, reducing the uncertainty of young and middle-aged PBT patients, and improving the patients' PTG can help reduce the fear of disease progression.
Collapse
Affiliation(s)
- Linjing Du
- Department of Neurosurgery, Affiliated Hospital of Nantong University, Nantong, China; Medical College of Nantong University, Nantong, China
| | - Jing Cai
- Department of Neurosurgery, Affiliated Hospital of Nantong University, Nantong, China; Medical College of Nantong University, Nantong, China
| | - Jiahui Yu
- Department of Neurosurgery, Affiliated Hospital of Nantong University, Nantong, China; Medical College of Nantong University, Nantong, China
| | - Xing Chen
- Department of Neurosurgery, Affiliated Hospital of Nantong University, Nantong, China; Medical College of Nantong University, Nantong, China
| | - Xueni Yang
- Department of Neurosurgery, Affiliated Hospital of Nantong University, Nantong, China; Medical College of Nantong University, Nantong, China
| | - Xiuqun Xu
- Department of Neurosurgery, Affiliated Hospital of Nantong University, Nantong, China; Department of Nursing, Affiliated Hospital of Nantong University, Nantong, China
| | - Xiaomei Zhang
- Department of Neurosurgery, Affiliated Hospital of Nantong University, Nantong, China; Department of Nursing, Affiliated Hospital of Nantong University, Nantong, China.
| |
Collapse
|
10
|
Li M, Zhao L, Hu C, Li Y, Yang Y, Zhang X, Li Q, Ma A, Cai J. Improvement of Lung Function by Micronutrient Supplementation in Patients with COPD: A Systematic Review and Meta-Analysis. Nutrients 2024; 16:1028. [PMID: 38613061 PMCID: PMC11013492 DOI: 10.3390/nu16071028] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2024] [Revised: 03/26/2024] [Accepted: 03/27/2024] [Indexed: 04/14/2024] Open
Abstract
BACKGROUND A healthy, well-balanced diet plays an essential role in respiratory diseases. Since micronutrient deficiency is relatively common in patients with chronic obstructive pulmonary disease (COPD), micronutrient supplementation might have the beneficial health effects in those patients. This systematic review and meta-analysis aimed to demonstrate the impact of micronutrient supplementation on the lung function of patients with COPD. METHODS The PubMed, Cochrane Library, and Web of Science databases were searched from their corresponding creation until February 2024. Search terms included 'chronic obstructive pulmonary disease', 'COPD', 'micronutrients', 'dietary supplements', 'vitamins', 'minerals', and 'randomized controlled trials'. Meta-analysis was performed to evaluate the effects of micronutrient supplementation alone or complex on lung function in patients with COPD. RESULTS A total of 43 RCTs fulfilled the inclusion criteria of this study. Meta-analysis revealed that vitamin D supplementation could significantly improve FEV1% (WMDdifferences between baseline and post-intervention (de): 6.39, 95% CI: 4.59, 8.18, p < 0.01; WMDpost-intervention indicators (af): 7.55, 95% CI: 5.86, 9.24, p < 0.01) and FEV1/FVC% (WMDde: 6.88, 95%CI: 2.11, 11.65, WMDaf: 7.64, 95% CI: 3.18, 12.10, p < 0.001), decrease the odds of acute exacerbations, and improve the level of T-cell subsets, including CD3+%, CD4+%, CD8+%, and CD4+/CD8+% (all p < 0.01). The effects of compound nutrients intervention were effective in improving FEV1% (WMDde: 8.38, 95%CI: 1.89, 14.87, WMDaf: 7.07, 95%CI: -0.34, 14.48) and FEV1/FVC% (WMDde: 7.58, 95% CI: 4.86, 10.29, WMDaf: 6.00, 95% CI: 3.19, 8.81). However, vitamin C and vitamin E supplementation alone had no significant effects on lung function (p > 0.05). CONCLUSIONS Micronutrient supplementation, such as vitamin D alone and compound nutrients, has improved effect on the lung function of patients with COPD. Therefore, proper supplementation with micronutrients would be beneficial to stabilize the condition and restore ventilation function for COPD patients.
Collapse
Affiliation(s)
- Mingxin Li
- School of Public Health, Qingdao University, Qingdao 266000, China; (M.L.); (L.Z.); (C.H.); (Y.Y.); (A.M.)
| | - Liangjie Zhao
- School of Public Health, Qingdao University, Qingdao 266000, China; (M.L.); (L.Z.); (C.H.); (Y.Y.); (A.M.)
| | - Chenchen Hu
- School of Public Health, Qingdao University, Qingdao 266000, China; (M.L.); (L.Z.); (C.H.); (Y.Y.); (A.M.)
| | - Yue Li
- Endemic and Parasitic Diseases Prevention and Control Division, Binzhou Centre for Disease Prevention and Control, Binzhou 256600, China;
| | - Yang Yang
- School of Public Health, Qingdao University, Qingdao 266000, China; (M.L.); (L.Z.); (C.H.); (Y.Y.); (A.M.)
- Institute of Nutrition and Health, Qingdao University, Qingdao 266000, China
| | - Xiaoqi Zhang
- Department of Respiratory, Weifang No. 2 People’s Hospital, Weifang 261000, China; (X.Z.); (Q.L.)
| | - Quanguo Li
- Department of Respiratory, Weifang No. 2 People’s Hospital, Weifang 261000, China; (X.Z.); (Q.L.)
| | - Aiguo Ma
- School of Public Health, Qingdao University, Qingdao 266000, China; (M.L.); (L.Z.); (C.H.); (Y.Y.); (A.M.)
- Institute of Nutrition and Health, Qingdao University, Qingdao 266000, China
| | - Jing Cai
- School of Public Health, Qingdao University, Qingdao 266000, China; (M.L.); (L.Z.); (C.H.); (Y.Y.); (A.M.)
| |
Collapse
|
11
|
Wu Y, Cai J, Pang B, Cao L, He Q, He Q, Zhang A. Bioinformatic Identification of Signaling Pathways and Hub Genes in Vascular Dementia. Actas Esp Psiquiatr 2024; 52:83-98. [PMID: 38622006 PMCID: PMC11015743 DOI: 10.62641/aep.v52i2.1601] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/17/2024]
Abstract
BACKGROUND Vascular dementia (VaD) is a prevalent neurodegenerative disease characterized by cognitive impairment due to cerebrovascular factors, affecting a significant portion of the aging population and highlighting the critical need to understand specific targets and mechanisms for effective prevention and treatment strategies. We aimed to identify pathways and crucial genes involved in the progression of VaD through bioinformatics analysis and subsequently validate these findings. METHODS We conducted differential expression analysis, Weighted Gene Co-expression Network Analysis (WGCNA), Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis, and Protein-Protein Interaction (PPI) analysis. We utilized pheochromocytoma 12 (PC12) cells to create an in vitro oxygen-glucose deprivation (OGD) model. We investigated the impact of overexpression and interference of adrenoceptor alpha 1D (ADRA1D) on OGD PC12 cells using TdT-mediated dUTP nick-end labeling (TUNEL), reverse transcription-quantitative polymerase chain reaction (RT-qPCR), western blot (WB), and Fluo-3-pentaacetoxymethyl ester (Fluo-3 AM) analysis. RESULTS We found 187 differentially expressed genes (DEGs) in the red module that were strongly associated with VaD and were primarily enriched in vasoconstriction, G protein-coupled amine receptor activity, and neuroactive ligand-receptor interaction, mitogen-activated protein kinase (MAPK) signaling pathway, and cell adhesion. Among these pathways, we identified ADRA1D as a gene shared by vasoconstriction, G protein-coupled amine receptor activity, and neuroactive ligand-receptor interaction. The TUNEL assay revealed a significant decrease in PC12 cell apoptosis with ADRA1D overexpression (p < 0.01) and a significant increase in apoptosis upon silencing ADRA1D (p < 0.01). RT-qPCR and WB analysis revealed elevated ADRA1D expression (p < 0.001) and decreased phospholipase C beta (PLCβ) and inositol 1,4,5-trisphosphate receptor (IP3R) expression (p < 0.05) with ADRA1D overexpression. Moreover, the Fluo-3 AM assessment indicated significantly lower intracellular Ca2+ levels with ADRA1D overexpression (p < 0.001). Conversely, interference with ADRA1D yielded opposite results. CONCLUSION Our study provides a new perspective on the pathogenic mechanisms of VaD and potential avenues for therapeutic intervention. The results highlight the role of ADRA1D in modulating cellular responses to OGD and VaD, suggesting its potential as a target for VaD treatment.
Collapse
Affiliation(s)
- Yuanhua Wu
- Department of Neurology, The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, 550002 Guiyang, Guizhou, China
| | - Jing Cai
- Department of Neurology, The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, 550002 Guiyang, Guizhou, China
| | - Bo Pang
- Department of Neurology, The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, 550002 Guiyang, Guizhou, China
| | - Liping Cao
- Department of Neurology, The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, 550002 Guiyang, Guizhou, China
| | - Qiankun He
- The First School of Clinical Medicine of Guizhou University of Traditional Chinese Medicine, 550001 Guiyang, Guizhou, China
| | - Qiansong He
- Department of Neurology, The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, 550002 Guiyang, Guizhou, China
| | - Anbang Zhang
- Department of Neurology, The First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, 550002 Guiyang, Guizhou, China
| |
Collapse
|
12
|
Chen X, Yang X, Li Y, Zhang X, Zhu Y, Du L, Cai J, Xu X. Influencing factors of kinesiophobia among stroke patients with hemiplegia: A mixed methods study. Clin Neurol Neurosurg 2024; 240:108254. [PMID: 38579553 DOI: 10.1016/j.clineuro.2024.108254] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/28/2023] [Revised: 01/05/2024] [Accepted: 03/21/2024] [Indexed: 04/07/2024]
Abstract
OBJECTIVES There is a scarcity of data regarding the effects of kinesiophobia on stroke patients with hemiplegia. Therefore, this paper aims to evaluate the level of kinesiophobia experienced by stroke patients with hemiplegia in China, examine the elements that influence it, and investigate the unique psychological experience of kinesiophobia combined with a qualitative study. METHODS This mixed study was conducted in two steps. Four approved scales were used to evaluate a total of 163 patients: (i) Tampa Scale of Kinesiophobia, (ii) Pain Catastrophizing Scale, (iii) Self-Efficacy for Exercise Scale, and (iv) Hospital Anxiety and Depression Scale. A multivariate linear regression model was used to evaluate the predictors of kinesiophobia in stroke patients with hemiplegia. Subsequently, semi-structured interviews with 15 stroke patients with hemiplegia were conducted using an objective sampling method, and the Colaizzi 7-step analysis process was utilized to analyze the interview data. RESULTS A total of 163 stroke patients with hemiplegia were included in this study, of them, 47.9% reported kinesiophobia. Multiple linear regression revealed that the influencing factors of kinesiophobia in stroke patients with hemiplegia were a history of falls, exaggeration, helplessness, anxiety, depression, and low exercise self-efficacy (P<0.05). The qualitative research focuses on two main topics: personal adoption of negative coping styles and insufficient external support. CONCLUSION Our study showed that the kinesiophobia in stroke patients with hemiplegia was high, with several factors influencing their kinesiophobia. Some of these factors are modifiable and should be considered when formulating kinesiophobia intervention strategies for stroke patients with hemiplegia.
Collapse
Affiliation(s)
- Xing Chen
- Medical College, Nantong University, 19th Qixiu Road, Nantong 226001, China; Department of Neurosurgery, Affiliated Hospital of Nantong University, 20th Xisi Road, Nantong 226001, China
| | - Xueni Yang
- Medical College, Nantong University, 19th Qixiu Road, Nantong 226001, China; Department of Neurosurgery, Affiliated Hospital of Nantong University, 20th Xisi Road, Nantong 226001, China
| | - Yanqing Li
- Department of Nursing, Affiliated Hospital of Nantong University, 20th Xisi Road, Nantong 226001, China
| | - Xiaomei Zhang
- Department of Nursing, Affiliated Hospital of Nantong University, 20th Xisi Road, Nantong 226001, China; Department of Neurosurgery, Affiliated Hospital of Nantong University, 20th Xisi Road, Nantong 226001, China.
| | - Yingqian Zhu
- Medical College, Nantong University, 19th Qixiu Road, Nantong 226001, China; Department of Neurosurgery, Affiliated Hospital of Nantong University, 20th Xisi Road, Nantong 226001, China
| | - Linjing Du
- Medical College, Nantong University, 19th Qixiu Road, Nantong 226001, China; Department of Neurosurgery, Affiliated Hospital of Nantong University, 20th Xisi Road, Nantong 226001, China
| | - Jing Cai
- Medical College, Nantong University, 19th Qixiu Road, Nantong 226001, China; Department of Neurosurgery, Affiliated Hospital of Nantong University, 20th Xisi Road, Nantong 226001, China
| | - Xiuqun Xu
- Department of Nursing, Affiliated Hospital of Nantong University, 20th Xisi Road, Nantong 226001, China; Department of Neurosurgery, Affiliated Hospital of Nantong University, 20th Xisi Road, Nantong 226001, China.
| |
Collapse
|
13
|
Pan B, Chen C, Zhao Y, Cai J, Fu S, Liu J. SIRT3: A Potential Target of Different Types of Osteoporosis. Cell Biochem Biophys 2024:10.1007/s12013-024-01254-4. [PMID: 38512537 DOI: 10.1007/s12013-024-01254-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/19/2024] [Accepted: 03/13/2024] [Indexed: 03/23/2024]
Abstract
Osteoporosis (OP) is a common age-related disease. OP is mainly a decrease in bone density and mass caused by the destruction of bone microstructure, which leads to an increase in bone fragility. SIRT3 is a mitochondrial deacetylase that plays critical roles in mitochondrial homeostasis, metabolic regulation, gene transcription, stress response, and gene stability. Studies have shown that the higher expression levels of SIRT3 are associated with decreased levels of oxidative stress in the body and may play important roles in the prevention of age-related diseases. SIRTs can enhance the osteogenic potential and osteoblastic activity of bone marrow mesenchymal stromal cells not only by enhancing PGC-1α, FOXO3, SOD2, and oxidative phosphorylation, but also by anti-aging and reducing mitochondrial autophagy. SIRT3 is able to upregulate antioxidant enzymes to exert an inhibitory effect on osteoclasts, however, it has been shown that the inflammatory cascade response can in turn increase SIRT3 and inhibit osteoclast differentiation through the AMPK-PGC-1β pathway. SIRT3 plays an important role in different types of osteoporosis by affecting osteoblasts, osteoclasts, and bone marrow mesenchymal cells. In this review, we discuss the classification and physiological functions of SIRTs, the effects of SIRT3 on OCs osteoblasts, and BMSCs, and the roles and mechanisms of SIRT3 in different types of OP, such as diabetic OP, glucocorticoid-induced OP, postmenopausal OP, and senile OP.
Collapse
Affiliation(s)
- Binjing Pan
- The First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China
| | - Chongyang Chen
- The First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China
| | - Yangting Zhao
- The First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China
| | - Jing Cai
- The First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China
| | - Songbo Fu
- The First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China
- Department of Endocrinology, The First Hospital of Lanzhou University, Lanzhou, Gansu, China
| | - Jingfang Liu
- The First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China.
- Department of Endocrinology, The First Hospital of Lanzhou University, Lanzhou, Gansu, China.
| |
Collapse
|
14
|
Li X, Cai J, Zhang H, Sun S, Zhao S, Wang Z, Nie X, Xu C, Zhang Y, Xiao H. A Trisulfide Bond Containing Biodegradable Polymer Delivering Pt(IV) Prodrugs to Deplete Glutathione and Donate H 2S to Boost Chemotherapy and Antitumor Immunity. ACS Nano 2024; 18:7852-7867. [PMID: 38437513 DOI: 10.1021/acsnano.3c06194] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 03/06/2024]
Abstract
The clinical application of cisplatin (CisPt) is limited by its dose-dependent toxicity. To overcome this, we developed reduction-responsive nanoparticles (NP(3S)s) for the targeted delivery of a platinum(IV) (Pt(IV)) prodrug to improve efficacy and reduce the toxicity. NP(3S)s could release Pt(II) and hydrogen sulfide (H2S) upon encountering intracellular glutathione, leading to potent anticancer effects. Notably, NP(3S)s induced DNA damage and activated the STING pathway, which is a known promoter for T cell activation. Comparative RNA profiling revealed that NP(3S)s outperformed CisPt in enhancing T cell immunity, antitumor immunity, and oxidative stress pathways. In vivo experiments showed that NP(3S)s accumulated in tumors, promoting CD8+ T cell infiltration and boosting antitumor immunity. Furthermore, NP(3S)s exhibited robust in vivo anticancer efficacy while minimizing the CisPt-induced liver toxicity. Overall, the results indicate NP(3S)s hold great promise for clinical translation due to their low toxicity profile and potent anticancer activity.
Collapse
Affiliation(s)
- Xinyi Li
- Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
- Department of Pathology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
| | - Jing Cai
- Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
| | - Hanchen Zhang
- Beijing National Laboratory for Molecular Sciences, State Key Laboratory of Polymer Physics and Chemistry, Institute of Chemistry, Chinese Academy of Sciences, Beijing 100190, University of Chinese Academy of Sciences, Beijing 100049, China
| | - Si Sun
- Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
| | - Simei Zhao
- Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
| | - Zehua Wang
- Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
| | - Xiu Nie
- Department of Pathology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
| | - Chun Xu
- School of Dentistry, The University of Queensland, Brisbane 4006, Australia
| | - Yuan Zhang
- Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
| | - Haihua Xiao
- Beijing National Laboratory for Molecular Sciences, State Key Laboratory of Polymer Physics and Chemistry, Institute of Chemistry, Chinese Academy of Sciences, Beijing 100190, University of Chinese Academy of Sciences, Beijing 100049, China
| |
Collapse
|
15
|
Zhao Y, Cheng J, Cai J, Qi B. Global-best brain storm optimization algorithm based on chaotic difference step and opposition-based learning. Sci Rep 2024; 14:6432. [PMID: 38499591 PMCID: PMC10948844 DOI: 10.1038/s41598-024-56919-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/08/2023] [Accepted: 03/12/2024] [Indexed: 03/20/2024] Open
Abstract
Recently, the following global-best strategy and discussion mechanism have been prevailing to solve the slow convergence and the low optimization accuracy in the brain storm optimization (BSO) algorithm. However, the traditional BSO algorithm also suffers from the problem that it is easy to fall into local optimum. Therefore, this work innovatively designed the chaotic difference step strategy. This strategy introduced four commonly used chaotic maps and difference step to expand the population search space to improve the situation. Moreover, opposition-based learning thought was innovatively adopted into the BSO algorithm. The thought aims to generate the opposition-based population, increase the search density, and make the algorithm out of the local optimum as soon as possible. In summary, this work proposed a global-best brain storm optimization algorithm based on the chaotic difference step and opposition-based learning (COGBSO). According to the CEC2013 benchmark test suit, 15 typical benchmark functions were selected, and multiple sets of simulation experiments were conducted on MATLAB. The COGBSO algorithm was also compared to recent competitive algorithms based on the complete CEC2018 benchmark test suit. The results demonstrate that the COGBSO outperforms BSO and other improved algorithms in solving complex optimization problems.
Collapse
Affiliation(s)
- Yanchi Zhao
- College of Intelligent Systems Science and Engineering, Harbin Engineering University, Harbin, 150001, China
| | - Jianhua Cheng
- College of Intelligent Systems Science and Engineering, Harbin Engineering University, Harbin, 150001, China.
| | - Jing Cai
- Beijing Institute of Space Long March Vehicle, Beijing, 100000, China
| | - Bing Qi
- College of Intelligent Systems Science and Engineering, Harbin Engineering University, Harbin, 150001, China
| |
Collapse
|
16
|
Li W, Huang Y, Xiao M, Zhao J, Du S, Wang Z, Hu S, Yang L, Cai J. PBRM1 presents a potential ctDNA marker to monitor response to neoadjuvant chemotherapy in cervical cancer. iScience 2024; 27:109160. [PMID: 38414861 PMCID: PMC10897912 DOI: 10.1016/j.isci.2024.109160] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/06/2023] [Revised: 11/06/2023] [Accepted: 02/05/2024] [Indexed: 02/29/2024] Open
Abstract
Neoadjuvant chemotherapy (NACT) is a therapeutic option for locally advanced cervical cancer (LACC) patients. This study was aimed to identify potential liquid biopsy biomarkers to monitor the NACT response. Through targeted next-generation sequencing (NGS) analysis of circulating tumor DNA (ctDNA) and tumor tissue DNA (ttDNA) taken from LACC patients undergoing platinum-based NACT, 64 genes with mutations emerge during NACT in the non-responders but none in the responders. Among them, the PBRM1, SETD2, and ROS1 mutations were frequently detected in the ctDNA and ttDNA of the non-responders, and mutant PBRM1 was associated with poorer survival of patients. In vitro, PBRM1 knockdown promoted resistance to cisplatin through boosting STAT3 signaling in cervical cancer cells, while it sensitized tumor cells to poly-ADP-ribose-polymerase inhibitor olaparib. These findings suggest that mutant PBRM1 is a potential ctDNA marker of emerging resistance to NACT and of increased sensitivity to olaparib, which warrants further clinical validation.
Collapse
Affiliation(s)
- Wenhan Li
- Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
| | - Yuhui Huang
- Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
| | - Man Xiao
- Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
| | - Jing Zhao
- Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
| | - Shi Du
- Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
| | - Zehua Wang
- Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
| | - Sha Hu
- Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
| | - Lu Yang
- Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
| | - Jing Cai
- Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
| |
Collapse
|
17
|
Liu Z, Xia Q, Cai J, Wang Z, Yang K, Chen D, Wei J, Chen C, Liu C, Chang W, Li Z, Li X, Yang Y, Yang L, Tan X. Nitrogen Fertilizers Affect Microbial Hitchhiking to the Plant Roots. J Agric Food Chem 2024; 72:4639-4648. [PMID: 38377485 DOI: 10.1021/acs.jafc.3c07623] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/22/2024]
Abstract
The phenomenon of microbial hitchhiking, where nonmotile microbes utilize transspecies motility to navigate within their environment, has been observed. However, the underlying factors driving microbial hitchhiking remain unclear. Our study explored how nitrogen fertilizers affect microbial hitchhiking in soil through an in situ planting experiment. We established twelve treatments encompassing the presence and absence of plants, the presence and absence of a filter membrane that is used to prevent hitchhiking, and three nitrogen levels. Results showed that nitrogen influenced bacterial diversity in all soils, an effect thwarted by filter membranes. In the presence of plants, nitrogen significantly affected the bacterial mobility, Bacillus abundance, and plant biomass, but these effects vanished when filters were used. The correlation between motile Bacillus and rhizosphere bacteria was strong without filters at the proper nitrogen levels but weakened with membrane treatments. Thus, plants and nitrogen together, not nitrogen alone, alter the soil microbiome via hitchhiking.
Collapse
Affiliation(s)
- Zhibin Liu
- Key Laboratory of Bio-Resource and Eco-Environment of Ministry of Education, College of Life Sciences, Sichuan University, Chengdu, Sichuan 610064, China
| | - Qini Xia
- Key Laboratory of Bio-Resource and Eco-Environment of Ministry of Education, College of Life Sciences, Sichuan University, Chengdu, Sichuan 610064, China
| | - Jing Cai
- West China School of Pharmacy, Sichuan University, Chengdu, Sichuan 610041, China
| | - Ziyuan Wang
- Key Laboratory of Bio-Resource and Eco-Environment of Ministry of Education, College of Life Sciences, Sichuan University, Chengdu, Sichuan 610064, China
| | - Kexin Yang
- Key Laboratory of Bio-Resource and Eco-Environment of Ministry of Education, College of Life Sciences, Sichuan University, Chengdu, Sichuan 610064, China
| | - Dixu Chen
- Key Laboratory of Bio-Resource and Eco-Environment of Ministry of Education, College of Life Sciences, Sichuan University, Chengdu, Sichuan 610064, China
| | - Jiahong Wei
- Key Laboratory of Bio-Resource and Eco-Environment of Ministry of Education, College of Life Sciences, Sichuan University, Chengdu, Sichuan 610064, China
| | - Cun Chen
- College of Chemistry and Life Science, Chengdu Normal University, Chengdu, Sichuan 611130, China
| | - Chao Liu
- State Key Laboratory of Hydraulics and Mountain River Engineering, Sichuan University, Chengdu, Sichuan 610065, China
- College of Water Resource and Hydropower, Sichuan University, Chengdu, Sichuan 610065, China
| | - Wei Chang
- Vegetable Germplasm Innovation and Variety Improvement Key Laboratory of Sichuan Province/Horticulture Research Institute, Sichuan Academy of Agricultural Sciences, Chengdu 610066, China
| | - Zhi Li
- Vegetable Germplasm Innovation and Variety Improvement Key Laboratory of Sichuan Province/Horticulture Research Institute, Sichuan Academy of Agricultural Sciences, Chengdu 610066, China
| | - Xufeng Li
- Key Laboratory of Bio-Resource and Eco-Environment of Ministry of Education, College of Life Sciences, Sichuan University, Chengdu, Sichuan 610064, China
| | - Yi Yang
- Key Laboratory of Bio-Resource and Eco-Environment of Ministry of Education, College of Life Sciences, Sichuan University, Chengdu, Sichuan 610064, China
| | - Liang Yang
- Vegetable Germplasm Innovation and Variety Improvement Key Laboratory of Sichuan Province/Horticulture Research Institute, Sichuan Academy of Agricultural Sciences, Chengdu 610066, China
| | - Xiao Tan
- State Key Laboratory of Hydraulics and Mountain River Engineering, Sichuan University, Chengdu, Sichuan 610065, China
- College of Water Resource and Hydropower, Sichuan University, Chengdu, Sichuan 610065, China
| |
Collapse
|
18
|
Cai J, Hu J, Xu T, Kang H. FIONA1-mediated mRNA m 6 A methylation regulates the response of Arabidopsis to salt stress. Plant Cell Environ 2024; 47:900-912. [PMID: 38193282 DOI: 10.1111/pce.14807] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/28/2023] [Revised: 12/03/2023] [Accepted: 12/23/2023] [Indexed: 01/10/2024]
Abstract
N6 -methyladenosine (m6 A) is an mRNA modification widely found in eukaryotes and plays a crucial role in plant development and stress responses. FIONA1 (FIO1) is a recently identified m6 A methyltransferase that regulates Arabidopsis (Arabidopsis thaliana) floral transition; however, its role in stress response remains unknown. In this study, we demonstrate that FIO1-mediated m6 A methylation plays a vital role in salt stress response in Arabidopsis. The loss-of-function fio1 mutant was sensitive to salt stress. Importantly, the complementation lines expressing the wild-type FIO1 exhibited the wild-type phenotype, whereas the complementation lines expressing the mutant FIO1m , in which two critical amino acid residues essential for methyltransferase activity were mutated, did not recover the wild-type phenotype under salt stress, indicating that the salt sensitivity is associated with FIO1 methyltransferase activity. Furthermore, FIO1-mediated m6 A methylation regulated ROS production and affected the transcript level of several salt stress-responsive genes via modulating their mRNA stability in an m6 A-dependent manner in response to salt stress. Importantly, FIO1 is associated with salt stress response by specifically targeting and differentially modulating several salt stress-responsive genes compared with other m6 A writer. Collectively, our findings highlight the molecular mechanism of FIO1-mediated m6 A methylation in the salt stress adaptation.
Collapse
Affiliation(s)
- Jing Cai
- Department of Applied Biology, College of Agriculture and Life Sciences, Chonnam National University, Gwangju, South Korea
| | - Jianzhong Hu
- Department of Applied Biology, College of Agriculture and Life Sciences, Chonnam National University, Gwangju, South Korea
| | - Tao Xu
- Jiangsu Key Laboratory of Phylogenomics and Comparative Genomics, School of Life Sciences, Jiangsu Normal University, Xuzhou, China
| | - Hunseung Kang
- Department of Applied Biology, College of Agriculture and Life Sciences, Chonnam National University, Gwangju, South Korea
- Jiangsu Key Laboratory of Phylogenomics and Comparative Genomics, School of Life Sciences, Jiangsu Normal University, Xuzhou, China
| |
Collapse
|
19
|
Sun H, Yang Z, Zhu J, Li J, Gong J, Chen L, Wang Z, Yin Y, Ren G, Cai J, Zhao L. Pseudo-medical image-guided technology based on 'CBCT-only' mode in esophageal cancer radiotherapy. Comput Methods Programs Biomed 2024; 245:108007. [PMID: 38241802 DOI: 10.1016/j.cmpb.2024.108007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/18/2023] [Revised: 11/03/2023] [Accepted: 01/03/2024] [Indexed: 01/21/2024]
Abstract
Purpose To minimize the various errors introduced by image-guided radiotherapy (IGRT) in the application of esophageal cancer treatment, this study proposes a novel technique based on the 'CBCT-only' mode of pseudo-medical image guidance. Methods The framework of this technology consists of two pseudo-medical image synthesis models in the CBCT→CT and the CT→PET direction. The former utilizes a dual-domain parallel deep learning model called AWM-PNet, which incorporates attention waning mechanisms. This model effectively suppresses artifacts in CBCT images in both the sinogram and spatial domains while efficiently capturing important image features and contextual information. The latter leverages tumor location and shape information provided by clinical experts. It introduces a PRAM-GAN model based on a prior region aware mechanism to establish a non-linear mapping relationship between CT and PET image domains. As a result, it enables the generation of pseudo-PET images that meet the clinical requirements for radiotherapy. Results The NRMSE and multi-scale SSIM (MS-SSIM) were utilized to evaluate the test set, and the results were presented as median values with lower quartile and upper quartile ranges. For the AWM-PNet model, the NRMSE and MS-SSIM values were 0.0218 (0.0143, 0.0255) and 0.9325 (0.9141, 0.9410), respectively. The PRAM-GAN model produced NRMSE and MS-SSIM values of 0.0404 (0.0356, 0.0476) and 0.9154 (0.8971, 0.9294), respectively. Statistical analysis revealed significant differences (p < 0.05) between these models and others. The numerical results of dose metrics, including D98 %, Dmean, and D2 %, validated the accuracy of HU values in the pseudo-CT images synthesized by the AWM-PNet. Furthermore, the Dice coefficient results confirmed statistically significant differences (p < 0.05) in GTV delineation between the pseudo-PET images synthesized using the PRAM-GAN model and other compared methods. Conclusion The AWM-PNet and PRAM-GAN models have the capability to generate accurate pseudo-CT and pseudo-PET images, respectively. The pseudo-image-guided technique based on the 'CBCT-only' mode shows promising prospects for application in esophageal cancer radiotherapy.
Collapse
Affiliation(s)
- Hongfei Sun
- Department of Radiation Oncology, Xijing Hospital, Fourth Military Medical University, Xi'an, China
| | - Zhi Yang
- Department of Radiation Oncology, Xijing Hospital, Fourth Military Medical University, Xi'an, China
| | - Jiarui Zhu
- Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong, China
| | - Jie Li
- Department of Radiation Oncology, Xijing Hospital, Fourth Military Medical University, Xi'an, China
| | - Jie Gong
- Department of Radiation Oncology, Xijing Hospital, Fourth Military Medical University, Xi'an, China
| | - Liting Chen
- Department of Radiation Oncology, Xijing Hospital, Fourth Military Medical University, Xi'an, China
| | - Zhongfei Wang
- Department of Radiation Oncology, Xijing Hospital, Fourth Military Medical University, Xi'an, China
| | - Yutian Yin
- Department of Radiation Oncology, Xijing Hospital, Fourth Military Medical University, Xi'an, China
| | - Ge Ren
- Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong, China.
| | - Jing Cai
- Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong, China.
| | - Lina Zhao
- Department of Radiation Oncology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
| |
Collapse
|
20
|
Jiang T, Lau SH, Zhang J, Chan LC, Wang W, Chan PK, Cai J, Wen C. Radiomics signature of osteoarthritis: Current status and perspective. J Orthop Translat 2024; 45:100-106. [PMID: 38524869 PMCID: PMC10958157 DOI: 10.1016/j.jot.2023.10.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/28/2023] [Revised: 10/05/2023] [Accepted: 10/10/2023] [Indexed: 03/26/2024] Open
Abstract
Osteoarthritis (OA) is one of the fast-growing disability-related diseases worldwide, which has significantly affected the quality of patients' lives and brings about substantial socioeconomic burdens in medical expenditure. There is currently no cure for OA once the bone damage is established. Unfortunately, the existing radiological examination is limited to grading the disease's severity and is insufficient to precisely diagnose OA, detect early OA or predict OA progression. Therefore, there is a pressing need to develop novel approaches in medical image analysis to detect subtle changes for identifying early OA development and rapid progressors. Recently, radiomics has emerged as a unique approach to extracting high-dimensional imaging features that quantitatively characterise visible or hidden information from routine medical images. Radiomics data mining via machine learning has empowered precise diagnoses and prognoses of disease, mainly in oncology. Mounting evidence has shown its great potential in aiding the diagnosis and contributing to the study of musculoskeletal diseases. This paper will summarise the current development of radiomics at the crossroads between engineering and medicine and discuss the application and perspectives of radiomics analysis for OA diagnosis and prognosis. The translational potential of this article Radiomics is a novel approach used in oncology, and it may also play an essential role in the diagnosis and prognosis of OA. By transforming medical images from qualitative interpretation to quantitative data, radiomics could be the solution for precise early OA detection, progression tracking, and treatment efficacy prediction. Since the application of radiomics in OA is still in the early stages and primarily focuses on fundamental studies, this review may inspire more explorations and bring more promising diagnoses, prognoses, and management results of OA.
Collapse
Affiliation(s)
- Tianshu Jiang
- Department of Biomedical Engineering, Faculty of Engineering, The Hong Kong Polytechnic University, Hong Kong SAR, China
| | - Sing-Hin Lau
- Department of Biomedical Engineering, Faculty of Engineering, The Hong Kong Polytechnic University, Hong Kong SAR, China
| | - Jiang Zhang
- Department of Health Technology and Informatics, Faculty of Health and Social Sciences, The Hong Kong Polytechnic University, Hong Kong SAR, China
| | - Lok-Chun Chan
- Department of Biomedical Engineering, Faculty of Engineering, The Hong Kong Polytechnic University, Hong Kong SAR, China
| | - Wei Wang
- Department of Biomedical Engineering, Faculty of Engineering, The Hong Kong Polytechnic University, Hong Kong SAR, China
| | - Ping-Keung Chan
- Department of Orthopaedics and Traumatology, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, China
| | - Jing Cai
- Department of Health Technology and Informatics, Faculty of Health and Social Sciences, The Hong Kong Polytechnic University, Hong Kong SAR, China
| | - Chunyi Wen
- Department of Biomedical Engineering, Faculty of Engineering, The Hong Kong Polytechnic University, Hong Kong SAR, China
| |
Collapse
|
21
|
Wang R, Lou J, Cai J. Strategies to attenuate ciprofloxacin inhibition on enhanced biological phosphorus removal from wastewater and its recoverability. J Environ Manage 2024; 354:120456. [PMID: 38412731 DOI: 10.1016/j.jenvman.2024.120456] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/28/2023] [Revised: 01/22/2024] [Accepted: 02/20/2024] [Indexed: 02/29/2024]
Abstract
The inhibiting effects of ciprofloxacin (CIP) on enhanced biological phosphorus removal (EBPR) were investigated with no change in reactor operation and with increased aeration rate and sludge retention time (SRT) to explore inhibition-alleviating solutions. Additionally, performance recoverability was evaluated. The results showed that the phosphorus removal efficiency in the presence of 0.002-0.092 mg/L CIP for 7 days was only 12.5%. Increasing the aeration rate relieved inhibition (33.5% phosphorus removal efficiency on Day 7), and increasing SRT slowed EBPR performance deterioration. The EBPR performance recovered from CIP inhibition and increases in the aeration rate and SRT resulted in different recovery phenomena. The maximum PO43--P release rate continued to decrease in the first 2 days of the recovery stage and then gradually increased. However, the maximum PO43--P uptake rate immediately increased at different rates among reactors, which might be attributed to variations in the microbial community structure, decreased poly-P content, and enhanced abundances of ABC transporters and quorum sensing. It was found that some microorganisms associated with phosphorus removal were more tolerant to CIP than glycogen accumulating organisms. Moreover, the increased relative abundance of the qepA gene indicated that the microorganisms in the EBPR system had strong antibiotic resistance capacity. The bacterial community structure was significantly affected by CIP and could not recover to the initial structure. The results help to provide technical support for the operation of the EBPR process in the presence of CIP and to increase the understanding of system recoverability.
Collapse
Affiliation(s)
- Ruyi Wang
- School of Environmental Science and Engineering, Zhejiang Gongshang University, Hangzhou, 310012, China.
| | - Juqing Lou
- School of Environmental Science and Engineering, Zhejiang Gongshang University, Hangzhou, 310012, China.
| | - Jing Cai
- School of Environmental Science and Engineering, Zhejiang Gongshang University, Hangzhou, 310012, China.
| |
Collapse
|
22
|
Lu X, Bai J, Tian Z, Li C, Ahmed N, Liu X, Cheng J, Lu L, Cai J, Jiang H, Wang W. Cyclization mechanism of monoterpenes catalyzed by monoterpene synthases in dipterocarpaceae. Synth Syst Biotechnol 2024; 9:11-18. [PMID: 38173809 PMCID: PMC10758623 DOI: 10.1016/j.synbio.2023.11.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/20/2023] [Revised: 11/07/2023] [Accepted: 11/25/2023] [Indexed: 01/05/2024] Open
Abstract
Monoterpenoids are typically present in the secretory tissues of higher plants, and their biosynthesis is catalyzed by the action of monoterpene synthases (MTSs). However, the knowledge about these enzymes is restricted in a few plant species. MTSs are responsible for the complex cyclization of monoterpene precursors, resulting in the production of diverse monoterpene products. These enzymatic reactions are considered exceptionally complex in nature. Therefore, it is crucial to understand the catalytic mechanism of MTSs to elucidate their ability to produce diverse or specific monoterpenoid products. In our study, we analyzed thirteen genomes of Dipterocarpaceae and identified 38 MTSs that generate a variety of monoterpene products. By focusing on four MTSs with different product spectra and analyzing the formation mechanism of acyclic, monocyclic and bicyclic products in MTSs, we observed that even a single amino acid mutation can change the specificity and diversity of MTS products, which is due to the synergistic effect between the shape of the active cavity and the stabilization of carbon-positive intermediates that the mutation changing. Notably, residues N340, I448, and phosphoric acid groups were found to be significant contributors to the stabilization of intermediate terpinyl and pinene cations. Alterations in these residues, either directly or indirectly, can impact the synthesis of single monoterpenes or their mixtures. By revealing the role of key residues in the catalytic process and establishing the interaction model between specific residues and complex monoterpenes in MTSs, it will be possible to reasonably design and engineer different catalytic activities into existing MTSs, laying a foundation for the artificial design and industrial application of MTSs.
Collapse
Affiliation(s)
- Xiaoyun Lu
- School of Ecology and Environment, Northwestern Polytechnical University, Xi'an, Shanxi, 710072, China
- Key Laboratory of Engineering Biology for Low-Carbon Manufacturing, Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin, 300308, China
| | - Jie Bai
- Key Laboratory of Engineering Biology for Low-Carbon Manufacturing, Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin, 300308, China
| | - Zunzhe Tian
- School of Ecology and Environment, Northwestern Polytechnical University, Xi'an, Shanxi, 710072, China
| | - Congyu Li
- Key Laboratory of Engineering Biology for Low-Carbon Manufacturing, Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin, 300308, China
| | - Nida Ahmed
- Key Laboratory of Engineering Biology for Low-Carbon Manufacturing, Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin, 300308, China
| | - Xiaonan Liu
- Key Laboratory of Engineering Biology for Low-Carbon Manufacturing, Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin, 300308, China
| | - Jian Cheng
- Key Laboratory of Engineering Biology for Low-Carbon Manufacturing, Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin, 300308, China
| | - Lina Lu
- Key Laboratory of Engineering Biology for Low-Carbon Manufacturing, Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin, 300308, China
| | - Jing Cai
- School of Ecology and Environment, Northwestern Polytechnical University, Xi'an, Shanxi, 710072, China
| | - Huifeng Jiang
- Key Laboratory of Engineering Biology for Low-Carbon Manufacturing, Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin, 300308, China
| | - Wen Wang
- School of Ecology and Environment, Northwestern Polytechnical University, Xi'an, Shanxi, 710072, China
| |
Collapse
|
23
|
Jian Z, Cai J, Chen R, Niu Y, Kan H. A bibliometric analysis of research on the health impacts of ozone air pollution. Environ Sci Pollut Res Int 2024; 31:16177-16187. [PMID: 38324150 DOI: 10.1007/s11356-024-32233-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/16/2023] [Accepted: 01/24/2024] [Indexed: 02/08/2024]
Abstract
Ground-level ozone (O3) is one of the major air pollutants. A large body of literature has linked O3 air pollution to various adverse human health effects. The objective of this study is to attain a comprehensive and in-depth understanding of the progress and frontiers of research on O3 and human health. We used bibliometric methods to summarize publications on O3 air pollution and public health between 1990 and 2022 obtained from the Web of Science Core Collection database. VOSviewer and R software were used for bibliometric analysis and visualization. A total of 4501 relevant papers were included in the analysis. There has been a significant increase in the number of publications since 2013, with the USA being the major contributor, followed by China and England. Harvard University was the most prolific research institution, followed by the US Environmental Protection Agency and the University of North Carolina System. Professor Joel Schwartz was the most published author and has established a complex network of national and international collaborations. Co-occurrence analysis of keywords suggested evolving research hotspots, from toxicological studies to population-based epidemiological studies and from the respiratory system to the extra-pulmonary system. Research on O3 and its human health effects has progressed rapidly over the past few decades, but academic disparities still persist between developed and developing countries. There is an urgent need to strengthen international cooperation to address the public health challenges posed by rising O3 air pollution in the future.
Collapse
Affiliation(s)
- Zhihan Jian
- School of Public Health, Key Lab of Public Health Safety of the Ministry of Education, NHC Key Lab of Health Technology Assessment, Fudan University, Shanghai, 200032, China
| | - Jing Cai
- School of Public Health, Key Lab of Public Health Safety of the Ministry of Education, NHC Key Lab of Health Technology Assessment, Fudan University, Shanghai, 200032, China
| | - Renjie Chen
- School of Public Health, Key Lab of Public Health Safety of the Ministry of Education, NHC Key Lab of Health Technology Assessment, Fudan University, Shanghai, 200032, China
| | - Yue Niu
- School of Public Health, Key Lab of Public Health Safety of the Ministry of Education, NHC Key Lab of Health Technology Assessment, Fudan University, Shanghai, 200032, China.
| | - Haidong Kan
- School of Public Health, Key Lab of Public Health Safety of the Ministry of Education, NHC Key Lab of Health Technology Assessment, Fudan University, Shanghai, 200032, China
| |
Collapse
|
24
|
Liu X, Gao R, Wu Q, Li G, Xu X, Li W, Liu P, Wang X, Cai J, Li M, Wang Z. ITGA7 loss drives the differentiation of adipose-derived mesenchymal stem cells to cancer-associated fibroblasts. Mol Carcinog 2024; 63:479-493. [PMID: 38174862 DOI: 10.1002/mc.23665] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/11/2023] [Revised: 11/09/2023] [Accepted: 11/21/2023] [Indexed: 01/05/2024]
Abstract
Cancer-associated fibroblasts (CAFs) represent a major cellular component of the tumor (pre-)metastatic niche and play an essential role in omental dissemination of ovarian cancer. The omentum is rich in adipose, and adipose-derived mesenchymal stem cells (ADSCs) have been identified as a source of CAFs. However, the molecular events driving the phenotype shift of ADSCs remain largely unexplored. In this research, we focus on integrins, transmembrane receptors that have been widely involved in cellular plasticity. We found that integrin α7 (ITGA7) was the only member of the integrin family that positively correlated with both overall survival and progression-free survival in ovarian cancer through GEPIA2. The immunohistochemistry signal of ITGA7 was apparent in the tumor stroma, and a lower omental ITGA7 level was associated with metastasis. Primary ADSCs were isolated from the omentum of patients with ovarian cancer and identified by cellular morphology, biomarkers, and multilineage differentiation. The conditional medium of ovarian cancer cells induced ITGA7 expression decrease and phenotypic changes in ADSCs. Downregulation of ITGA7 in primary omental ADSCs led to decrease in stemness properties and emerge of characteristic morphology and biomarkers of CAFs. Moreover, the conditioned medium of ADSCs with ITGA7 depletion exhibited enhanced abilities to improve the migration and invasion of ovarian cancer cells in vitro. Overall, these findings indicate that loss of ITGA7 may induce the differentiation of ADSCs to CAFs that contribute to a tumor-supportive niche.
Collapse
Affiliation(s)
- Xiaoli Liu
- Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
| | - Rui Gao
- Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
| | - Qiulei Wu
- Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
| | - Guoqing Li
- Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
| | - Xiaohan Xu
- Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
| | - Wenhan Li
- Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
| | - Pan Liu
- Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
| | - Xiaoman Wang
- Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
| | - Jing Cai
- Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
| | - Min Li
- Obstetrics and Gynecology Department, Center for Reproductive Medicine, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China
| | - Zehua Wang
- Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
| |
Collapse
|
25
|
Cheng KH, Li W, Lee FKH, Li T, Cai J. Pixelwise Gradient Model with GAN for Virtual Contrast Enhancement in MRI Imaging. Cancers (Basel) 2024; 16:999. [PMID: 38473363 DOI: 10.3390/cancers16050999] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/29/2024] [Revised: 02/24/2024] [Accepted: 02/27/2024] [Indexed: 03/14/2024] Open
Abstract
Background: The development of advanced computational models for medical imaging is crucial for improving diagnostic accuracy in healthcare. This paper introduces a novel approach for virtual contrast enhancement (VCE) in magnetic resonance imaging (MRI), particularly focusing on nasopharyngeal cancer (NPC). Methods: The proposed model, Pixelwise Gradient Model with GAN for Virtual Contrast Enhancement (PGMGVCE), makes use of pixelwise gradient methods with Generative Adversarial Networks (GANs) to enhance T1-weighted (T1-w) and T2-weighted (T2-w) MRI images. This approach combines the benefits of both modalities to simulate the effects of gadolinium-based contrast agents, thereby reducing associated risks. Various modifications of PGMGVCE, including changing hyperparameters, using normalization methods (z-score, Sigmoid and Tanh) and training the model with T1-w or T2-w images only, were tested to optimize the model's performance. Results: PGMGVCE demonstrated a similar accuracy to the existing model in terms of mean absolute error (MAE) (8.56 ± 0.45 for Li's model; 8.72 ± 0.48 for PGMGVCE), mean square error (MSE) (12.43 ± 0.67 for Li's model; 12.81 ± 0.73 for PGMGVCE) and structural similarity index (SSIM) (0.71 ± 0.08 for Li's model; 0.73 ± 0.12 for PGMGVCE). However, it showed improvements in texture representation, as indicated by total mean square variation per mean intensity (TMSVPMI) (0.124 ± 0.022 for ground truth; 0.079 ± 0.024 for Li's model; 0.120 ± 0.027 for PGMGVCE), total absolute variation per mean intensity (TAVPMI) (0.159 ± 0.031 for ground truth; 0.100 ± 0.032 for Li's model; 0.153 ± 0.029 for PGMGVCE), Tenengrad function per mean intensity (TFPMI) (1.222 ± 0.241 for ground truth; 0.981 ± 0.213 for Li's model; 1.194 ± 0.223 for PGMGVCE) and variance function per mean intensity (VFPMI) (0.0811 ± 0.005 for ground truth; 0.0667 ± 0.006 for Li's model; 0.0761 ± 0.006 for PGMGVCE). Conclusions: PGMGVCE presents an innovative and safe approach to VCE in MRI, demonstrating the power of deep learning in enhancing medical imaging. This model paves the way for more accurate and risk-free diagnostic tools in medical imaging.
Collapse
Affiliation(s)
- Ka-Hei Cheng
- Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong SAR, China
| | - Wen Li
- Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong SAR, China
| | - Francis Kar-Ho Lee
- Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong SAR, China
| | - Tian Li
- Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong SAR, China
| | - Jing Cai
- Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong SAR, China
- The Hong Kong Polytechnic University Shenzhen Research Institute, Shenzhen 518000, China
| |
Collapse
|
26
|
Wang R, Liu CN, Segar ST, Jiang YT, Zhang KJ, Jiang K, Wang G, Cai J, Chen LF, Chen S, Cheng J, Compton SG, Deng JY, Ding YY, Du FK, Hu XD, Hu XH, Kang L, Li DH, Lu L, Li YY, Tang L, Tong X, Wang ZS, Xu WW, Yang Y, Zang RG, Zu ZX, Zhang YY, Chen XY. Dipterocarpoidae genomics reveal their demography and adaptations to Asian rainforests. Nat Commun 2024; 15:1683. [PMID: 38395938 PMCID: PMC10891123 DOI: 10.1038/s41467-024-45836-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/12/2022] [Accepted: 02/01/2024] [Indexed: 02/25/2024] Open
Abstract
Dipterocarpoideae species form the emergent layer of Asian rainforests. They are the indicator species for Asian rainforest distribution, but they are severely threatened. Here, to understand their adaptation and population decline, we assemble high-quality genomes of seven Dipterocarpoideae species including two autotetraploid species. We estimate the divergence time between Dipterocarpoideae and Malvaceae and within Dipterocarpoideae to be 108.2 (97.8‒118.2) and 88.4 (77.7‒102.9) million years ago, and we identify a whole genome duplication event preceding dipterocarp lineage diversification. We find several genes that showed a signature of selection, likely associated with the adaptation to Asian rainforests. By resequencing of two endangered species, we detect an expansion of effective population size after the last glacial period and a recent sharp decline coinciding with the history of local human activities. Our findings contribute to understanding the diversification and adaptation of dipterocarps and highlight anthropogenic disturbances as a major factor in their endangered status.
Collapse
Affiliation(s)
- Rong Wang
- Zhejiang Tiantong Forest Ecosystem National Observation and Research Station, Shanghai Key Lab for Urban Ecological Processes and Eco-Restoration, School of Ecological and Environmental Sciences, East China Normal University, Shanghai, China.
| | - Chao-Nan Liu
- Zhejiang Tiantong Forest Ecosystem National Observation and Research Station, Shanghai Key Lab for Urban Ecological Processes and Eco-Restoration, School of Ecological and Environmental Sciences, East China Normal University, Shanghai, China
| | - Simon T Segar
- Agriculture & Environment Department, Harper Adams University, Newport, United Kingdom
| | - Yu-Ting Jiang
- Zhejiang Tiantong Forest Ecosystem National Observation and Research Station, Shanghai Key Lab for Urban Ecological Processes and Eco-Restoration, School of Ecological and Environmental Sciences, East China Normal University, Shanghai, China
| | | | - Kai Jiang
- Zhejiang Tiantong Forest Ecosystem National Observation and Research Station, Shanghai Key Lab for Urban Ecological Processes and Eco-Restoration, School of Ecological and Environmental Sciences, East China Normal University, Shanghai, China
- Shanghai Key Laboratory of Plant Functional Genomics and Resources, Shanghai Chenshan Botanical Garden, Shanghai, China
| | - Gang Wang
- CAS Key Laboratory of Tropical Forest Ecology, Xishuangbanna Tropical Botanical Garden, Chinese Academy of Sciences, Mengla, Yunnan, China
| | - Jing Cai
- School of Ecology and Environment, Northwestern Polytechnical University, Xi'an, 710072, China
| | - Lu-Fan Chen
- Zhejiang Tiantong Forest Ecosystem National Observation and Research Station, Shanghai Key Lab for Urban Ecological Processes and Eco-Restoration, School of Ecological and Environmental Sciences, East China Normal University, Shanghai, China
| | - Shan Chen
- Zhejiang Tiantong Forest Ecosystem National Observation and Research Station, Shanghai Key Lab for Urban Ecological Processes and Eco-Restoration, School of Ecological and Environmental Sciences, East China Normal University, Shanghai, China
| | - Jing Cheng
- Zhejiang Tiantong Forest Ecosystem National Observation and Research Station, Shanghai Key Lab for Urban Ecological Processes and Eco-Restoration, School of Ecological and Environmental Sciences, East China Normal University, Shanghai, China
| | | | - Jun-Yin Deng
- Zhejiang Tiantong Forest Ecosystem National Observation and Research Station, Shanghai Key Lab for Urban Ecological Processes and Eco-Restoration, School of Ecological and Environmental Sciences, East China Normal University, Shanghai, China
| | - Yuan-Yuan Ding
- Zhejiang Tiantong Forest Ecosystem National Observation and Research Station, Shanghai Key Lab for Urban Ecological Processes and Eco-Restoration, School of Ecological and Environmental Sciences, East China Normal University, Shanghai, China
| | - Fang K Du
- School of Ecology and Nature Conservation, Beijing Forestry University, Beijing, China
| | - Xiao-Di Hu
- Novogene Bioinformatics Institute, Beijing, China
| | - Xing-Hua Hu
- Guangxi Institute of Botany, Guangxi Zhuang Autonomous Region and the Chinese Academy of Sciences, Guilin, China
| | - Ling Kang
- Novogene Bioinformatics Institute, Beijing, China
| | - Dong-Hai Li
- College of Ecology and Environment, Hainan University, Haikou, China
| | - Ling Lu
- Zhejiang Tiantong Forest Ecosystem National Observation and Research Station, Shanghai Key Lab for Urban Ecological Processes and Eco-Restoration, School of Ecological and Environmental Sciences, East China Normal University, Shanghai, China
| | - Yuan-Yuan Li
- Zhejiang Tiantong Forest Ecosystem National Observation and Research Station, Shanghai Key Lab for Urban Ecological Processes and Eco-Restoration, School of Ecological and Environmental Sciences, East China Normal University, Shanghai, China
| | - Liang Tang
- Key Laboratory of Genetics and Germplasm Innovation of Tropical Special Forest Trees and Ornamental Plants, Hainan University, Haikou, China
| | - Xin Tong
- Zhejiang Tiantong Forest Ecosystem National Observation and Research Station, Shanghai Key Lab for Urban Ecological Processes and Eco-Restoration, School of Ecological and Environmental Sciences, East China Normal University, Shanghai, China
- Shanghai Key Laboratory of Plant Functional Genomics and Resources, Shanghai Chenshan Botanical Garden, Shanghai, China
| | - Zheng-Shi Wang
- Zhejiang Tiantong Forest Ecosystem National Observation and Research Station, Shanghai Key Lab for Urban Ecological Processes and Eco-Restoration, School of Ecological and Environmental Sciences, East China Normal University, Shanghai, China
| | - Wei-Wei Xu
- Novogene Bioinformatics Institute, Beijing, China
| | - Yang Yang
- Zhejiang Tiantong Forest Ecosystem National Observation and Research Station, Shanghai Key Lab for Urban Ecological Processes and Eco-Restoration, School of Ecological and Environmental Sciences, East China Normal University, Shanghai, China
| | - Run-Guo Zang
- Ecology and Nature Conservation Institute, Chinese Academy of Forestry, Beijing, China
| | - Zhuo-Xin Zu
- Novogene Bioinformatics Institute, Beijing, China
| | - Yuan-Ye Zhang
- Key Laboratory of the Ministry of Education for Coastal and Wetland Ecosystems, College of the Environment and Ecology, Xiamen University, Xiamen, Fujian, China.
| | - Xiao-Yong Chen
- Zhejiang Tiantong Forest Ecosystem National Observation and Research Station, Shanghai Key Lab for Urban Ecological Processes and Eco-Restoration, School of Ecological and Environmental Sciences, East China Normal University, Shanghai, China.
- Shanghai Engineering Research Center of Sustainable Plant Innovation, Shanghai, China.
- Shanghai Institute of Pollution Control and Ecological Security, Shanghai, China.
- Institute of Eco-Chongming, Shanghai, China.
| |
Collapse
|
27
|
Wong YL, Li T, Liu C, Lee HFV, Cheung LYA, Hui ESK, Cao P, Cai J. Reconstruction of multi-phase parametric maps in 4D-magnetic resonance fingerprinting (4D-MRF) by optimization of local T1 and T2 sensitivities. Med Phys 2024. [PMID: 38386904 DOI: 10.1002/mp.17001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/21/2023] [Revised: 01/18/2024] [Accepted: 01/23/2024] [Indexed: 02/24/2024] Open
Abstract
BACKGROUND Time-resolved magnetic resonance fingerprinting (MRF), or 4D-MRF, has been demonstrated its feasibility in motion management in radiotherapy (RT). However, the prohibitive long acquisition time is one of challenges of the clinical implementation of 4D-MRF. The shortening of acquisition time causes data insufficiency in each respiratory phase, leading to poor accuracies and consistencies of the predicted tissues' properties of each phase. PURPOSE To develop a technique for the reconstruction of multi-phase parametric maps in four-dimensional magnetic resonance fingerprinting (4D-MRF) through the optimization of local T1 and T2 sensitivities. METHODS The proposed technique employed an iterative optimization to tailor the data arrangement of each phase by manipulation of inter-phase frames, such that the T1 and T2 sensitivities, which were quantified by the modified Minkowski distance, of the truncated signal evolution curve was maximized. The multi-phase signal evolution curves were modified by sliding window reconstruction and inter-phase frame sharing (SWIFS). Motion correction (MC) and dot product matching were sequentially performed on the modified signal evolution and dictionary to reconstruct the multi-parametric maps. The proposed technique was evaluated by numerical simulations using the extended cardiac-torso (XCAT) phantom with regular and irregular breathing patterns, and by in vivo MRF data of three health volunteers and six liver cancer patients acquired at a 3.0 T scanner. RESULTS In simulation study, the proposed SWIFS approach achieved the overall mean absolute percentage error (MAPE) of 8.62% ± 1.59% and 16.2% ± 3.88% for the eight-phases T1 and T2 maps, respectively, in the sagittal view with irregular breathing patterns. In contrast, the overall MAPE of T1 and T2 maps generated by the conventional approach with multiple MRF repetitions were 22.1% ± 11.0% and 30.8% ± 14.9%, respectively. For in-vivo study, the predicted mean T1 and T2 of liver by the proposed SWIFS approach were 795 ms ± 38.9 ms and 58.3 ms ± 11.7 ms, respectively. CONCLUSIONS Both simulation and in vivo results showed that the approach empowered by T1 and T2 sensitivities optimization and sliding window under the shortened acquisition of MRF had superior performance in the estimation of multi-phase T1 and T2 maps as compared to the conventional approach with oversampling of MRF data.
Collapse
Affiliation(s)
- Yat Lam Wong
- Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong, China
- Department of Clinical Oncology, Queen Mary Hospital, Hong Kong, China
| | - Tian Li
- Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong, China
| | - Chenyang Liu
- Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong, China
| | - Ho-Fun Victor Lee
- Department of Clinical Oncology, The University of Hong Kong, Hong Kong, China
| | - Lai-Yin Andy Cheung
- Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong, China
- Department of Clinical Oncology, Oncology Center, St. Paul's Hospital, Hong Kong, China
| | - Edward Sai Kam Hui
- Department of Imaging and Interventional Radiology, The Chinese University of Hong Kong, Hong Kong, China
| | - Peng Cao
- Department of Diagnostic Radiology, The University of Hong Kong, Hong Kong, China
| | - Jing Cai
- Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong, China
| |
Collapse
|
28
|
Zhu M, Sun S, Huang L, Chen M, Cai J, Wang Z, Cai L. Case report: diagnosis and treatment of advanced high-grade serous ovarian carcinoma aided by 68Ga-FAPI PET/MR scan. Am J Nucl Med Mol Imaging 2024; 14:72-77. [PMID: 38500744 PMCID: PMC10944375] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Received: 11/18/2023] [Accepted: 02/11/2024] [Indexed: 03/20/2024]
Abstract
High-grade serous ovarian cancer (HGSOC) is the most common type of epithelial ovarian cancer with insidious onset, rapid growth, and invasive spread. Here, we reported the diagnosis and treatment of a 53-year-old patient with a history of hysterectomy aided by the 68Ga-FAPI PET/MR scan. The patient was first presented to the local hospital with a lump on the left side of the neck with a biopsy suggesting metastatic cancer. Pelvic ultrasonography revealed two irregular masses. After admission, tumor markers, pathology consultation of the biopsy, and the 68Ga-FAPI PET/MR scan were administered. The biopsy of the lump suggested poorly differentiated adenocarcinoma and CA125 was elevated at 530.6 U/ml. The 68Ga-FAPI PET/MR scan showed several abnormal lymph nodes and two soft tissue masses with borders of dispersed restriction displaying internally uneven signals depicted by slightly elongated T1 and T2 signals within the pelvic cavity suggesting that pelvic mass could be the primary lesion. The patient received cytoreductive surgery including bilateral adnexectomy, omentectomy, and appendectomy. Post-surgical pathology suggested left and right HGSOC with left fallopian tube invasion. The patient completed six courses of first-line chemotherapy and remained progression-free for 14 months up to date. To conclude, 68Ga-FAPI PET/MR aids in primary tumor determination and tumor burden assessment and provides a guide for the management of late-stage HGSOC patients.
Collapse
Affiliation(s)
- Mengna Zhu
- Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan 430022, Hubei, P. R. China
| | - Si Sun
- Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan 430022, Hubei, P. R. China
| | - Lin Huang
- Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan 430022, Hubei, P. R. China
| | - Mengqing Chen
- Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan 430022, Hubei, P. R. China
| | - Jing Cai
- Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan 430022, Hubei, P. R. China
| | - Zehua Wang
- Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan 430022, Hubei, P. R. China
| | - Liqiong Cai
- Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan 430022, Hubei, P. R. China
| |
Collapse
|
29
|
Pan B, Zhao Y, Chen C, Cai J, Li K, Wang Y, Liu J. The relationship between advanced liver fibrosis and osteoporosis in type 2 diabetes patients with MAFLD. Endocrine 2024:10.1007/s12020-024-03724-4. [PMID: 38367145 DOI: 10.1007/s12020-024-03724-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/22/2023] [Accepted: 02/02/2024] [Indexed: 02/19/2024]
Abstract
PURPOSE To investigate the relationship between advanced liver fibrosis and osteoporosis in metabolic-associated fatty liver disease (MAFLD) in patients with type 2 diabetes mellitus (T2DM). METHODS A total of 1144 T2DM patients were divided into the MAFLD and non-MAFLD groups, 460 T2DM patients with MAFLD (277 males aged ≥50 years and 183 postmenopausal females) were divided into N1 (advanced liver fibrosis excluded), N2 (indeterminate advanced liver fibrosis), and N3 (advanced liver fibrosis) groups according to the non-alcoholic fatty liver fibrosis score (NFS), the differences in bone mineral density (BMD) levels and prevalence of osteoporosis were compared. Based on the tertile levels of BMD of the lumbar spine (L), T2DM patients were divided into three groups (T1, T2, and T3), and the differences in the prevalence of advanced liver fibrosis were compared. RESULTS The BMD levels of the L4, and L1-4 in the MAFLD group were lower than those of the non-MAFLD groups in male and female T2DM patients .The BMD levels of the total hip, L4, and L1-4 in the N3 group were lower than those of the N2 and N1 groups in male and female T2DM patients with MAFLD, and the prevalence of osteoporosis in the N3 group of males was higher than that in the N1 group. The BMD levels of the total hip, L4, and L1-4 were negatively correlated with NFS in both males and females. The BMD levels of the total hip and L4 in males, and the BMD level of L4 in females were negatively associated with NFS. The prevalence of advanced liver fibrosis was higher in the T1 group than in the T2 and T3 groups in T2DM patients with MAFLD. CONCLUSION The BMD levels in male aged ≥50 years or postmenopausal female diabetic patients with MAFLD were negatively correlated with the degree of advanced liver fibrosis, which means an increased risk of liver fibrosis with decreasing BMD.
Collapse
Affiliation(s)
- Binjing Pan
- The First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China
| | - Yangting Zhao
- The First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China
| | - Chongyang Chen
- The First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China
| | - Jing Cai
- The First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China
| | - Kai Li
- The First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China
| | - Yawen Wang
- The First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China
| | - Jingfang Liu
- The First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China.
- Department of Endocrinology, the First Hospital of Lanzhou University, Lanzhou, Gansu, China.
| |
Collapse
|
30
|
Cai J, Li S, Wang Q, Deng D, Wang S, Ge L, Cui Y, Shen Y, Shen Q. Developing a detection strategy for ten paralytic shellfish poisonings in urine, combining high-throughput DESI-MS screening and accurate UPLC-QqQ/MS quantification. J Chromatogr B Analyt Technol Biomed Life Sci 2024; 1234:124036. [PMID: 38330520 DOI: 10.1016/j.jchromb.2024.124036] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/14/2023] [Revised: 12/27/2023] [Accepted: 01/25/2024] [Indexed: 02/10/2024]
Abstract
Paralytic shellfish poisoning (PSP) is the most widespread and harmful form of shellfish poisoning with high mortality rate. In this study, a combined desorption electrospray ionization mass spectrometry (DESI-MS) and ultra-performance liquid chromatography triple quadrupole mass spectrometry (UPLC-QqQ/MS) method was established for the detection of PSPs in urine. The method was optimized using a spray solution of methanol and water (1:1, v/v) containing 0.1 % FA, at a flow rate of 2.5 µL·min-1 and an applied voltage of 3 kV. The limit of detection (LOD) for PSPs detection by DESI-MS was in the range of 87-265 μg·L-1, which basically meets the requirements for the rapid screening of PSPs. The LOD for UPLC-QqQ/MS was in the range of 2.2-14.9 μg·L-1, with a limit of quantification (LOQ) of 7.3-49.7 μg·L-1, thus fulfilling the quantitative demand for PSPs in urine. Finally, after spiking the urine samples of six volunteers with PSPs to a concentration of 100 μg·L-1, DESI-MS successfully and efficiently detected the positive samples. Subsequently, UPLC-QqQ/MS was employed for precise quantification, yielding results in the range of 84.6-95.1 μg·L-1. The experimental findings demonstrated that the combination of DESI-MS and UPLC-QqQ/MS enables high-throughput, rapid screening of samples and accurate quantification of positive samples, providing assurance for food safety and human health.
Collapse
Affiliation(s)
- Jing Cai
- Department of Forensic Science, Zhejiang Police College, Hangzhou 310053, China
| | - Shiyan Li
- Aquatic Products Quality Inspection Center of Zhejiang Province, Hangzhou 310012, China
| | - Qingcheng Wang
- Hangzhou Linping Hospital of Traditional Chinese Medicine, Linping 311106, Zhejiang, China
| | - Dan Deng
- Hangzhou Linping Hospital of Traditional Chinese and Western Medicine, Linping 311100, Zhejiang, China
| | - Shitong Wang
- Collaborative Innovation Center of Seafood Deep Processing, Zhejiang Province Joint Key Laboratory of Aquatic Products Processing, Institute of Seafood, Zhejiang Gongshang University, Hangzhou 330009, China
| | - Lijun Ge
- Collaborative Innovation Center of Seafood Deep Processing, Zhejiang Province Joint Key Laboratory of Aquatic Products Processing, Institute of Seafood, Zhejiang Gongshang University, Hangzhou 330009, China
| | - Yiwei Cui
- Collaborative Innovation Center of Seafood Deep Processing, Zhejiang Province Joint Key Laboratory of Aquatic Products Processing, Institute of Seafood, Zhejiang Gongshang University, Hangzhou 330009, China
| | - Yuejian Shen
- Hangzhou Linping Hospital of Traditional Chinese Medicine, Linping 311106, Zhejiang, China.
| | - Qing Shen
- Panvascular Diseases Research Center, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou 324000, China; Collaborative Innovation Center of Seafood Deep Processing, Zhejiang Province Joint Key Laboratory of Aquatic Products Processing, Institute of Seafood, Zhejiang Gongshang University, Hangzhou 330009, China.
| |
Collapse
|
31
|
Liu LJ, Liu CK, Cai J, Deng JJ, He XJ, Zhou SD. The complete plastomes of thirteen Libanotis (Apiaceae, Apioideae) plants: comparative and phylogenetic analyses provide insights into the plastome evolution and taxonomy of Libanotis. BMC Plant Biol 2024; 24:106. [PMID: 38342898 PMCID: PMC10860227 DOI: 10.1186/s12870-024-04784-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/11/2023] [Accepted: 01/30/2024] [Indexed: 02/13/2024]
Abstract
BACKGROUND The genus Libanotis Haller ex Zinn, nom. cons., a contentious member of Apiaceae, encompasses numerous economically and medicinally significant plants, comprising approximately 30 species distributed across Eurasia. Despite many previous taxonomic insights into it, phylogenetic studies of the genus are still lacking. And the establishment of a robust phylogenetic framework remains elusive, impeding advancements and revisions in the taxonomic system for this genus. Plastomes with greater variability in their genetic characteristics hold promise for building a more robust Libanotis phylogeny. RESULTS During our research, we sequenced, assembled, and annotated complete plastomes for twelve Libanotis species belong to three sections and two closely related taxa. We conducted a comprehensive comparative analysis through totally thirteen Libanotis plastomes for the genus, including an additional plastome that had been published. Our results suggested that Libanotis plastome was highly conserved between different subclades, while the coding regions were more conserved than the non-coding regions, and the IR regions were more conserved than the single copy regions. Nevertheless, eight mutation hotspot regions were identified among plastomes, which can be considered as candidate DNA barcodes for accurate species identification in Libanotis. The phylogenetic analyses generated a robustly framework for Libanotis and revealed that Libanotis was not a monophyletic group and their all three sections were polygenetic. Libanotis schrenkiana was sister to L. sibirica, type species of this genus, but the remainders scattered within Selineae. CONCLUSION The plastomes of Libanotis exhibited a high degree of conservation and was effective in enhancing the support and resolution of phylogenetic analyses within this genus. Based on evidence from both phylogeny and morphology, we propose the recognition of "Libanotis sensu stricto" and provide taxonomic recommendations for other taxa that previously belonged to Libanotis. In conclusion, our study not only revealed the phylogenetic position and plastid evolution of Libanotis, but also provided new insights into the phylogeny of the family Apiaceae and phylogenetic relationships within the tribe Selineae.
Collapse
Affiliation(s)
- Li-Jia Liu
- Key Laboratory of Bio‑Resources and Eco‑Environment of Ministry of Education, College of Life Sciences, Sichuan University, Chengdu, 610065, China
| | - Chang-Kun Liu
- Key Laboratory of Bio‑Resources and Eco‑Environment of Ministry of Education, College of Life Sciences, Sichuan University, Chengdu, 610065, China
- College of Resources Environment and Chemistry, Chuxiong Normal University, Chuxiong, 675000, China
| | - Jing Cai
- Key Laboratory of Bio‑Resources and Eco‑Environment of Ministry of Education, College of Life Sciences, Sichuan University, Chengdu, 610065, China
| | - Jiao-Jiao Deng
- Key Laboratory of Bio‑Resources and Eco‑Environment of Ministry of Education, College of Life Sciences, Sichuan University, Chengdu, 610065, China
| | - Xing-Jin He
- Key Laboratory of Bio‑Resources and Eco‑Environment of Ministry of Education, College of Life Sciences, Sichuan University, Chengdu, 610065, China.
| | - Song-Dong Zhou
- Key Laboratory of Bio‑Resources and Eco‑Environment of Ministry of Education, College of Life Sciences, Sichuan University, Chengdu, 610065, China.
| |
Collapse
|
32
|
Aleksa P, Ghorbani-Asl M, Iqbal S, Martuza MA, Bremerich A, Wilks D, Cai J, Chagas T, Ohmann R, Krasheninnikov A, Busse C. Transition from fractal-dendritic to compact islands for the 2D-ferroelectric SnSe on graphene/Ir(111). Nanotechnology 2024; 35:175707. [PMID: 38253004 DOI: 10.1088/1361-6528/ad2156] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/04/2023] [Accepted: 01/22/2024] [Indexed: 01/24/2024]
Abstract
Epitaxial growth is a versatile method to prepare two-dimensional van der Waals ferroelectrics like group IV monochalcogenides which have potential for novel electronic devices and sensors. We systematically study SnSe monolayer islands grown by molecular beam epitaxy, especially the effect of annealing temperature on shape and morphology of the edges. Characterization of the samples by scanning tunneling microscopy reveals that the shape of the islands changes from fractal-dendritic after deposition at room temperature to a compact rhombic shape through annealing, but ripening processes are absent up to the desorption temperature. A two-step growth process leads to large, epitaxially aligned rhombic islands bounded by well-defined110-edges (armchair-like), which we claim to be the equilibrium shape of the stoichiometric SnSe monolayer islands. The relaxation of the energetically favorable edges is detected in atomically resolved STM images. The experimental findings are supported by the results of our first-principles calculations, which provide insights into the energetics of the edges, their reconstructions, and yields the equilibrium shapes of the islands which are in good agreement with the experiment.
Collapse
Affiliation(s)
- P Aleksa
- Department Physik, Universität Siegen, D-57072 Siegen, Germany
| | - M Ghorbani-Asl
- Institute of Ion Beam Physics and Materials Research Helmholtz-Zentrum Dresden-Rossendorf D-01328 Dresden, Germany
| | - S Iqbal
- Department Physik, Universität Siegen, D-57072 Siegen, Germany
| | - M A Martuza
- Department Physik, Universität Siegen, D-57072 Siegen, Germany
| | - A Bremerich
- Department Physik, Universität Siegen, D-57072 Siegen, Germany
| | - D Wilks
- Department Physik, Universität Siegen, D-57072 Siegen, Germany
| | - J Cai
- Department Physik, Universität Siegen, D-57072 Siegen, Germany
| | - T Chagas
- Department Physik, Universität Siegen, D-57072 Siegen, Germany
| | - R Ohmann
- Department Physik, Universität Siegen, D-57072 Siegen, Germany
| | - A Krasheninnikov
- Institute of Ion Beam Physics and Materials Research Helmholtz-Zentrum Dresden-Rossendorf D-01328 Dresden, Germany
- Department of Applied Physics, Aalto University, PO Box 11100, FI-00076 Aalto, Finland
| | - C Busse
- Department Physik, Universität Siegen, D-57072 Siegen, Germany
| |
Collapse
|
33
|
Zhu S, Xu X, Zou R, Lu Z, Yan Y, Li S, Wu Y, Cai J, Li L, Xiang J, Huang Q. Nomograms for assessing the rupture risk of anterior choroid artery aneurysms based on clinical, morphological, and hemodynamic features. Front Neurol 2024; 15:1304270. [PMID: 38390597 PMCID: PMC10882079 DOI: 10.3389/fneur.2024.1304270] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/29/2023] [Accepted: 01/17/2024] [Indexed: 02/24/2024] Open
Abstract
Background and purpose A notable prevalence of subarachnoid hemorrhage is evident among patients with anterior choroidal artery aneurysms in clinical practice. To evaluate the risk of rupture in unruptured anterior choroidal artery aneurysms, we conducted a comprehensive analysis of risk factors and subsequently developed two nomograms. Methods A total of 120 cases of anterior choroidal artery aneurysms (66 unruptured and 54 ruptured) from 4 medical institutions were assessed utilizing computational fluid dynamics (CFD) and digital subtraction angiography (DSA). The training set, consisting of 98 aneurysms from 3 hospitals, was established, with an additional 22 cases from the fourth hospital forming the external validation set. Statistical differences between the two data sets were thoroughly compared. The significance of 9 clinical baseline characteristics, 11 aneurysm morphology parameters, and 4 hemodynamic parameters concerning aneurysm rupture was evaluated within the training set. Candidate selection for constructing the nomogram models involved regression analysis and variance inflation factors. Discrimination, calibration, and clinical utility of the models in both training and validation sets were assessed using area under curves (AUC), calibration plots, and decision curve analysis (DCA). The DeLong test, net reclassification index (NRI), and integrated discrimination improvement (IDI) were employed to compare the effectiveness of classification across models. Results Two nomogram models were ultimately constructed: model 1, incorporating clinical, morphological, and hemodynamic parameters (C + M + H), and model 2, relying primarily on clinical and morphological parameters (C + M). Multivariate analysis identified smoking, size ratio (SR), normalized wall shear stress (NWSS), and average oscillatory shear index (OSIave) as optimal candidates for model development. In the training set, model 1 (C + M + H) achieved an AUC of 0.795 (95% CI: 0.706 ~ 0.884), demonstrating a sensitivity of 95.6% and a specificity of 54.7%. Model 2 (C + M) had an AUC of 0.706 (95% CI: 0.604 ~ 0.808), with corresponding sensitivity and specificity of 82.4 and 50.3%, respectively. Similarly, AUCs for models 1 and 2 in the external validation set were calculated to be 0.709 and 0.674, respectively. Calibration plots illustrated a consistent correlation between model evaluations and real-world observations in both sets. DCA demonstrated that the model incorporating hemodynamic parameters offered higher clinical benefits. In the training set, NRI (0.224, p = 0.007), IDI (0.585, p = 0.002), and DeLong test (change = 0.089, p = 0.008) were all significant. In the external validation set, NRI, IDI, and DeLong test statistics were 0.624 (p = 0.063), 0.572 (p = 0.044), and 0.035 (p = 0.047), respectively. Conclusion Multidimensional nomograms have the potential to enhance risk assessment and patient-specific treatment of anterior choroidal artery aneurysms. Validated by an external cohort, the model incorporating clinical, morphological, and hemodynamic features may provide improved classification of rupture states.
Collapse
Affiliation(s)
- Shijie Zhu
- Department of Neurovascular Center, Changhai Hospital, Naval Medical University, Shanghai, China
| | - Xiaolong Xu
- Department of Neurovascular Center, Changhai Hospital, Naval Medical University, Shanghai, China
| | - Rong Zou
- ArteryFlow Technology Co., Ltd., Hangzhou, Zhejiang, China
| | - Zhiwen Lu
- Department of Neurovascular Center, Changhai Hospital, Naval Medical University, Shanghai, China
| | - Yazhou Yan
- Department of Neurosurgery, 971 Hospital of People's Liberation Army (PLA), Qingdao, China
| | - Siqi Li
- Department of Neurovascular Center, Changhai Hospital, Naval Medical University, Shanghai, China
| | - Yina Wu
- Department of Neurovascular Center, Changhai Hospital, Naval Medical University, Shanghai, China
| | - Jing Cai
- Department of Neurosurgery, Linyi People's Hospital, Linyi, China
| | - Li Li
- Cerebrovascular Department of Interventional Center, Henan Provincial People's Hospital, Zhengzhou, China
| | - Jianping Xiang
- ArteryFlow Technology Co., Ltd., Hangzhou, Zhejiang, China
| | - Qinghai Huang
- Department of Neurovascular Center, Changhai Hospital, Naval Medical University, Shanghai, China
| |
Collapse
|
34
|
Cai J, Jiang Y, Xu Y, Jiang Z, Young C, Li H, Ortiz-Guzman J, Zhuo Y, Li Y, Xu Y, Arenkiel BR, Tong Q. An excitatory projection from the basal forebrain to the ventral tegmental area that underlies anorexia-like phenotypes. Neuron 2024; 112:458-472.e6. [PMID: 38056455 PMCID: PMC10922337 DOI: 10.1016/j.neuron.2023.11.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/10/2023] [Revised: 10/04/2023] [Accepted: 11/03/2023] [Indexed: 12/08/2023]
Abstract
Maladaptation in balancing internal energy needs and external threat cues may result in eating disorders. However, brain mechanisms underlying such maladaptations remain elusive. Here, we identified that the basal forebrain (BF) sends glutamatergic projections to glutamatergic neurons in the ventral tegmental area (VTA) in mice. Glutamatergic neurons in both regions displayed correlated responses to various stressors. Notably, in vivo manipulation of BF terminals in the VTA revealed that the glutamatergic BF → VTA circuit reduces appetite, increases locomotion, and elicits avoidance. Consistently, activation of VTA glutamatergic neurons reduced body weight, blunted food motivation, and caused hyperactivity with behavioral signs of anxiety, all hallmarks of typical anorexia symptoms. Importantly, activation of BF glutamatergic terminals in the VTA reduced dopamine release in the nucleus accumbens. Collectively, our results point to overactivation of the glutamatergic BF → VTA circuit as a potential cause of anorexia-like phenotypes involving reduced dopamine release.
Collapse
Affiliation(s)
- Jing Cai
- Brown Foundation of Molecular Medicine for the Prevention of Human Diseases of McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX 77030, USA; MD Anderson Cancer Center & UTHealth Graduate School for Biomedical Sciences, University of Texas Health Science at Houston, Houston, TX 77030, USA
| | - Yanyan Jiang
- Brown Foundation of Molecular Medicine for the Prevention of Human Diseases of McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX 77030, USA
| | - Yuanzhong Xu
- Brown Foundation of Molecular Medicine for the Prevention of Human Diseases of McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX 77030, USA
| | - Zhiying Jiang
- Brown Foundation of Molecular Medicine for the Prevention of Human Diseases of McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX 77030, USA
| | - Claire Young
- Brown Foundation of Molecular Medicine for the Prevention of Human Diseases of McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX 77030, USA
| | - Hongli Li
- Brown Foundation of Molecular Medicine for the Prevention of Human Diseases of McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX 77030, USA
| | - Joshua Ortiz-Guzman
- Department of Molecular and Human Genetics and Department of Neuroscience, Baylor College of Medicine, and Jan and Dan Duncan Neurological Research Institute, Texas Children's Hospital, Houston, TX 77030, USA
| | - Yizhou Zhuo
- State Key Laboratory of Membrane Biology, Peking University School of Life Sciences, PKU-IDG/McGovern Institute for Brain Research, Beijing 100871, China
| | - Yulong Li
- State Key Laboratory of Membrane Biology, Peking University School of Life Sciences, PKU-IDG/McGovern Institute for Brain Research, Beijing 100871, China
| | - Yong Xu
- USDA/ARS Children's Nutrition Research Center, Department of Pediatrics, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA
| | - Benjamin R Arenkiel
- Department of Molecular and Human Genetics and Department of Neuroscience, Baylor College of Medicine, and Jan and Dan Duncan Neurological Research Institute, Texas Children's Hospital, Houston, TX 77030, USA; USDA/ARS Children's Nutrition Research Center, Department of Pediatrics, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA.
| | - Qingchun Tong
- Brown Foundation of Molecular Medicine for the Prevention of Human Diseases of McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX 77030, USA; MD Anderson Cancer Center & UTHealth Graduate School for Biomedical Sciences, University of Texas Health Science at Houston, Houston, TX 77030, USA; Department of Neurobiology and Anatomy of McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX 77030, USA.
| |
Collapse
|
35
|
Zhong Z, Tan X, An X, Li J, Cai J, Jiang Y, Taufique SKT, Li B, Shi Q, Zhao M, Wang Y, Luo Q, Wang H. Administration of blue light in the morning and no blue-ray light in the evening improves the circadian functions of non-24-hour shift workers. Chronobiol Int 2024; 41:267-282. [PMID: 38267234 DOI: 10.1080/07420528.2024.2305218] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2023] [Accepted: 01/07/2024] [Indexed: 01/26/2024]
Abstract
In modern 24-hour society, various round-the-clock services have entailed shift work, resulting in non-24-hour schedules. However, the extent of behavioral and physiological alterations by non-24-hour schedules remains unclear, and particularly, effective interventions to restore the circadian functions of non-24-hour shift workers are rarely explored. In this study, we investigate the effects of a simulated non-24-hour military shift work schedule on daily rhythms and sleep, and establish an intervention measure to restore the circadian functions of non-24-hour shift workers. The three stages of experiments were conducted. The stage-one experiment was to establish a comprehensive evaluation index of the circadian rhythms and sleep for all 60 participants by analyzing wristwatch-recorded physiological parameters and sleep. The stage-two experiment evaluated the effects of an intervention strategy on physiological rhythms and sleep. The stage-three experiment was to examine the participants' physiological and behavioral disturbances under the simulated non-24-hour military shift work schedule and their improvements by the optimal lighting apparatus. We found that wristwatch-recorded physiological parameters display robust rhythmicity, and the phases of systolic blood pressures and heart rates can be used as reliable estimators for the human body time. The simulated non-24-hour military shift work schedule significantly disrupts the daily rhythms of oxygen saturation levels, blood pressures, heart rates, and reduces sleep quality. Administration of blue light in the morning and no blue-ray light in the evening improves the amplitude and synchronization of daily rhythms of the non-24-hour participants. These findings demonstrate the harmful consequences of the non-24-hour shift work schedule and provide a non-invasive strategy to improve the well-being and work efficiency of the non-24-hour shift population.
Collapse
Affiliation(s)
- Zhaomin Zhong
- Center for Circadian Clocks, Soochow University, Suzhou, Jiangsu, China
- School of Biology & Basic Medical Sciences, Suzhou Medical College, Soochow University, Suzhou, Jiangsu, China
| | - Xiaohui Tan
- Center for Circadian Clocks, Soochow University, Suzhou, Jiangsu, China
- School of Biology & Basic Medical Sciences, Suzhou Medical College, Soochow University, Suzhou, Jiangsu, China
| | - Xingna An
- Center for Circadian Clocks, Soochow University, Suzhou, Jiangsu, China
- School of Biology & Basic Medical Sciences, Suzhou Medical College, Soochow University, Suzhou, Jiangsu, China
| | - Jie Li
- Center for Circadian Clocks, Soochow University, Suzhou, Jiangsu, China
- School of Biology & Basic Medical Sciences, Suzhou Medical College, Soochow University, Suzhou, Jiangsu, China
| | - Jing Cai
- Center for Circadian Clocks, Soochow University, Suzhou, Jiangsu, China
- School of Biology & Basic Medical Sciences, Suzhou Medical College, Soochow University, Suzhou, Jiangsu, China
| | - Yunchun Jiang
- Center for Circadian Clocks, Soochow University, Suzhou, Jiangsu, China
- School of Biology & Basic Medical Sciences, Suzhou Medical College, Soochow University, Suzhou, Jiangsu, China
| | - S K Tahajjul Taufique
- Center for Circadian Clocks, Soochow University, Suzhou, Jiangsu, China
- School of Biology & Basic Medical Sciences, Suzhou Medical College, Soochow University, Suzhou, Jiangsu, China
| | - Bo Li
- Center for Circadian Clocks, Soochow University, Suzhou, Jiangsu, China
- School of Biology & Basic Medical Sciences, Suzhou Medical College, Soochow University, Suzhou, Jiangsu, China
| | - Quan Shi
- Center for Circadian Clocks, Soochow University, Suzhou, Jiangsu, China
- School of Biology & Basic Medical Sciences, Suzhou Medical College, Soochow University, Suzhou, Jiangsu, China
| | - Meng Zhao
- Center for Circadian Clocks, Soochow University, Suzhou, Jiangsu, China
- School of Biology & Basic Medical Sciences, Suzhou Medical College, Soochow University, Suzhou, Jiangsu, China
| | - Yali Wang
- Department of Neurology, Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China
| | - Qun Luo
- Naval Medical Center, PLA Naval Medical University, Shanghai, China
| | - Han Wang
- Center for Circadian Clocks, Soochow University, Suzhou, Jiangsu, China
- School of Biology & Basic Medical Sciences, Suzhou Medical College, Soochow University, Suzhou, Jiangsu, China
| |
Collapse
|
36
|
Chen Z, Wo BWB, Chan OL, Huang YH, Teng X, Zhang J, Dong Y, Xiao L, Ren G, Cai J. Deep learning-based bronchial tree-guided semi-automatic segmentation of pulmonary segments in computed tomography images. Quant Imaging Med Surg 2024; 14:1636-1651. [PMID: 38415134 PMCID: PMC10895116 DOI: 10.21037/qims-23-1251] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2023] [Accepted: 11/23/2023] [Indexed: 02/29/2024]
Abstract
Background Pulmonary segments are valuable because they can provide more precise localization and intricate details of lung cancer than lung lobes. With advances in precision therapy, there is an increasing demand for the identification and visualization of pulmonary segments in computed tomography (CT) images to aid in the precise treatment of lung cancer. This study aimed to integrate multiple deep-learning models to accurately segment pulmonary segments in CT images using a bronchial tree (BT)-based approach. Methods The proposed segmentation method for pulmonary segments using the BT-based approach comprised the following five essential steps: (I) segmentation of the lung using a U-Net (R231) (public access) model; (II) segmentation of the lobes using a V-Net (self-developed) model; (III) segmentation of the airway using a combination of a differential geometric approach method and a BronchiNet (public access) model; (IV) labeling of the BT branches based on anatomical position; and (V) segmentation of the pulmonary segments based on the distance of each voxel to the labeled BT branches. This five-step process was applied to 14 high-resolution breath-hold CT images and compared against manual segmentations for evaluation. Results For the lung segmentation, the lung mask had a mean dice similarity coefficient (DSC) of 0.98±0.03. For the lobe segmentation, the V-Net model had a mean DSC of 0.94±0.06. For the airway segmentation, the average total length of the segmented airway trees per image scan was 1,902.8±502.1 mm, and the average number of the maximum airway tree generations was 8.5±1.3. For the segmentation of the pulmonary segments, the proposed method had a DSC of 0.73±0.11 and a mean surface distance of 6.1±2.9 mm. Conclusions This study demonstrated the feasibility of combining multiple deep-learning models for the auxiliary segmentation of pulmonary segments on CT images using a BT-based approach. The results highlighted the potential of the BT-based method for the semi-automatic segmentation of the pulmonary segment.
Collapse
Affiliation(s)
- Zhi Chen
- Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong, China
| | - Bar Wai Barry Wo
- Department of Clinical Oncology, Tuen Mun Hospital, Hong Kong, China
| | - Oi Ling Chan
- Department of Radiology, Tuen Mun Hospital, Hong Kong, China
| | - Yu-Hua Huang
- Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong, China
| | - Xinzhi Teng
- Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong, China
| | - Jiang Zhang
- Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong, China
| | - Yanjing Dong
- Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong, China
| | - Li Xiao
- Department of Clinical Oncology, Tuen Mun Hospital, Hong Kong, China
| | - Ge Ren
- Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong, China
| | - Jing Cai
- Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong, China
| |
Collapse
|
37
|
Khanna AR, Muñoz W, Kim YJ, Kfir Y, Paulk AC, Jamali M, Cai J, Mustroph ML, Caprara I, Hardstone R, Mejdell M, Meszéna D, Zuckerman A, Schweitzer J, Cash S, Williams ZM. Single-neuronal elements of speech production in humans. Nature 2024; 626:603-610. [PMID: 38297120 PMCID: PMC10866697 DOI: 10.1038/s41586-023-06982-w] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/22/2023] [Accepted: 12/14/2023] [Indexed: 02/02/2024]
Abstract
Humans are capable of generating extraordinarily diverse articulatory movement combinations to produce meaningful speech. This ability to orchestrate specific phonetic sequences, and their syllabification and inflection over subsecond timescales allows us to produce thousands of word sounds and is a core component of language1,2. The fundamental cellular units and constructs by which we plan and produce words during speech, however, remain largely unknown. Here, using acute ultrahigh-density Neuropixels recordings capable of sampling across the cortical column in humans, we discover neurons in the language-dominant prefrontal cortex that encoded detailed information about the phonetic arrangement and composition of planned words during the production of natural speech. These neurons represented the specific order and structure of articulatory events before utterance and reflected the segmentation of phonetic sequences into distinct syllables. They also accurately predicted the phonetic, syllabic and morphological components of upcoming words and showed a temporally ordered dynamic. Collectively, we show how these mixtures of cells are broadly organized along the cortical column and how their activity patterns transition from articulation planning to production. We also demonstrate how these cells reliably track the detailed composition of consonant and vowel sounds during perception and how they distinguish processes specifically related to speaking from those related to listening. Together, these findings reveal a remarkably structured organization and encoding cascade of phonetic representations by prefrontal neurons in humans and demonstrate a cellular process that can support the production of speech.
Collapse
Affiliation(s)
- Arjun R Khanna
- Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
| | - William Muñoz
- Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
| | | | - Yoav Kfir
- Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
| | - Angelique C Paulk
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
| | - Mohsen Jamali
- Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
| | - Jing Cai
- Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
| | - Martina L Mustroph
- Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
| | - Irene Caprara
- Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
| | - Richard Hardstone
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
| | - Mackenna Mejdell
- Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
| | - Domokos Meszéna
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
| | | | - Jeffrey Schweitzer
- Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
| | - Sydney Cash
- Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
| | - Ziv M Williams
- Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
- Harvard-MIT Division of Health Sciences and Technology, Boston, MA, USA.
- Harvard Medical School, Program in Neuroscience, Boston, MA, USA.
| |
Collapse
|
38
|
Cai J, Du L, Chen C, Xu X, Li Y, Yang X, Chen X, Yu J, Zhang X. Status and Influencing Factors of Body Image Disturbance in Patients With Hemifacial Spasm: A Quantitative and Qualitative Study. World Neurosurg 2024; 182:e186-e195. [PMID: 38006931 DOI: 10.1016/j.wneu.2023.11.072] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/25/2023] [Revised: 11/15/2023] [Accepted: 11/16/2023] [Indexed: 11/27/2023]
Abstract
OBJECTIVE Patients diagnosed with hemifacial spasm (HFS) often experience significant facial changes that affect their body image and potentially have a negative impact on their physical and psychological well-being. This study therefore seeks to identify the current state of body image of Chinese patients with HFS, analyze the factors that influence it, and further explore their experiences based on their level of body image disturbance (BID) using a mixed methods approach. METHODS A mixed-methods study was conducted between January 2021 and June 2023. Phase I encompassed the completion of questionnaires by 124 participants. Subsequently, in Phase II, in-depth interviews were conducted with 15 individuals selected from Phase I to gain deeper insights into their specific experiences with BID. RESULTS Patients afflicted with HFS achieved Body Image Scale scores 9.00 (0.00, 12.00). Age, anxiety, depression, and fear of negative evaluation were identified as predictors of exacerbated BID (P < 0.05). Qualitative research predominantly centered on 2 primary themes: the experiences and outward manifestations of BID in HFS patients. These individuals expressed dissatisfaction with their appearance, apprehensions about being the focus of attention, and instances of social avoidance. CONCLUSIONS Owing to varying degrees of anxiety, depression, and apprehension about external evaluation, individuals grappling with HFS are susceptible to experiencing BID. Consequently, when devising interventions, it is imperative to conduct a comprehensive assessment of the patient's condition and implement targeted measures aimed at ameliorating body image, ultimately enhancing the overall quality of life for the patient.
Collapse
Affiliation(s)
- Jing Cai
- Department of Nursing, Medical School of Nantong University, Nantong, China; Department of Nursing, Affiliated Hospital of Nantong University, Nantong, China
| | - Linjing Du
- Department of Nursing, Medical School of Nantong University, Nantong, China; Department of Nursing, Affiliated Hospital of Nantong University, Nantong, China
| | - Chunxiang Chen
- Department of Nursing, Affiliated Hospital of Nantong University, Nantong, China; Department of Neurosurgery, Affiliated Hospital of Nantong University, Nantong, China
| | - Xiuqun Xu
- Department of Nursing, Affiliated Hospital of Nantong University, Nantong, China; Department of Neurosurgery, Affiliated Hospital of Nantong University, Nantong, China
| | - Yanqing Li
- Department of Nursing, Affiliated Hospital of Nantong University, Nantong, China
| | - Xueni Yang
- Department of Nursing, Medical School of Nantong University, Nantong, China; Department of Nursing, Affiliated Hospital of Nantong University, Nantong, China
| | - Xing Chen
- Department of Nursing, Medical School of Nantong University, Nantong, China; Department of Nursing, Affiliated Hospital of Nantong University, Nantong, China
| | - Jiahui Yu
- Department of Nursing, Medical School of Nantong University, Nantong, China; Department of Nursing, Affiliated Hospital of Nantong University, Nantong, China
| | - Xiaomei Zhang
- Department of Nursing, Affiliated Hospital of Nantong University, Nantong, China; Department of Neurosurgery, Affiliated Hospital of Nantong University, Nantong, China.
| |
Collapse
|
39
|
Shao X, Tian Y, Liu J, Yan Z, Ding Y, Hao X, Wang D, Shen L, Luo E, Guo XE, Luo P, Luo W, Cai J, Jing D. Rescuing SERCA2 pump deficiency improves bone mechano-responsiveness in type 2 diabetes by shaping osteocyte calcium dynamics. Nat Commun 2024; 15:890. [PMID: 38291059 PMCID: PMC10828510 DOI: 10.1038/s41467-024-45023-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/17/2022] [Accepted: 01/12/2024] [Indexed: 02/01/2024] Open
Abstract
Type 2 diabetes (T2D)-related fragility fractures represent an increasingly tough medical challenge, and the current treatment options are limited. Mechanical loading is essential for maintaining bone integrity, although bone mechano-responsiveness in T2D remains poorly characterized. Herein, we report that exogenous cyclic loading-induced improvements in bone architecture and strength are compromised in both genetically spontaneous and experimentally-induced T2D mice. T2D-induced reduction in bone mechano-responsiveness is directly associated with the weakened Ca2+ oscillatory dynamics of osteocytes, although not those of osteoblasts, which is dependent on PPARα-mediated specific reduction in osteocytic SERCA2 pump expression. Treatment with the SERCA2 agonist istaroxime was demonstrated to improve T2D bone mechano-responsiveness by rescuing osteocyte Ca2+ dynamics and the associated regulation of osteoblasts and osteoclasts. Moreover, T2D-induced deterioration of bone mechano-responsiveness is blunted in mice with osteocytic SERCA2 overexpression. Collectively, our study provides mechanistic insights into T2D-mediated deterioration of bone mechano-responsiveness and identifies a promising countermeasure against T2D-associated fragility fractures.
Collapse
Affiliation(s)
- Xi Shao
- Department of Biomedical Engineering, Fourth Military Medical University, Xi'an, China
| | - Yulan Tian
- Department of Biomedical Engineering, Fourth Military Medical University, Xi'an, China
| | - Juan Liu
- Department of Biomedical Engineering, Fourth Military Medical University, Xi'an, China
| | - Zedong Yan
- Department of Biomedical Engineering, Fourth Military Medical University, Xi'an, China
| | - Yuanjun Ding
- Department of Biomedical Engineering, Fourth Military Medical University, Xi'an, China
| | - Xiaoxia Hao
- Department of Biomedical Engineering, Fourth Military Medical University, Xi'an, China
| | - Dan Wang
- Department of Biomedical Engineering, Fourth Military Medical University, Xi'an, China
| | - Liangliang Shen
- The State Key Laboratory of Cancer Biology, Department of Biochemistry and Molecular Biology, Fourth Military Medical University, Xi'an, China
| | - Erping Luo
- Department of Biomedical Engineering, Fourth Military Medical University, Xi'an, China
| | - X Edward Guo
- Bone Bioengineering Laboratory, Department of Biomedical Engineering, Columbia University, New York, NY, USA
| | - Peng Luo
- Department of Neurosurgery, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
| | - Wenjing Luo
- The Ministry of Education Key Lab of Hazard Assessment and Control in Special Operational Environment, Fourth Military Medical University, Xi'an, China.
| | - Jing Cai
- College of Basic Medicine, Shaanxi University of Chinese Medicine, Xianyang, China.
| | - Da Jing
- Department of Biomedical Engineering, Fourth Military Medical University, Xi'an, China.
- The Ministry of Education Key Lab of Hazard Assessment and Control in Special Operational Environment, Fourth Military Medical University, Xi'an, China.
| |
Collapse
|
40
|
Cai J, Zhang ZX, Qiao T, Li XQ, Wang W. [To investigate the role of the AAC-8 scoring in predicting restenosis or occlusion of lower extremity arteries after dilatation and angioplasty with DCB]. Zhonghua Yi Xue Za Zhi 2024; 104:332-336. [PMID: 38281800 DOI: 10.3760/cma.j.cn112137-20231007-00659] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 01/30/2024]
Abstract
Objective: To investigate the role of the Abdominal Aortic Calcification-8 (AAC-8) scoring system in predicting restenosis or occlusion of lower extremity arteries after dilatation and angioplasty with drug-coated balloon (DCB). Methods: In this retrospective study, 62 patients who underwent dilatation and angioplasty with DCB for lower limb atherosclerotic obliterans (ASO) were enrolled from September 2018 to June 2022 in Nanjing Drum Tower Hospital Affiliated to Nanjing University Medical School. Among them who aged (73.9±11.3) years, 37 were males and 25 were females. Patients were divided into two groups according to the condition of the lower extremity arteries after dilatation and angioplasty with DCB: recurrence group (n=26) and patency group (n=36). Logistic regression was used to analyze the factors associated with restenosis or occlusion of lower extremity arteries after dilatation and angioplasty with DCB. The predictive value of the AAC-8 score for restenosis or occlusion of the lower extremity arteries after dilatation and angioplasty with DCB was analyzed using the receiver operating characteristic curves (ROC curves). Results: The postoperative follow-up was 16.30 (10.97, 24.10) months in the patency group and 9.03 (6.98, 15.31) months in the recurrence group. The results of multifactorial logistic regression analysis showed that an elevated AAC-8 score (OR=1.388, 95%CI: 1.067-1.806, P=0.015) was an associated factor of restenosis or occlusion of the lower extremity arteries after dilatation and angioplasty with DCB. The ROC curve analysis showed that the area under the curve (AUC) of the AAC-8 score for predicting restenosis or occlusion of the lower extremity arteries after dilatation and angioplasty with DCB was 0.687 (95%CI: 0.550-0.824, P=0.013), with a cut-off value of 5.5 points, a sensitivity of 65.4% and a specificity of 69.5%. Conclusions: Elevated AAC-8 score is associated with restenosis or occlusion of the lower extremity arteries after dilatation and angioplasty with DCB. When the cut-off value is 5.5, the AAC-8 score predicts restenosis or occlusion of the lower extremity arteries after DCB dilation and angioplasty with a sensitivity of 65.4% and a specificity of 69.5%.
Collapse
Affiliation(s)
- J Cai
- Department of Vascular Surgery, Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School, Nanjing 210008, China
| | - Z X Zhang
- Department of Vascular Surgery, Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School, Nanjing 210008, China
| | - T Qiao
- Department of Vascular Surgery, Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School, Nanjing 210008, China
| | - X Q Li
- Department of Vascular Surgery, Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School, Nanjing 210008, China
| | - W Wang
- Department of Vascular Surgery, Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School, Nanjing 210008, China
| |
Collapse
|
41
|
Guo W, Li B, Xu W, Cheng C, Qiu C, Sam SK, Zhang J, Teng X, Meng L, Zheng X, Wang Y, Lou Z, Mao R, Lei H, Zhang Y, Zhou T, Li A, Cai J, Ge H. Multi-omics and Multi-VOIs to predict esophageal fistula in esophageal cancer patients treated with radiotherapy. J Cancer Res Clin Oncol 2024; 150:39. [PMID: 38280037 PMCID: PMC10821966 DOI: 10.1007/s00432-023-05520-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/10/2023] [Accepted: 11/20/2023] [Indexed: 01/29/2024]
Abstract
OBJECTIVE This study aimed to develop a prediction model for esophageal fistula (EF) in esophageal cancer (EC) patients treated with intensity-modulated radiation therapy (IMRT), by integrating multi-omics features from multiple volumes of interest (VOIs). METHODS We retrospectively analyzed pretreatment planning computed tomographic (CT) images, three-dimensional dose distributions, and clinical factors of 287 EC patients. Nine groups of features from different combination of omics [Radiomics (R), Dosiomics (D), and RD (the combination of R and D)], and VOIs [esophagus (ESO), gross tumor volume (GTV), and EG (the combination of ESO and GTV)] were extracted and separately selected by unsupervised (analysis of variance (ANOVA) and Pearson correlation test) and supervised (Student T test) approaches. The final model performance was evaluated using five metrics: average area under the receiver-operator-characteristics curve (AUC), accuracy, precision, recall, and F1 score. RESULTS For multi-omics using RD features, the model performance in EG model shows: AUC, 0.817 ± 0.031; 95% CI 0.805, 0.825; p < 0.001, which is better than single VOI (ESO or GTV). CONCLUSION Integrating multi-omics features from multi-VOIs enables better prediction of EF in EC patients treated with IMRT. The incorporation of dosiomics features can enhance the model performance of the prediction.
Collapse
Affiliation(s)
- Wei Guo
- Department of Radiation Oncology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, 127 Dong Ming Rd, Zhengzhou, Henan Province, China
| | - Bing Li
- Department of Radiation Oncology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, 127 Dong Ming Rd, Zhengzhou, Henan Province, China
| | - Wencai Xu
- Department of Radiation Oncology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, 127 Dong Ming Rd, Zhengzhou, Henan Province, China
| | - Chen Cheng
- Department of Radiation Oncology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, 127 Dong Ming Rd, Zhengzhou, Henan Province, China
| | - Chengyu Qiu
- Department of Medical Informatics, Nantong University, Nantong, China
| | - Sai-Kit Sam
- Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong SAR, China
| | - Jiang Zhang
- Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong SAR, China
| | - Xinzhi Teng
- Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong SAR, China
| | - Lingguang Meng
- Department of Radiation Oncology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, 127 Dong Ming Rd, Zhengzhou, Henan Province, China
| | - Xiaoli Zheng
- Department of Radiation Oncology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, 127 Dong Ming Rd, Zhengzhou, Henan Province, China
| | - Yuan Wang
- Department of Radiation Oncology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, 127 Dong Ming Rd, Zhengzhou, Henan Province, China
| | - Zhaoyang Lou
- Department of Radiation Oncology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, 127 Dong Ming Rd, Zhengzhou, Henan Province, China
| | - Ronghu Mao
- Department of Radiation Oncology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, 127 Dong Ming Rd, Zhengzhou, Henan Province, China
| | - Hongchang Lei
- Department of Radiation Oncology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, 127 Dong Ming Rd, Zhengzhou, Henan Province, China
| | - Yuanpeng Zhang
- Department of Medical Informatics, Nantong University, Nantong, China
| | - Ta Zhou
- School of Electrical and Information Engineering, Jiangsu University of Science and Technology, Zhenjiang, China
| | - Aijia Li
- Zhengzhou University School of Medicine, Zhengzhou, China
| | - Jing Cai
- Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong SAR, China
| | - Hong Ge
- Department of Radiation Oncology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, 127 Dong Ming Rd, Zhengzhou, Henan Province, China.
| |
Collapse
|
42
|
Wang Q, Cai J, Wang J, Zhou C, Wen X, Zhang J, Mao H. Development and Application of the Anti-High-Temperature Delayed Crosslinking Polymer as a Gel Plugging Additive for Drilling Fluid. Gels 2024; 10:73. [PMID: 38247795 PMCID: PMC10815597 DOI: 10.3390/gels10010073] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/21/2023] [Revised: 01/04/2024] [Accepted: 01/08/2024] [Indexed: 01/23/2024] Open
Abstract
With the gradual deepening of the exploration and development of deep and ultra-deep oil and gas resources, the problem of lost circulation in drilling operations is becoming more and more complex. From field experience, conventional plugging materials cannot fully meet the technical requirements of plugging operations in drilling engineering. In this study, a high-temperature- and salt-resistant polymer HDZ-A was synthesized. A high-temperature and delayed crosslinking polymer gel plugging agent can be prepared by adding a certain concentration of a crosslinking agent and a retarder. In this paper, the optimum synthesis conditions of the HDZ-A were determined with orthogonal experiments using viscoelasticity and viscosity as evaluation criteria for newly developed polymers. The molecular structure, temperature resistance, and relative molecular mass of HDZ-A were determined using infrared spectroscopy, nuclear magnetic resonance spectroscopy, and gel permeation chromatography. In addition, the optimal formula of the gel plugging agent was determined using gel strength as the evaluation standard. The results show that the newly developed gel plugging agent has stable performance after high-temperature crosslinking, and can resist high temperatures of 160 °C during formation. Under conditions of 160 °C, the gelation time can reach 4.5 h, and the plugging efficiency can reach more than 97%. Finally, the field test of the newly developed high-temperature-resistant delayed crosslinking polymer gel plugging agent was carried out in the direct exploration well KT-14X in the Ordos Basin. The field test showed that the plugging effect of the HDZ-A gel plugging agent was remarkable.
Collapse
Affiliation(s)
- Quanyang Wang
- Drilling Engineering Research Institute, Sinopec Xinan Oilfield Service Corporation, Deyang 618000, China; (Q.W.)
| | - Jing Cai
- Drilling Engineering Research Institute, Sinopec Xinan Oilfield Service Corporation, Deyang 618000, China; (Q.W.)
| | - Jiannan Wang
- Drilling Engineering Research Institute, Sinopec Xinan Oilfield Service Corporation, Deyang 618000, China; (Q.W.)
| | - Chenghua Zhou
- Drilling Engineering Research Institute, Sinopec Xinan Oilfield Service Corporation, Deyang 618000, China; (Q.W.)
| | - Xinxin Wen
- College of Energy Resources, Chengdu University of Technology, Chengdu 610059, China; (X.W.)
| | - Jiang Zhang
- College of Energy Resources, Chengdu University of Technology, Chengdu 610059, China; (X.W.)
| | - Hui Mao
- College of Energy Resources, Chengdu University of Technology, Chengdu 610059, China; (X.W.)
| |
Collapse
|
43
|
Ma LJ, Liu X, Guo L, Luo Y, Zhang B, Cui X, Yang K, Cai J, Liu F, Ma N, Yang FQ, He X, Shi SP, Wan JB. Discovery of plant chemical defence mediated by a two-component system involving β-glucosidase in Panax species. Nat Commun 2024; 15:602. [PMID: 38238334 PMCID: PMC10796634 DOI: 10.1038/s41467-024-44854-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2023] [Accepted: 01/07/2024] [Indexed: 01/22/2024] Open
Abstract
Plants usually produce defence metabolites in non-active forms to minimize the risk of harm to themselves and spatiotemporally activate these defence metabolites upon pathogen attack. This so-called two-component system plays a decisive role in the chemical defence of various plants. Here, we discovered that Panax notoginseng, a valuable medicinal plant, has evolved a two-component chemical defence system composed of a chloroplast-localized β-glucosidase, denominated PnGH1, and its substrates 20(S)-protopanaxadiol ginsenosides. The β-glucosidase and its substrates are spatially separated in cells under physiological conditions, and ginsenoside hydrolysis is therefore activated only upon chloroplast disruption, which is caused by the induced exoenzymes of pathogenic fungi upon exposure to plant leaves. This activation of PnGH1-mediated hydrolysis results in the production of a series of less-polar ginsenosides by selective hydrolysis of an outer glucose at the C-3 site, with a broader spectrum and more potent antifungal activity in vitro and in vivo than the precursor molecules. Furthermore, such β-glucosidase-mediated hydrolysis upon fungal infection was also found in the congeneric species P. quinquefolium and P. ginseng. Our findings reveal a two-component chemical defence system in Panax species and offer insights for developing botanical pesticides for disease management in Panax species.
Collapse
Affiliation(s)
- Li-Juan Ma
- State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, China
| | - Xiao Liu
- Modern Research Center for Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China
| | - Liwei Guo
- State Key Laboratory for Conservation and Utilization of Bio-Resources in Yunnan, Yunnan Agricultural University, Kunming, Yunnan, China
| | - Yuan Luo
- Modern Research Center for Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China
| | - Beibei Zhang
- Modern Research Center for Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China
- State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, 100050, Beijing, China
| | - Xiaoxue Cui
- Modern Research Center for Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China
| | - Kuan Yang
- State Key Laboratory for Conservation and Utilization of Bio-Resources in Yunnan, Yunnan Agricultural University, Kunming, Yunnan, China
| | - Jing Cai
- School of Ecology and Environment, Northwestern Polytechnical University, Xi'an, Shaanxi, China
| | - Fang Liu
- State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, China
| | - Ni Ma
- Department of Product Development, Wenshan Sanqi Institute of Science and Technology, Wenshan University, Wenshan, Yunnan, China
| | - Feng-Qing Yang
- Department of Pharmaceutical Engineering, School of Chemistry and Chemical Engineering, Chongqing University, 401331, Chongqing, China
| | - Xiahong He
- State Key Laboratory for Conservation and Utilization of Bio-Resources in Yunnan, Yunnan Agricultural University, Kunming, Yunnan, China.
- Ministry of Education Key Laboratory for Forest Resources Conservation and Utilization in the Southwest Mountains of China, Southwest Forestry University, 650224, Kunming, Yunnan, China.
| | - She-Po Shi
- Modern Research Center for Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
| | - Jian-Bo Wan
- State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, China.
| |
Collapse
|
44
|
Gong L, Li G, Yi X, Han Q, Wu Q, Ying F, Shen L, Cao Y, Liu X, Gao L, Li W, Wang Z, Cai J. Tumor-derived small extracellular vesicles facilitate omental metastasis of ovarian cancer by triggering activation of mesenchymal stem cells. Cell Commun Signal 2024; 22:47. [PMID: 38233863 PMCID: PMC10795335 DOI: 10.1186/s12964-023-01413-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/23/2023] [Accepted: 11/29/2023] [Indexed: 01/19/2024] Open
Abstract
BACKGROUND Omental metastasis is the major cause of ovarian cancer recurrence and shortens patient survival, which can be largely attributed to the dynamic evolution of the fertile metastatic microenvironment driven by cancer cells. Previously, we found that adipose-derived mesenchymal stem cells (ADSCs) undergoing a phenotype shift toward cancer-associated fibroblasts (CAFs) participated in the orchestrated omental premetastatic niche for ovarian cancer. Here, we aim to elucidate the underlying mechanisms. METHODS Small extracellular vesicles were isolated from ovarian cancer cell lines (ES-2 and its highly metastatic subline, ES-2-HM) and patient ascites using ultracentrifugation. Functional experiments, including Transwell and EdU assays, and molecular detection, including Western blot, immunofluorescence, and RT-qPCR, were performed to investigate the activation of ADSCs in vitro. High-throughput transcriptional sequencing and functional assays were employed to identify the crucial functional molecules inducing CAF-like activation of ADSCs and the downstream effector of miR-320a. The impact of extracellular vesicles and miR-320a-activated ADSCs on tumor growth and metastasis was assessed in subcutaneous and orthotopic ovarian cancer xenograft mouse models. The expression of miR-320a in human samples was evaluated using in situ hybridization staining. RESULTS Primary human ADSCs cocultured with small extracellular vesicles, especially those derived from ES-2-HM, exhibited boosted migration, invasion, and proliferation capacities and elevated α-SMA and FAP levels. Tumor-derived small extracellular vesicles increased α-SMA-positive stromal cells, fostered omental metastasis, and shortened the survival of mice harboring orthotopic ovarian cancer xenografts. miR-320a was abundant in highly metastatic cell-derived extracellular vesicles, evoked dramatic CAF-like transition of ADSCs, targeted the 3'-untranslated region of integrin subunit alpha 7 and attenuated its expression. miR-320a overexpression in ovarian cancer was associated with omental metastasis and shorter survival. miR-320a-activated ADSCs facilitated tumor cell growth and omental metastasis. Depletion of integrin alpha 7 triggered CAF-like activation of ADSCs in vitro. Video Abstract CONCLUSIONS: miR-320a in small extracellular vesicles secreted by tumor cells targets integrin subunit alpha 7 in ADSCs and drives CAF-like activation, which in turn facilitates omental metastasis of ovarian cancer.
Collapse
Affiliation(s)
- Lanqing Gong
- Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China
| | - Guoqing Li
- Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China
| | - Xiaoqing Yi
- Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China
| | - Qing Han
- Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China
- Department of Obstetrics and Gynecology, The First College of Clinical Medical Science, China Three Gorges University, Yichang, Hubei, 443000, China
| | - Qiulei Wu
- Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China
| | - Feiquan Ying
- Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China
| | - Lu Shen
- Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China
- Department of Gynecology and Obstetrics, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou, Jiangsu, China
| | - Ying Cao
- Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China
- Department of Obstetrics and Gynecology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China
| | - Xiaoli Liu
- Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China
| | - Lingling Gao
- Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China
| | - Wenhan Li
- Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China
| | - Zehua Wang
- Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
| | - Jing Cai
- Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
| |
Collapse
|
45
|
Cai J, Yuan X, Sun Y, Chen J, Li P, Yang S, Long M. Bacillus velezensis A2 Can Protect against Damage to IPEC-J2 Cells Induced by Zearalenone via the Wnt/FRZB/β-Catenin Signaling Pathway. Toxins (Basel) 2024; 16:44. [PMID: 38251260 PMCID: PMC10818814 DOI: 10.3390/toxins16010044] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/11/2023] [Revised: 01/09/2024] [Accepted: 01/10/2024] [Indexed: 01/23/2024] Open
Abstract
Zearalenone (ZEA) has adverse effects on human and animal health, and finding effective strategies to combat its toxicity is essential. The probiotic Bacillus velezensis A2 shows various beneficial physiological functions, including the potential to combat fungal toxins. However, the detailed mechanism by which the Bacillus velezensis A2 strain achieves this protective effect is not yet fully revealed. This experiment was based on transcriptome data to study the protective mechanism of Bacillus velezensis A2 against ZEA-induced damage to IPEC-J2 cells. The experiment was divided into CON, A2, ZEA, and A2+ZEA groups. This research used an oxidation kit to measure oxidative damage indicators, the terminal deoxynucleotidyl transferase-mediated nick end labeling (TUNEL) method to detect cell apoptosis, flow cytometry to determine the cell cycle, and transcriptome sequencing to screen and identify differentially expressed genes. In addition, gene ontology (GO) and the Kyoto Encyclopedia of Genes and Genomes (KEGG) were adopted to screen out relevant signaling pathways. Finally, to determine whether A2 can alleviate the damage caused by ZEA to cells, the genes and proteins involved in inflammation, cell apoptosis, cell cycles, and related pathways were validated using a quantitative reverse transcription polymerase chain reaction (qRT-PCR) and Western blot methods. Compared with the CON group, the levels of reactive oxygen species (ROS) and malondialdehyde (MDA) in the ZEA group increased significantly (p < 0.01), while the levels of antioxidant enzyme activity, total superoxide dismutase (T-SOD), glutathione peroxidase (GSH-PX), total antioxidant capacity (T-AOC), and catalase (CAT) decreased significantly (p < 0.01). Compared with the ZEA group, the A2+ZEA group showed a significant decrease in ROS and MDA levels (p < 0.01), while the levels of T-SOD, GSH-PX, T-AOC, and CAT increased significantly (p < 0.01). TUNEL and cell cycle results indicated that compared with the ZEA group, the A2+ZEA group demonstrated a significant decrease in the cell apoptosis rate (p < 0.01), and the cell cycle was restored. Combining transcriptome data, qRT-PCR, and Western blot, the results showed that compared with the CON group, the mRNA and protein expression levels of Wnt10 and β-catenin increased significantly (p < 0.01), while the expression level of FRZB decreased significantly (p < 0.01); compared with the ZEA group, the expression levels of these mRNA and proteins were reversed. Bacillus velezensis A2 can increase the antioxidant level, reduce inflammatory damage, decrease cell apoptosis, and correct the cell cycle when that damage is being caused by ZEA. The protective mechanism may be related to the regulation of the Wnt/FRZB cell/β-catenin signaling pathway.
Collapse
Affiliation(s)
| | | | | | | | | | | | - Miao Long
- Key Laboratory of Zoonosis of Liaoning Province, College of Animal Science and Veterinary Medicine, Shenyang Agricultural University, Shenyang 110866, China; (J.C.); (X.Y.); (Y.S.); (J.C.); (P.L.); (S.Y.)
| |
Collapse
|
46
|
Li W, Partridge SC, Newitt DC, Steingrimsson J, Marques HS, Bolan PJ, Hirano M, Bearce BA, Kalpathy-Cramer J, Boss MA, Teng X, Zhang J, Cai J, Kontos D, Cohen EA, Mankowski WC, Liu M, Ha R, Pellicer-Valero OJ, Maier-Hein K, Rabinovici-Cohen S, Tlusty T, Ozery-Flato M, Parekh VS, Jacobs MA, Yan R, Sung K, Kazerouni AS, DiCarlo JC, Yankeelov TE, Chenevert TL, Hylton NM. Breast Multiparametric MRI for Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer: The BMMR2 Challenge. Radiol Imaging Cancer 2024; 6:e230033. [PMID: 38180338 PMCID: PMC10825718 DOI: 10.1148/rycan.230033] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/05/2023] [Revised: 09/13/2023] [Accepted: 11/02/2023] [Indexed: 01/06/2024]
Abstract
Purpose To describe the design, conduct, and results of the Breast Multiparametric MRI for prediction of neoadjuvant chemotherapy Response (BMMR2) challenge. Materials and Methods The BMMR2 computational challenge opened on May 28, 2021, and closed on December 21, 2021. The goal of the challenge was to identify image-based markers derived from multiparametric breast MRI, including diffusion-weighted imaging (DWI) and dynamic contrast-enhanced (DCE) MRI, along with clinical data for predicting pathologic complete response (pCR) following neoadjuvant treatment. Data included 573 breast MRI studies from 191 women (mean age [±SD], 48.9 years ± 10.56) in the I-SPY 2/American College of Radiology Imaging Network (ACRIN) 6698 trial (ClinicalTrials.gov: NCT01042379). The challenge cohort was split into training (60%) and test (40%) sets, with teams blinded to test set pCR outcomes. Prediction performance was evaluated by area under the receiver operating characteristic curve (AUC) and compared with the benchmark established from the ACRIN 6698 primary analysis. Results Eight teams submitted final predictions. Entries from three teams had point estimators of AUC that were higher than the benchmark performance (AUC, 0.782 [95% CI: 0.670, 0.893], with AUCs of 0.803 [95% CI: 0.702, 0.904], 0.838 [95% CI: 0.748, 0.928], and 0.840 [95% CI: 0.748, 0.932]). A variety of approaches were used, ranging from extraction of individual features to deep learning and artificial intelligence methods, incorporating DCE and DWI alone or in combination. Conclusion The BMMR2 challenge identified several models with high predictive performance, which may further expand the value of multiparametric breast MRI as an early marker of treatment response. Clinical trial registration no. NCT01042379 Keywords: MRI, Breast, Tumor Response Supplemental material is available for this article. © RSNA, 2024.
Collapse
Affiliation(s)
- Wen Li
- From the Department of Radiology & Biomedical Imaging,
University of California San Francisco, San Francisco, Calif (W.L., D.C.N.,
N.M.H.); Department of Radiology, University of Washington, Fred Hutchinson
Cancer Center, 1100 Fairview Ave N, Seattle, WA 98109 (S.C.P., M.H., A.S.K.);
Center for Statistical Sciences, Brown University, Providence, RI (J.S.,
H.S.M.); Center for Magnetic Resonance Research, University of Minnesota,
Minneapolis, Minn (P.J.B.); Athinoula A. Martinos Center for Biomedical Imaging,
Harvard University, Charlestown, Mass (B.A.B., J.K.C.); Center for Research and
Innovation, American College of Radiology, Philadelphia, Pa (M.A.B.); Department
of Health Technology and Informatics, The Hong Kong Polytechnic University, Hung
Hom, Kowloon, Hong Kong SAR (X.T., J.Z., J.C.); Department of Radiology,
University of Pennsylvania, Philadelphia, Pa (D.K., E.A.C., W.C.M.); Department
of Radiology, Columbia University Medical Center, New York, NY (M.L., R.H.);
Division of Medical Image Computing, German Cancer Research Center, Heidelberg,
Germany (O.J.P.V., K.M.H.); Department of Radiation Oncology, Heidelberg
University Hospital, Heidelberg, Germany (K.M.H.); IBM Research-Israel, Haifa
University Campus, Mount Carmel, Haifa, Israel (S.R.C., T.T., M.O.F.);
University of Maryland Medical Intelligent Imaging (UM2ii) Center and Department
of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of
Medicine, Baltimore, Md (V.S.P.); The Russell H. Morgan Department of Radiology
and Radiological Science, The Johns Hopkins School of Medicine, Sidney Kimmel
Comprehensive Cancer Center, The Johns Hopkins School of Medicine, Baltimore, Md
(V.S.P., M.A.J.); Department of Diagnostic and Interventional Imaging, UT Health
at Houston, Houston, Tex (M.A.J.); Department of Radiological Sciences, David
Geffen School of Medicine, University of California, Los Angeles, Calif (R.Y.,
K.S.); Department of Bioengineering, Henry Samueli School of Engineering,
University of California, Los Angeles, Calif (R.Y., K.S.); Livestrong Cancer
Institutes (J.C.D., T.E.Y.), Departments of Biomedical Engineering, Diagnostic
Medicine, and Oncology (T.E.Y.), and The Oden Institute for Computational
Engineering and Sciences, The University of Texas at Austin, Austin, Tex
(J.C.D., T.E.Y.); Department of Imaging Physics, The University of Texas MD
Anderson Cancer Center, Houston, Tex (T.E.Y.); and Department of Radiology,
University of Michigan, Ann Arbor, Mich (T.L.C.)
| | - Savannah C. Partridge
- From the Department of Radiology & Biomedical Imaging,
University of California San Francisco, San Francisco, Calif (W.L., D.C.N.,
N.M.H.); Department of Radiology, University of Washington, Fred Hutchinson
Cancer Center, 1100 Fairview Ave N, Seattle, WA 98109 (S.C.P., M.H., A.S.K.);
Center for Statistical Sciences, Brown University, Providence, RI (J.S.,
H.S.M.); Center for Magnetic Resonance Research, University of Minnesota,
Minneapolis, Minn (P.J.B.); Athinoula A. Martinos Center for Biomedical Imaging,
Harvard University, Charlestown, Mass (B.A.B., J.K.C.); Center for Research and
Innovation, American College of Radiology, Philadelphia, Pa (M.A.B.); Department
of Health Technology and Informatics, The Hong Kong Polytechnic University, Hung
Hom, Kowloon, Hong Kong SAR (X.T., J.Z., J.C.); Department of Radiology,
University of Pennsylvania, Philadelphia, Pa (D.K., E.A.C., W.C.M.); Department
of Radiology, Columbia University Medical Center, New York, NY (M.L., R.H.);
Division of Medical Image Computing, German Cancer Research Center, Heidelberg,
Germany (O.J.P.V., K.M.H.); Department of Radiation Oncology, Heidelberg
University Hospital, Heidelberg, Germany (K.M.H.); IBM Research-Israel, Haifa
University Campus, Mount Carmel, Haifa, Israel (S.R.C., T.T., M.O.F.);
University of Maryland Medical Intelligent Imaging (UM2ii) Center and Department
of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of
Medicine, Baltimore, Md (V.S.P.); The Russell H. Morgan Department of Radiology
and Radiological Science, The Johns Hopkins School of Medicine, Sidney Kimmel
Comprehensive Cancer Center, The Johns Hopkins School of Medicine, Baltimore, Md
(V.S.P., M.A.J.); Department of Diagnostic and Interventional Imaging, UT Health
at Houston, Houston, Tex (M.A.J.); Department of Radiological Sciences, David
Geffen School of Medicine, University of California, Los Angeles, Calif (R.Y.,
K.S.); Department of Bioengineering, Henry Samueli School of Engineering,
University of California, Los Angeles, Calif (R.Y., K.S.); Livestrong Cancer
Institutes (J.C.D., T.E.Y.), Departments of Biomedical Engineering, Diagnostic
Medicine, and Oncology (T.E.Y.), and The Oden Institute for Computational
Engineering and Sciences, The University of Texas at Austin, Austin, Tex
(J.C.D., T.E.Y.); Department of Imaging Physics, The University of Texas MD
Anderson Cancer Center, Houston, Tex (T.E.Y.); and Department of Radiology,
University of Michigan, Ann Arbor, Mich (T.L.C.)
| | - David C. Newitt
- From the Department of Radiology & Biomedical Imaging,
University of California San Francisco, San Francisco, Calif (W.L., D.C.N.,
N.M.H.); Department of Radiology, University of Washington, Fred Hutchinson
Cancer Center, 1100 Fairview Ave N, Seattle, WA 98109 (S.C.P., M.H., A.S.K.);
Center for Statistical Sciences, Brown University, Providence, RI (J.S.,
H.S.M.); Center for Magnetic Resonance Research, University of Minnesota,
Minneapolis, Minn (P.J.B.); Athinoula A. Martinos Center for Biomedical Imaging,
Harvard University, Charlestown, Mass (B.A.B., J.K.C.); Center for Research and
Innovation, American College of Radiology, Philadelphia, Pa (M.A.B.); Department
of Health Technology and Informatics, The Hong Kong Polytechnic University, Hung
Hom, Kowloon, Hong Kong SAR (X.T., J.Z., J.C.); Department of Radiology,
University of Pennsylvania, Philadelphia, Pa (D.K., E.A.C., W.C.M.); Department
of Radiology, Columbia University Medical Center, New York, NY (M.L., R.H.);
Division of Medical Image Computing, German Cancer Research Center, Heidelberg,
Germany (O.J.P.V., K.M.H.); Department of Radiation Oncology, Heidelberg
University Hospital, Heidelberg, Germany (K.M.H.); IBM Research-Israel, Haifa
University Campus, Mount Carmel, Haifa, Israel (S.R.C., T.T., M.O.F.);
University of Maryland Medical Intelligent Imaging (UM2ii) Center and Department
of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of
Medicine, Baltimore, Md (V.S.P.); The Russell H. Morgan Department of Radiology
and Radiological Science, The Johns Hopkins School of Medicine, Sidney Kimmel
Comprehensive Cancer Center, The Johns Hopkins School of Medicine, Baltimore, Md
(V.S.P., M.A.J.); Department of Diagnostic and Interventional Imaging, UT Health
at Houston, Houston, Tex (M.A.J.); Department of Radiological Sciences, David
Geffen School of Medicine, University of California, Los Angeles, Calif (R.Y.,
K.S.); Department of Bioengineering, Henry Samueli School of Engineering,
University of California, Los Angeles, Calif (R.Y., K.S.); Livestrong Cancer
Institutes (J.C.D., T.E.Y.), Departments of Biomedical Engineering, Diagnostic
Medicine, and Oncology (T.E.Y.), and The Oden Institute for Computational
Engineering and Sciences, The University of Texas at Austin, Austin, Tex
(J.C.D., T.E.Y.); Department of Imaging Physics, The University of Texas MD
Anderson Cancer Center, Houston, Tex (T.E.Y.); and Department of Radiology,
University of Michigan, Ann Arbor, Mich (T.L.C.)
| | - Jon Steingrimsson
- From the Department of Radiology & Biomedical Imaging,
University of California San Francisco, San Francisco, Calif (W.L., D.C.N.,
N.M.H.); Department of Radiology, University of Washington, Fred Hutchinson
Cancer Center, 1100 Fairview Ave N, Seattle, WA 98109 (S.C.P., M.H., A.S.K.);
Center for Statistical Sciences, Brown University, Providence, RI (J.S.,
H.S.M.); Center for Magnetic Resonance Research, University of Minnesota,
Minneapolis, Minn (P.J.B.); Athinoula A. Martinos Center for Biomedical Imaging,
Harvard University, Charlestown, Mass (B.A.B., J.K.C.); Center for Research and
Innovation, American College of Radiology, Philadelphia, Pa (M.A.B.); Department
of Health Technology and Informatics, The Hong Kong Polytechnic University, Hung
Hom, Kowloon, Hong Kong SAR (X.T., J.Z., J.C.); Department of Radiology,
University of Pennsylvania, Philadelphia, Pa (D.K., E.A.C., W.C.M.); Department
of Radiology, Columbia University Medical Center, New York, NY (M.L., R.H.);
Division of Medical Image Computing, German Cancer Research Center, Heidelberg,
Germany (O.J.P.V., K.M.H.); Department of Radiation Oncology, Heidelberg
University Hospital, Heidelberg, Germany (K.M.H.); IBM Research-Israel, Haifa
University Campus, Mount Carmel, Haifa, Israel (S.R.C., T.T., M.O.F.);
University of Maryland Medical Intelligent Imaging (UM2ii) Center and Department
of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of
Medicine, Baltimore, Md (V.S.P.); The Russell H. Morgan Department of Radiology
and Radiological Science, The Johns Hopkins School of Medicine, Sidney Kimmel
Comprehensive Cancer Center, The Johns Hopkins School of Medicine, Baltimore, Md
(V.S.P., M.A.J.); Department of Diagnostic and Interventional Imaging, UT Health
at Houston, Houston, Tex (M.A.J.); Department of Radiological Sciences, David
Geffen School of Medicine, University of California, Los Angeles, Calif (R.Y.,
K.S.); Department of Bioengineering, Henry Samueli School of Engineering,
University of California, Los Angeles, Calif (R.Y., K.S.); Livestrong Cancer
Institutes (J.C.D., T.E.Y.), Departments of Biomedical Engineering, Diagnostic
Medicine, and Oncology (T.E.Y.), and The Oden Institute for Computational
Engineering and Sciences, The University of Texas at Austin, Austin, Tex
(J.C.D., T.E.Y.); Department of Imaging Physics, The University of Texas MD
Anderson Cancer Center, Houston, Tex (T.E.Y.); and Department of Radiology,
University of Michigan, Ann Arbor, Mich (T.L.C.)
| | - Helga S. Marques
- From the Department of Radiology & Biomedical Imaging,
University of California San Francisco, San Francisco, Calif (W.L., D.C.N.,
N.M.H.); Department of Radiology, University of Washington, Fred Hutchinson
Cancer Center, 1100 Fairview Ave N, Seattle, WA 98109 (S.C.P., M.H., A.S.K.);
Center for Statistical Sciences, Brown University, Providence, RI (J.S.,
H.S.M.); Center for Magnetic Resonance Research, University of Minnesota,
Minneapolis, Minn (P.J.B.); Athinoula A. Martinos Center for Biomedical Imaging,
Harvard University, Charlestown, Mass (B.A.B., J.K.C.); Center for Research and
Innovation, American College of Radiology, Philadelphia, Pa (M.A.B.); Department
of Health Technology and Informatics, The Hong Kong Polytechnic University, Hung
Hom, Kowloon, Hong Kong SAR (X.T., J.Z., J.C.); Department of Radiology,
University of Pennsylvania, Philadelphia, Pa (D.K., E.A.C., W.C.M.); Department
of Radiology, Columbia University Medical Center, New York, NY (M.L., R.H.);
Division of Medical Image Computing, German Cancer Research Center, Heidelberg,
Germany (O.J.P.V., K.M.H.); Department of Radiation Oncology, Heidelberg
University Hospital, Heidelberg, Germany (K.M.H.); IBM Research-Israel, Haifa
University Campus, Mount Carmel, Haifa, Israel (S.R.C., T.T., M.O.F.);
University of Maryland Medical Intelligent Imaging (UM2ii) Center and Department
of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of
Medicine, Baltimore, Md (V.S.P.); The Russell H. Morgan Department of Radiology
and Radiological Science, The Johns Hopkins School of Medicine, Sidney Kimmel
Comprehensive Cancer Center, The Johns Hopkins School of Medicine, Baltimore, Md
(V.S.P., M.A.J.); Department of Diagnostic and Interventional Imaging, UT Health
at Houston, Houston, Tex (M.A.J.); Department of Radiological Sciences, David
Geffen School of Medicine, University of California, Los Angeles, Calif (R.Y.,
K.S.); Department of Bioengineering, Henry Samueli School of Engineering,
University of California, Los Angeles, Calif (R.Y., K.S.); Livestrong Cancer
Institutes (J.C.D., T.E.Y.), Departments of Biomedical Engineering, Diagnostic
Medicine, and Oncology (T.E.Y.), and The Oden Institute for Computational
Engineering and Sciences, The University of Texas at Austin, Austin, Tex
(J.C.D., T.E.Y.); Department of Imaging Physics, The University of Texas MD
Anderson Cancer Center, Houston, Tex (T.E.Y.); and Department of Radiology,
University of Michigan, Ann Arbor, Mich (T.L.C.)
| | - Patrick J. Bolan
- From the Department of Radiology & Biomedical Imaging,
University of California San Francisco, San Francisco, Calif (W.L., D.C.N.,
N.M.H.); Department of Radiology, University of Washington, Fred Hutchinson
Cancer Center, 1100 Fairview Ave N, Seattle, WA 98109 (S.C.P., M.H., A.S.K.);
Center for Statistical Sciences, Brown University, Providence, RI (J.S.,
H.S.M.); Center for Magnetic Resonance Research, University of Minnesota,
Minneapolis, Minn (P.J.B.); Athinoula A. Martinos Center for Biomedical Imaging,
Harvard University, Charlestown, Mass (B.A.B., J.K.C.); Center for Research and
Innovation, American College of Radiology, Philadelphia, Pa (M.A.B.); Department
of Health Technology and Informatics, The Hong Kong Polytechnic University, Hung
Hom, Kowloon, Hong Kong SAR (X.T., J.Z., J.C.); Department of Radiology,
University of Pennsylvania, Philadelphia, Pa (D.K., E.A.C., W.C.M.); Department
of Radiology, Columbia University Medical Center, New York, NY (M.L., R.H.);
Division of Medical Image Computing, German Cancer Research Center, Heidelberg,
Germany (O.J.P.V., K.M.H.); Department of Radiation Oncology, Heidelberg
University Hospital, Heidelberg, Germany (K.M.H.); IBM Research-Israel, Haifa
University Campus, Mount Carmel, Haifa, Israel (S.R.C., T.T., M.O.F.);
University of Maryland Medical Intelligent Imaging (UM2ii) Center and Department
of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of
Medicine, Baltimore, Md (V.S.P.); The Russell H. Morgan Department of Radiology
and Radiological Science, The Johns Hopkins School of Medicine, Sidney Kimmel
Comprehensive Cancer Center, The Johns Hopkins School of Medicine, Baltimore, Md
(V.S.P., M.A.J.); Department of Diagnostic and Interventional Imaging, UT Health
at Houston, Houston, Tex (M.A.J.); Department of Radiological Sciences, David
Geffen School of Medicine, University of California, Los Angeles, Calif (R.Y.,
K.S.); Department of Bioengineering, Henry Samueli School of Engineering,
University of California, Los Angeles, Calif (R.Y., K.S.); Livestrong Cancer
Institutes (J.C.D., T.E.Y.), Departments of Biomedical Engineering, Diagnostic
Medicine, and Oncology (T.E.Y.), and The Oden Institute for Computational
Engineering and Sciences, The University of Texas at Austin, Austin, Tex
(J.C.D., T.E.Y.); Department of Imaging Physics, The University of Texas MD
Anderson Cancer Center, Houston, Tex (T.E.Y.); and Department of Radiology,
University of Michigan, Ann Arbor, Mich (T.L.C.)
| | - Michael Hirano
- From the Department of Radiology & Biomedical Imaging,
University of California San Francisco, San Francisco, Calif (W.L., D.C.N.,
N.M.H.); Department of Radiology, University of Washington, Fred Hutchinson
Cancer Center, 1100 Fairview Ave N, Seattle, WA 98109 (S.C.P., M.H., A.S.K.);
Center for Statistical Sciences, Brown University, Providence, RI (J.S.,
H.S.M.); Center for Magnetic Resonance Research, University of Minnesota,
Minneapolis, Minn (P.J.B.); Athinoula A. Martinos Center for Biomedical Imaging,
Harvard University, Charlestown, Mass (B.A.B., J.K.C.); Center for Research and
Innovation, American College of Radiology, Philadelphia, Pa (M.A.B.); Department
of Health Technology and Informatics, The Hong Kong Polytechnic University, Hung
Hom, Kowloon, Hong Kong SAR (X.T., J.Z., J.C.); Department of Radiology,
University of Pennsylvania, Philadelphia, Pa (D.K., E.A.C., W.C.M.); Department
of Radiology, Columbia University Medical Center, New York, NY (M.L., R.H.);
Division of Medical Image Computing, German Cancer Research Center, Heidelberg,
Germany (O.J.P.V., K.M.H.); Department of Radiation Oncology, Heidelberg
University Hospital, Heidelberg, Germany (K.M.H.); IBM Research-Israel, Haifa
University Campus, Mount Carmel, Haifa, Israel (S.R.C., T.T., M.O.F.);
University of Maryland Medical Intelligent Imaging (UM2ii) Center and Department
of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of
Medicine, Baltimore, Md (V.S.P.); The Russell H. Morgan Department of Radiology
and Radiological Science, The Johns Hopkins School of Medicine, Sidney Kimmel
Comprehensive Cancer Center, The Johns Hopkins School of Medicine, Baltimore, Md
(V.S.P., M.A.J.); Department of Diagnostic and Interventional Imaging, UT Health
at Houston, Houston, Tex (M.A.J.); Department of Radiological Sciences, David
Geffen School of Medicine, University of California, Los Angeles, Calif (R.Y.,
K.S.); Department of Bioengineering, Henry Samueli School of Engineering,
University of California, Los Angeles, Calif (R.Y., K.S.); Livestrong Cancer
Institutes (J.C.D., T.E.Y.), Departments of Biomedical Engineering, Diagnostic
Medicine, and Oncology (T.E.Y.), and The Oden Institute for Computational
Engineering and Sciences, The University of Texas at Austin, Austin, Tex
(J.C.D., T.E.Y.); Department of Imaging Physics, The University of Texas MD
Anderson Cancer Center, Houston, Tex (T.E.Y.); and Department of Radiology,
University of Michigan, Ann Arbor, Mich (T.L.C.)
| | - Benjamin Aaron Bearce
- From the Department of Radiology & Biomedical Imaging,
University of California San Francisco, San Francisco, Calif (W.L., D.C.N.,
N.M.H.); Department of Radiology, University of Washington, Fred Hutchinson
Cancer Center, 1100 Fairview Ave N, Seattle, WA 98109 (S.C.P., M.H., A.S.K.);
Center for Statistical Sciences, Brown University, Providence, RI (J.S.,
H.S.M.); Center for Magnetic Resonance Research, University of Minnesota,
Minneapolis, Minn (P.J.B.); Athinoula A. Martinos Center for Biomedical Imaging,
Harvard University, Charlestown, Mass (B.A.B., J.K.C.); Center for Research and
Innovation, American College of Radiology, Philadelphia, Pa (M.A.B.); Department
of Health Technology and Informatics, The Hong Kong Polytechnic University, Hung
Hom, Kowloon, Hong Kong SAR (X.T., J.Z., J.C.); Department of Radiology,
University of Pennsylvania, Philadelphia, Pa (D.K., E.A.C., W.C.M.); Department
of Radiology, Columbia University Medical Center, New York, NY (M.L., R.H.);
Division of Medical Image Computing, German Cancer Research Center, Heidelberg,
Germany (O.J.P.V., K.M.H.); Department of Radiation Oncology, Heidelberg
University Hospital, Heidelberg, Germany (K.M.H.); IBM Research-Israel, Haifa
University Campus, Mount Carmel, Haifa, Israel (S.R.C., T.T., M.O.F.);
University of Maryland Medical Intelligent Imaging (UM2ii) Center and Department
of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of
Medicine, Baltimore, Md (V.S.P.); The Russell H. Morgan Department of Radiology
and Radiological Science, The Johns Hopkins School of Medicine, Sidney Kimmel
Comprehensive Cancer Center, The Johns Hopkins School of Medicine, Baltimore, Md
(V.S.P., M.A.J.); Department of Diagnostic and Interventional Imaging, UT Health
at Houston, Houston, Tex (M.A.J.); Department of Radiological Sciences, David
Geffen School of Medicine, University of California, Los Angeles, Calif (R.Y.,
K.S.); Department of Bioengineering, Henry Samueli School of Engineering,
University of California, Los Angeles, Calif (R.Y., K.S.); Livestrong Cancer
Institutes (J.C.D., T.E.Y.), Departments of Biomedical Engineering, Diagnostic
Medicine, and Oncology (T.E.Y.), and The Oden Institute for Computational
Engineering and Sciences, The University of Texas at Austin, Austin, Tex
(J.C.D., T.E.Y.); Department of Imaging Physics, The University of Texas MD
Anderson Cancer Center, Houston, Tex (T.E.Y.); and Department of Radiology,
University of Michigan, Ann Arbor, Mich (T.L.C.)
| | - Jayashree Kalpathy-Cramer
- From the Department of Radiology & Biomedical Imaging,
University of California San Francisco, San Francisco, Calif (W.L., D.C.N.,
N.M.H.); Department of Radiology, University of Washington, Fred Hutchinson
Cancer Center, 1100 Fairview Ave N, Seattle, WA 98109 (S.C.P., M.H., A.S.K.);
Center for Statistical Sciences, Brown University, Providence, RI (J.S.,
H.S.M.); Center for Magnetic Resonance Research, University of Minnesota,
Minneapolis, Minn (P.J.B.); Athinoula A. Martinos Center for Biomedical Imaging,
Harvard University, Charlestown, Mass (B.A.B., J.K.C.); Center for Research and
Innovation, American College of Radiology, Philadelphia, Pa (M.A.B.); Department
of Health Technology and Informatics, The Hong Kong Polytechnic University, Hung
Hom, Kowloon, Hong Kong SAR (X.T., J.Z., J.C.); Department of Radiology,
University of Pennsylvania, Philadelphia, Pa (D.K., E.A.C., W.C.M.); Department
of Radiology, Columbia University Medical Center, New York, NY (M.L., R.H.);
Division of Medical Image Computing, German Cancer Research Center, Heidelberg,
Germany (O.J.P.V., K.M.H.); Department of Radiation Oncology, Heidelberg
University Hospital, Heidelberg, Germany (K.M.H.); IBM Research-Israel, Haifa
University Campus, Mount Carmel, Haifa, Israel (S.R.C., T.T., M.O.F.);
University of Maryland Medical Intelligent Imaging (UM2ii) Center and Department
of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of
Medicine, Baltimore, Md (V.S.P.); The Russell H. Morgan Department of Radiology
and Radiological Science, The Johns Hopkins School of Medicine, Sidney Kimmel
Comprehensive Cancer Center, The Johns Hopkins School of Medicine, Baltimore, Md
(V.S.P., M.A.J.); Department of Diagnostic and Interventional Imaging, UT Health
at Houston, Houston, Tex (M.A.J.); Department of Radiological Sciences, David
Geffen School of Medicine, University of California, Los Angeles, Calif (R.Y.,
K.S.); Department of Bioengineering, Henry Samueli School of Engineering,
University of California, Los Angeles, Calif (R.Y., K.S.); Livestrong Cancer
Institutes (J.C.D., T.E.Y.), Departments of Biomedical Engineering, Diagnostic
Medicine, and Oncology (T.E.Y.), and The Oden Institute for Computational
Engineering and Sciences, The University of Texas at Austin, Austin, Tex
(J.C.D., T.E.Y.); Department of Imaging Physics, The University of Texas MD
Anderson Cancer Center, Houston, Tex (T.E.Y.); and Department of Radiology,
University of Michigan, Ann Arbor, Mich (T.L.C.)
| | - Michael A. Boss
- From the Department of Radiology & Biomedical Imaging,
University of California San Francisco, San Francisco, Calif (W.L., D.C.N.,
N.M.H.); Department of Radiology, University of Washington, Fred Hutchinson
Cancer Center, 1100 Fairview Ave N, Seattle, WA 98109 (S.C.P., M.H., A.S.K.);
Center for Statistical Sciences, Brown University, Providence, RI (J.S.,
H.S.M.); Center for Magnetic Resonance Research, University of Minnesota,
Minneapolis, Minn (P.J.B.); Athinoula A. Martinos Center for Biomedical Imaging,
Harvard University, Charlestown, Mass (B.A.B., J.K.C.); Center for Research and
Innovation, American College of Radiology, Philadelphia, Pa (M.A.B.); Department
of Health Technology and Informatics, The Hong Kong Polytechnic University, Hung
Hom, Kowloon, Hong Kong SAR (X.T., J.Z., J.C.); Department of Radiology,
University of Pennsylvania, Philadelphia, Pa (D.K., E.A.C., W.C.M.); Department
of Radiology, Columbia University Medical Center, New York, NY (M.L., R.H.);
Division of Medical Image Computing, German Cancer Research Center, Heidelberg,
Germany (O.J.P.V., K.M.H.); Department of Radiation Oncology, Heidelberg
University Hospital, Heidelberg, Germany (K.M.H.); IBM Research-Israel, Haifa
University Campus, Mount Carmel, Haifa, Israel (S.R.C., T.T., M.O.F.);
University of Maryland Medical Intelligent Imaging (UM2ii) Center and Department
of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of
Medicine, Baltimore, Md (V.S.P.); The Russell H. Morgan Department of Radiology
and Radiological Science, The Johns Hopkins School of Medicine, Sidney Kimmel
Comprehensive Cancer Center, The Johns Hopkins School of Medicine, Baltimore, Md
(V.S.P., M.A.J.); Department of Diagnostic and Interventional Imaging, UT Health
at Houston, Houston, Tex (M.A.J.); Department of Radiological Sciences, David
Geffen School of Medicine, University of California, Los Angeles, Calif (R.Y.,
K.S.); Department of Bioengineering, Henry Samueli School of Engineering,
University of California, Los Angeles, Calif (R.Y., K.S.); Livestrong Cancer
Institutes (J.C.D., T.E.Y.), Departments of Biomedical Engineering, Diagnostic
Medicine, and Oncology (T.E.Y.), and The Oden Institute for Computational
Engineering and Sciences, The University of Texas at Austin, Austin, Tex
(J.C.D., T.E.Y.); Department of Imaging Physics, The University of Texas MD
Anderson Cancer Center, Houston, Tex (T.E.Y.); and Department of Radiology,
University of Michigan, Ann Arbor, Mich (T.L.C.)
| | - Xinzhi Teng
- From the Department of Radiology & Biomedical Imaging,
University of California San Francisco, San Francisco, Calif (W.L., D.C.N.,
N.M.H.); Department of Radiology, University of Washington, Fred Hutchinson
Cancer Center, 1100 Fairview Ave N, Seattle, WA 98109 (S.C.P., M.H., A.S.K.);
Center for Statistical Sciences, Brown University, Providence, RI (J.S.,
H.S.M.); Center for Magnetic Resonance Research, University of Minnesota,
Minneapolis, Minn (P.J.B.); Athinoula A. Martinos Center for Biomedical Imaging,
Harvard University, Charlestown, Mass (B.A.B., J.K.C.); Center for Research and
Innovation, American College of Radiology, Philadelphia, Pa (M.A.B.); Department
of Health Technology and Informatics, The Hong Kong Polytechnic University, Hung
Hom, Kowloon, Hong Kong SAR (X.T., J.Z., J.C.); Department of Radiology,
University of Pennsylvania, Philadelphia, Pa (D.K., E.A.C., W.C.M.); Department
of Radiology, Columbia University Medical Center, New York, NY (M.L., R.H.);
Division of Medical Image Computing, German Cancer Research Center, Heidelberg,
Germany (O.J.P.V., K.M.H.); Department of Radiation Oncology, Heidelberg
University Hospital, Heidelberg, Germany (K.M.H.); IBM Research-Israel, Haifa
University Campus, Mount Carmel, Haifa, Israel (S.R.C., T.T., M.O.F.);
University of Maryland Medical Intelligent Imaging (UM2ii) Center and Department
of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of
Medicine, Baltimore, Md (V.S.P.); The Russell H. Morgan Department of Radiology
and Radiological Science, The Johns Hopkins School of Medicine, Sidney Kimmel
Comprehensive Cancer Center, The Johns Hopkins School of Medicine, Baltimore, Md
(V.S.P., M.A.J.); Department of Diagnostic and Interventional Imaging, UT Health
at Houston, Houston, Tex (M.A.J.); Department of Radiological Sciences, David
Geffen School of Medicine, University of California, Los Angeles, Calif (R.Y.,
K.S.); Department of Bioengineering, Henry Samueli School of Engineering,
University of California, Los Angeles, Calif (R.Y., K.S.); Livestrong Cancer
Institutes (J.C.D., T.E.Y.), Departments of Biomedical Engineering, Diagnostic
Medicine, and Oncology (T.E.Y.), and The Oden Institute for Computational
Engineering and Sciences, The University of Texas at Austin, Austin, Tex
(J.C.D., T.E.Y.); Department of Imaging Physics, The University of Texas MD
Anderson Cancer Center, Houston, Tex (T.E.Y.); and Department of Radiology,
University of Michigan, Ann Arbor, Mich (T.L.C.)
| | - Jiang Zhang
- From the Department of Radiology & Biomedical Imaging,
University of California San Francisco, San Francisco, Calif (W.L., D.C.N.,
N.M.H.); Department of Radiology, University of Washington, Fred Hutchinson
Cancer Center, 1100 Fairview Ave N, Seattle, WA 98109 (S.C.P., M.H., A.S.K.);
Center for Statistical Sciences, Brown University, Providence, RI (J.S.,
H.S.M.); Center for Magnetic Resonance Research, University of Minnesota,
Minneapolis, Minn (P.J.B.); Athinoula A. Martinos Center for Biomedical Imaging,
Harvard University, Charlestown, Mass (B.A.B., J.K.C.); Center for Research and
Innovation, American College of Radiology, Philadelphia, Pa (M.A.B.); Department
of Health Technology and Informatics, The Hong Kong Polytechnic University, Hung
Hom, Kowloon, Hong Kong SAR (X.T., J.Z., J.C.); Department of Radiology,
University of Pennsylvania, Philadelphia, Pa (D.K., E.A.C., W.C.M.); Department
of Radiology, Columbia University Medical Center, New York, NY (M.L., R.H.);
Division of Medical Image Computing, German Cancer Research Center, Heidelberg,
Germany (O.J.P.V., K.M.H.); Department of Radiation Oncology, Heidelberg
University Hospital, Heidelberg, Germany (K.M.H.); IBM Research-Israel, Haifa
University Campus, Mount Carmel, Haifa, Israel (S.R.C., T.T., M.O.F.);
University of Maryland Medical Intelligent Imaging (UM2ii) Center and Department
of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of
Medicine, Baltimore, Md (V.S.P.); The Russell H. Morgan Department of Radiology
and Radiological Science, The Johns Hopkins School of Medicine, Sidney Kimmel
Comprehensive Cancer Center, The Johns Hopkins School of Medicine, Baltimore, Md
(V.S.P., M.A.J.); Department of Diagnostic and Interventional Imaging, UT Health
at Houston, Houston, Tex (M.A.J.); Department of Radiological Sciences, David
Geffen School of Medicine, University of California, Los Angeles, Calif (R.Y.,
K.S.); Department of Bioengineering, Henry Samueli School of Engineering,
University of California, Los Angeles, Calif (R.Y., K.S.); Livestrong Cancer
Institutes (J.C.D., T.E.Y.), Departments of Biomedical Engineering, Diagnostic
Medicine, and Oncology (T.E.Y.), and The Oden Institute for Computational
Engineering and Sciences, The University of Texas at Austin, Austin, Tex
(J.C.D., T.E.Y.); Department of Imaging Physics, The University of Texas MD
Anderson Cancer Center, Houston, Tex (T.E.Y.); and Department of Radiology,
University of Michigan, Ann Arbor, Mich (T.L.C.)
| | - Jing Cai
- From the Department of Radiology & Biomedical Imaging,
University of California San Francisco, San Francisco, Calif (W.L., D.C.N.,
N.M.H.); Department of Radiology, University of Washington, Fred Hutchinson
Cancer Center, 1100 Fairview Ave N, Seattle, WA 98109 (S.C.P., M.H., A.S.K.);
Center for Statistical Sciences, Brown University, Providence, RI (J.S.,
H.S.M.); Center for Magnetic Resonance Research, University of Minnesota,
Minneapolis, Minn (P.J.B.); Athinoula A. Martinos Center for Biomedical Imaging,
Harvard University, Charlestown, Mass (B.A.B., J.K.C.); Center for Research and
Innovation, American College of Radiology, Philadelphia, Pa (M.A.B.); Department
of Health Technology and Informatics, The Hong Kong Polytechnic University, Hung
Hom, Kowloon, Hong Kong SAR (X.T., J.Z., J.C.); Department of Radiology,
University of Pennsylvania, Philadelphia, Pa (D.K., E.A.C., W.C.M.); Department
of Radiology, Columbia University Medical Center, New York, NY (M.L., R.H.);
Division of Medical Image Computing, German Cancer Research Center, Heidelberg,
Germany (O.J.P.V., K.M.H.); Department of Radiation Oncology, Heidelberg
University Hospital, Heidelberg, Germany (K.M.H.); IBM Research-Israel, Haifa
University Campus, Mount Carmel, Haifa, Israel (S.R.C., T.T., M.O.F.);
University of Maryland Medical Intelligent Imaging (UM2ii) Center and Department
of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of
Medicine, Baltimore, Md (V.S.P.); The Russell H. Morgan Department of Radiology
and Radiological Science, The Johns Hopkins School of Medicine, Sidney Kimmel
Comprehensive Cancer Center, The Johns Hopkins School of Medicine, Baltimore, Md
(V.S.P., M.A.J.); Department of Diagnostic and Interventional Imaging, UT Health
at Houston, Houston, Tex (M.A.J.); Department of Radiological Sciences, David
Geffen School of Medicine, University of California, Los Angeles, Calif (R.Y.,
K.S.); Department of Bioengineering, Henry Samueli School of Engineering,
University of California, Los Angeles, Calif (R.Y., K.S.); Livestrong Cancer
Institutes (J.C.D., T.E.Y.), Departments of Biomedical Engineering, Diagnostic
Medicine, and Oncology (T.E.Y.), and The Oden Institute for Computational
Engineering and Sciences, The University of Texas at Austin, Austin, Tex
(J.C.D., T.E.Y.); Department of Imaging Physics, The University of Texas MD
Anderson Cancer Center, Houston, Tex (T.E.Y.); and Department of Radiology,
University of Michigan, Ann Arbor, Mich (T.L.C.)
| | - Despina Kontos
- From the Department of Radiology & Biomedical Imaging,
University of California San Francisco, San Francisco, Calif (W.L., D.C.N.,
N.M.H.); Department of Radiology, University of Washington, Fred Hutchinson
Cancer Center, 1100 Fairview Ave N, Seattle, WA 98109 (S.C.P., M.H., A.S.K.);
Center for Statistical Sciences, Brown University, Providence, RI (J.S.,
H.S.M.); Center for Magnetic Resonance Research, University of Minnesota,
Minneapolis, Minn (P.J.B.); Athinoula A. Martinos Center for Biomedical Imaging,
Harvard University, Charlestown, Mass (B.A.B., J.K.C.); Center for Research and
Innovation, American College of Radiology, Philadelphia, Pa (M.A.B.); Department
of Health Technology and Informatics, The Hong Kong Polytechnic University, Hung
Hom, Kowloon, Hong Kong SAR (X.T., J.Z., J.C.); Department of Radiology,
University of Pennsylvania, Philadelphia, Pa (D.K., E.A.C., W.C.M.); Department
of Radiology, Columbia University Medical Center, New York, NY (M.L., R.H.);
Division of Medical Image Computing, German Cancer Research Center, Heidelberg,
Germany (O.J.P.V., K.M.H.); Department of Radiation Oncology, Heidelberg
University Hospital, Heidelberg, Germany (K.M.H.); IBM Research-Israel, Haifa
University Campus, Mount Carmel, Haifa, Israel (S.R.C., T.T., M.O.F.);
University of Maryland Medical Intelligent Imaging (UM2ii) Center and Department
of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of
Medicine, Baltimore, Md (V.S.P.); The Russell H. Morgan Department of Radiology
and Radiological Science, The Johns Hopkins School of Medicine, Sidney Kimmel
Comprehensive Cancer Center, The Johns Hopkins School of Medicine, Baltimore, Md
(V.S.P., M.A.J.); Department of Diagnostic and Interventional Imaging, UT Health
at Houston, Houston, Tex (M.A.J.); Department of Radiological Sciences, David
Geffen School of Medicine, University of California, Los Angeles, Calif (R.Y.,
K.S.); Department of Bioengineering, Henry Samueli School of Engineering,
University of California, Los Angeles, Calif (R.Y., K.S.); Livestrong Cancer
Institutes (J.C.D., T.E.Y.), Departments of Biomedical Engineering, Diagnostic
Medicine, and Oncology (T.E.Y.), and The Oden Institute for Computational
Engineering and Sciences, The University of Texas at Austin, Austin, Tex
(J.C.D., T.E.Y.); Department of Imaging Physics, The University of Texas MD
Anderson Cancer Center, Houston, Tex (T.E.Y.); and Department of Radiology,
University of Michigan, Ann Arbor, Mich (T.L.C.)
| | - Eric A. Cohen
- From the Department of Radiology & Biomedical Imaging,
University of California San Francisco, San Francisco, Calif (W.L., D.C.N.,
N.M.H.); Department of Radiology, University of Washington, Fred Hutchinson
Cancer Center, 1100 Fairview Ave N, Seattle, WA 98109 (S.C.P., M.H., A.S.K.);
Center for Statistical Sciences, Brown University, Providence, RI (J.S.,
H.S.M.); Center for Magnetic Resonance Research, University of Minnesota,
Minneapolis, Minn (P.J.B.); Athinoula A. Martinos Center for Biomedical Imaging,
Harvard University, Charlestown, Mass (B.A.B., J.K.C.); Center for Research and
Innovation, American College of Radiology, Philadelphia, Pa (M.A.B.); Department
of Health Technology and Informatics, The Hong Kong Polytechnic University, Hung
Hom, Kowloon, Hong Kong SAR (X.T., J.Z., J.C.); Department of Radiology,
University of Pennsylvania, Philadelphia, Pa (D.K., E.A.C., W.C.M.); Department
of Radiology, Columbia University Medical Center, New York, NY (M.L., R.H.);
Division of Medical Image Computing, German Cancer Research Center, Heidelberg,
Germany (O.J.P.V., K.M.H.); Department of Radiation Oncology, Heidelberg
University Hospital, Heidelberg, Germany (K.M.H.); IBM Research-Israel, Haifa
University Campus, Mount Carmel, Haifa, Israel (S.R.C., T.T., M.O.F.);
University of Maryland Medical Intelligent Imaging (UM2ii) Center and Department
of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of
Medicine, Baltimore, Md (V.S.P.); The Russell H. Morgan Department of Radiology
and Radiological Science, The Johns Hopkins School of Medicine, Sidney Kimmel
Comprehensive Cancer Center, The Johns Hopkins School of Medicine, Baltimore, Md
(V.S.P., M.A.J.); Department of Diagnostic and Interventional Imaging, UT Health
at Houston, Houston, Tex (M.A.J.); Department of Radiological Sciences, David
Geffen School of Medicine, University of California, Los Angeles, Calif (R.Y.,
K.S.); Department of Bioengineering, Henry Samueli School of Engineering,
University of California, Los Angeles, Calif (R.Y., K.S.); Livestrong Cancer
Institutes (J.C.D., T.E.Y.), Departments of Biomedical Engineering, Diagnostic
Medicine, and Oncology (T.E.Y.), and The Oden Institute for Computational
Engineering and Sciences, The University of Texas at Austin, Austin, Tex
(J.C.D., T.E.Y.); Department of Imaging Physics, The University of Texas MD
Anderson Cancer Center, Houston, Tex (T.E.Y.); and Department of Radiology,
University of Michigan, Ann Arbor, Mich (T.L.C.)
| | - Walter C. Mankowski
- From the Department of Radiology & Biomedical Imaging,
University of California San Francisco, San Francisco, Calif (W.L., D.C.N.,
N.M.H.); Department of Radiology, University of Washington, Fred Hutchinson
Cancer Center, 1100 Fairview Ave N, Seattle, WA 98109 (S.C.P., M.H., A.S.K.);
Center for Statistical Sciences, Brown University, Providence, RI (J.S.,
H.S.M.); Center for Magnetic Resonance Research, University of Minnesota,
Minneapolis, Minn (P.J.B.); Athinoula A. Martinos Center for Biomedical Imaging,
Harvard University, Charlestown, Mass (B.A.B., J.K.C.); Center for Research and
Innovation, American College of Radiology, Philadelphia, Pa (M.A.B.); Department
of Health Technology and Informatics, The Hong Kong Polytechnic University, Hung
Hom, Kowloon, Hong Kong SAR (X.T., J.Z., J.C.); Department of Radiology,
University of Pennsylvania, Philadelphia, Pa (D.K., E.A.C., W.C.M.); Department
of Radiology, Columbia University Medical Center, New York, NY (M.L., R.H.);
Division of Medical Image Computing, German Cancer Research Center, Heidelberg,
Germany (O.J.P.V., K.M.H.); Department of Radiation Oncology, Heidelberg
University Hospital, Heidelberg, Germany (K.M.H.); IBM Research-Israel, Haifa
University Campus, Mount Carmel, Haifa, Israel (S.R.C., T.T., M.O.F.);
University of Maryland Medical Intelligent Imaging (UM2ii) Center and Department
of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of
Medicine, Baltimore, Md (V.S.P.); The Russell H. Morgan Department of Radiology
and Radiological Science, The Johns Hopkins School of Medicine, Sidney Kimmel
Comprehensive Cancer Center, The Johns Hopkins School of Medicine, Baltimore, Md
(V.S.P., M.A.J.); Department of Diagnostic and Interventional Imaging, UT Health
at Houston, Houston, Tex (M.A.J.); Department of Radiological Sciences, David
Geffen School of Medicine, University of California, Los Angeles, Calif (R.Y.,
K.S.); Department of Bioengineering, Henry Samueli School of Engineering,
University of California, Los Angeles, Calif (R.Y., K.S.); Livestrong Cancer
Institutes (J.C.D., T.E.Y.), Departments of Biomedical Engineering, Diagnostic
Medicine, and Oncology (T.E.Y.), and The Oden Institute for Computational
Engineering and Sciences, The University of Texas at Austin, Austin, Tex
(J.C.D., T.E.Y.); Department of Imaging Physics, The University of Texas MD
Anderson Cancer Center, Houston, Tex (T.E.Y.); and Department of Radiology,
University of Michigan, Ann Arbor, Mich (T.L.C.)
| | - Michael Liu
- From the Department of Radiology & Biomedical Imaging,
University of California San Francisco, San Francisco, Calif (W.L., D.C.N.,
N.M.H.); Department of Radiology, University of Washington, Fred Hutchinson
Cancer Center, 1100 Fairview Ave N, Seattle, WA 98109 (S.C.P., M.H., A.S.K.);
Center for Statistical Sciences, Brown University, Providence, RI (J.S.,
H.S.M.); Center for Magnetic Resonance Research, University of Minnesota,
Minneapolis, Minn (P.J.B.); Athinoula A. Martinos Center for Biomedical Imaging,
Harvard University, Charlestown, Mass (B.A.B., J.K.C.); Center for Research and
Innovation, American College of Radiology, Philadelphia, Pa (M.A.B.); Department
of Health Technology and Informatics, The Hong Kong Polytechnic University, Hung
Hom, Kowloon, Hong Kong SAR (X.T., J.Z., J.C.); Department of Radiology,
University of Pennsylvania, Philadelphia, Pa (D.K., E.A.C., W.C.M.); Department
of Radiology, Columbia University Medical Center, New York, NY (M.L., R.H.);
Division of Medical Image Computing, German Cancer Research Center, Heidelberg,
Germany (O.J.P.V., K.M.H.); Department of Radiation Oncology, Heidelberg
University Hospital, Heidelberg, Germany (K.M.H.); IBM Research-Israel, Haifa
University Campus, Mount Carmel, Haifa, Israel (S.R.C., T.T., M.O.F.);
University of Maryland Medical Intelligent Imaging (UM2ii) Center and Department
of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of
Medicine, Baltimore, Md (V.S.P.); The Russell H. Morgan Department of Radiology
and Radiological Science, The Johns Hopkins School of Medicine, Sidney Kimmel
Comprehensive Cancer Center, The Johns Hopkins School of Medicine, Baltimore, Md
(V.S.P., M.A.J.); Department of Diagnostic and Interventional Imaging, UT Health
at Houston, Houston, Tex (M.A.J.); Department of Radiological Sciences, David
Geffen School of Medicine, University of California, Los Angeles, Calif (R.Y.,
K.S.); Department of Bioengineering, Henry Samueli School of Engineering,
University of California, Los Angeles, Calif (R.Y., K.S.); Livestrong Cancer
Institutes (J.C.D., T.E.Y.), Departments of Biomedical Engineering, Diagnostic
Medicine, and Oncology (T.E.Y.), and The Oden Institute for Computational
Engineering and Sciences, The University of Texas at Austin, Austin, Tex
(J.C.D., T.E.Y.); Department of Imaging Physics, The University of Texas MD
Anderson Cancer Center, Houston, Tex (T.E.Y.); and Department of Radiology,
University of Michigan, Ann Arbor, Mich (T.L.C.)
| | - Richard Ha
- From the Department of Radiology & Biomedical Imaging,
University of California San Francisco, San Francisco, Calif (W.L., D.C.N.,
N.M.H.); Department of Radiology, University of Washington, Fred Hutchinson
Cancer Center, 1100 Fairview Ave N, Seattle, WA 98109 (S.C.P., M.H., A.S.K.);
Center for Statistical Sciences, Brown University, Providence, RI (J.S.,
H.S.M.); Center for Magnetic Resonance Research, University of Minnesota,
Minneapolis, Minn (P.J.B.); Athinoula A. Martinos Center for Biomedical Imaging,
Harvard University, Charlestown, Mass (B.A.B., J.K.C.); Center for Research and
Innovation, American College of Radiology, Philadelphia, Pa (M.A.B.); Department
of Health Technology and Informatics, The Hong Kong Polytechnic University, Hung
Hom, Kowloon, Hong Kong SAR (X.T., J.Z., J.C.); Department of Radiology,
University of Pennsylvania, Philadelphia, Pa (D.K., E.A.C., W.C.M.); Department
of Radiology, Columbia University Medical Center, New York, NY (M.L., R.H.);
Division of Medical Image Computing, German Cancer Research Center, Heidelberg,
Germany (O.J.P.V., K.M.H.); Department of Radiation Oncology, Heidelberg
University Hospital, Heidelberg, Germany (K.M.H.); IBM Research-Israel, Haifa
University Campus, Mount Carmel, Haifa, Israel (S.R.C., T.T., M.O.F.);
University of Maryland Medical Intelligent Imaging (UM2ii) Center and Department
of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of
Medicine, Baltimore, Md (V.S.P.); The Russell H. Morgan Department of Radiology
and Radiological Science, The Johns Hopkins School of Medicine, Sidney Kimmel
Comprehensive Cancer Center, The Johns Hopkins School of Medicine, Baltimore, Md
(V.S.P., M.A.J.); Department of Diagnostic and Interventional Imaging, UT Health
at Houston, Houston, Tex (M.A.J.); Department of Radiological Sciences, David
Geffen School of Medicine, University of California, Los Angeles, Calif (R.Y.,
K.S.); Department of Bioengineering, Henry Samueli School of Engineering,
University of California, Los Angeles, Calif (R.Y., K.S.); Livestrong Cancer
Institutes (J.C.D., T.E.Y.), Departments of Biomedical Engineering, Diagnostic
Medicine, and Oncology (T.E.Y.), and The Oden Institute for Computational
Engineering and Sciences, The University of Texas at Austin, Austin, Tex
(J.C.D., T.E.Y.); Department of Imaging Physics, The University of Texas MD
Anderson Cancer Center, Houston, Tex (T.E.Y.); and Department of Radiology,
University of Michigan, Ann Arbor, Mich (T.L.C.)
| | - Oscar J. Pellicer-Valero
- From the Department of Radiology & Biomedical Imaging,
University of California San Francisco, San Francisco, Calif (W.L., D.C.N.,
N.M.H.); Department of Radiology, University of Washington, Fred Hutchinson
Cancer Center, 1100 Fairview Ave N, Seattle, WA 98109 (S.C.P., M.H., A.S.K.);
Center for Statistical Sciences, Brown University, Providence, RI (J.S.,
H.S.M.); Center for Magnetic Resonance Research, University of Minnesota,
Minneapolis, Minn (P.J.B.); Athinoula A. Martinos Center for Biomedical Imaging,
Harvard University, Charlestown, Mass (B.A.B., J.K.C.); Center for Research and
Innovation, American College of Radiology, Philadelphia, Pa (M.A.B.); Department
of Health Technology and Informatics, The Hong Kong Polytechnic University, Hung
Hom, Kowloon, Hong Kong SAR (X.T., J.Z., J.C.); Department of Radiology,
University of Pennsylvania, Philadelphia, Pa (D.K., E.A.C., W.C.M.); Department
of Radiology, Columbia University Medical Center, New York, NY (M.L., R.H.);
Division of Medical Image Computing, German Cancer Research Center, Heidelberg,
Germany (O.J.P.V., K.M.H.); Department of Radiation Oncology, Heidelberg
University Hospital, Heidelberg, Germany (K.M.H.); IBM Research-Israel, Haifa
University Campus, Mount Carmel, Haifa, Israel (S.R.C., T.T., M.O.F.);
University of Maryland Medical Intelligent Imaging (UM2ii) Center and Department
of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of
Medicine, Baltimore, Md (V.S.P.); The Russell H. Morgan Department of Radiology
and Radiological Science, The Johns Hopkins School of Medicine, Sidney Kimmel
Comprehensive Cancer Center, The Johns Hopkins School of Medicine, Baltimore, Md
(V.S.P., M.A.J.); Department of Diagnostic and Interventional Imaging, UT Health
at Houston, Houston, Tex (M.A.J.); Department of Radiological Sciences, David
Geffen School of Medicine, University of California, Los Angeles, Calif (R.Y.,
K.S.); Department of Bioengineering, Henry Samueli School of Engineering,
University of California, Los Angeles, Calif (R.Y., K.S.); Livestrong Cancer
Institutes (J.C.D., T.E.Y.), Departments of Biomedical Engineering, Diagnostic
Medicine, and Oncology (T.E.Y.), and The Oden Institute for Computational
Engineering and Sciences, The University of Texas at Austin, Austin, Tex
(J.C.D., T.E.Y.); Department of Imaging Physics, The University of Texas MD
Anderson Cancer Center, Houston, Tex (T.E.Y.); and Department of Radiology,
University of Michigan, Ann Arbor, Mich (T.L.C.)
| | - Klaus Maier-Hein
- From the Department of Radiology & Biomedical Imaging,
University of California San Francisco, San Francisco, Calif (W.L., D.C.N.,
N.M.H.); Department of Radiology, University of Washington, Fred Hutchinson
Cancer Center, 1100 Fairview Ave N, Seattle, WA 98109 (S.C.P., M.H., A.S.K.);
Center for Statistical Sciences, Brown University, Providence, RI (J.S.,
H.S.M.); Center for Magnetic Resonance Research, University of Minnesota,
Minneapolis, Minn (P.J.B.); Athinoula A. Martinos Center for Biomedical Imaging,
Harvard University, Charlestown, Mass (B.A.B., J.K.C.); Center for Research and
Innovation, American College of Radiology, Philadelphia, Pa (M.A.B.); Department
of Health Technology and Informatics, The Hong Kong Polytechnic University, Hung
Hom, Kowloon, Hong Kong SAR (X.T., J.Z., J.C.); Department of Radiology,
University of Pennsylvania, Philadelphia, Pa (D.K., E.A.C., W.C.M.); Department
of Radiology, Columbia University Medical Center, New York, NY (M.L., R.H.);
Division of Medical Image Computing, German Cancer Research Center, Heidelberg,
Germany (O.J.P.V., K.M.H.); Department of Radiation Oncology, Heidelberg
University Hospital, Heidelberg, Germany (K.M.H.); IBM Research-Israel, Haifa
University Campus, Mount Carmel, Haifa, Israel (S.R.C., T.T., M.O.F.);
University of Maryland Medical Intelligent Imaging (UM2ii) Center and Department
of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of
Medicine, Baltimore, Md (V.S.P.); The Russell H. Morgan Department of Radiology
and Radiological Science, The Johns Hopkins School of Medicine, Sidney Kimmel
Comprehensive Cancer Center, The Johns Hopkins School of Medicine, Baltimore, Md
(V.S.P., M.A.J.); Department of Diagnostic and Interventional Imaging, UT Health
at Houston, Houston, Tex (M.A.J.); Department of Radiological Sciences, David
Geffen School of Medicine, University of California, Los Angeles, Calif (R.Y.,
K.S.); Department of Bioengineering, Henry Samueli School of Engineering,
University of California, Los Angeles, Calif (R.Y., K.S.); Livestrong Cancer
Institutes (J.C.D., T.E.Y.), Departments of Biomedical Engineering, Diagnostic
Medicine, and Oncology (T.E.Y.), and The Oden Institute for Computational
Engineering and Sciences, The University of Texas at Austin, Austin, Tex
(J.C.D., T.E.Y.); Department of Imaging Physics, The University of Texas MD
Anderson Cancer Center, Houston, Tex (T.E.Y.); and Department of Radiology,
University of Michigan, Ann Arbor, Mich (T.L.C.)
| | - Simona Rabinovici-Cohen
- From the Department of Radiology & Biomedical Imaging,
University of California San Francisco, San Francisco, Calif (W.L., D.C.N.,
N.M.H.); Department of Radiology, University of Washington, Fred Hutchinson
Cancer Center, 1100 Fairview Ave N, Seattle, WA 98109 (S.C.P., M.H., A.S.K.);
Center for Statistical Sciences, Brown University, Providence, RI (J.S.,
H.S.M.); Center for Magnetic Resonance Research, University of Minnesota,
Minneapolis, Minn (P.J.B.); Athinoula A. Martinos Center for Biomedical Imaging,
Harvard University, Charlestown, Mass (B.A.B., J.K.C.); Center for Research and
Innovation, American College of Radiology, Philadelphia, Pa (M.A.B.); Department
of Health Technology and Informatics, The Hong Kong Polytechnic University, Hung
Hom, Kowloon, Hong Kong SAR (X.T., J.Z., J.C.); Department of Radiology,
University of Pennsylvania, Philadelphia, Pa (D.K., E.A.C., W.C.M.); Department
of Radiology, Columbia University Medical Center, New York, NY (M.L., R.H.);
Division of Medical Image Computing, German Cancer Research Center, Heidelberg,
Germany (O.J.P.V., K.M.H.); Department of Radiation Oncology, Heidelberg
University Hospital, Heidelberg, Germany (K.M.H.); IBM Research-Israel, Haifa
University Campus, Mount Carmel, Haifa, Israel (S.R.C., T.T., M.O.F.);
University of Maryland Medical Intelligent Imaging (UM2ii) Center and Department
of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of
Medicine, Baltimore, Md (V.S.P.); The Russell H. Morgan Department of Radiology
and Radiological Science, The Johns Hopkins School of Medicine, Sidney Kimmel
Comprehensive Cancer Center, The Johns Hopkins School of Medicine, Baltimore, Md
(V.S.P., M.A.J.); Department of Diagnostic and Interventional Imaging, UT Health
at Houston, Houston, Tex (M.A.J.); Department of Radiological Sciences, David
Geffen School of Medicine, University of California, Los Angeles, Calif (R.Y.,
K.S.); Department of Bioengineering, Henry Samueli School of Engineering,
University of California, Los Angeles, Calif (R.Y., K.S.); Livestrong Cancer
Institutes (J.C.D., T.E.Y.), Departments of Biomedical Engineering, Diagnostic
Medicine, and Oncology (T.E.Y.), and The Oden Institute for Computational
Engineering and Sciences, The University of Texas at Austin, Austin, Tex
(J.C.D., T.E.Y.); Department of Imaging Physics, The University of Texas MD
Anderson Cancer Center, Houston, Tex (T.E.Y.); and Department of Radiology,
University of Michigan, Ann Arbor, Mich (T.L.C.)
| | - Tal Tlusty
- From the Department of Radiology & Biomedical Imaging,
University of California San Francisco, San Francisco, Calif (W.L., D.C.N.,
N.M.H.); Department of Radiology, University of Washington, Fred Hutchinson
Cancer Center, 1100 Fairview Ave N, Seattle, WA 98109 (S.C.P., M.H., A.S.K.);
Center for Statistical Sciences, Brown University, Providence, RI (J.S.,
H.S.M.); Center for Magnetic Resonance Research, University of Minnesota,
Minneapolis, Minn (P.J.B.); Athinoula A. Martinos Center for Biomedical Imaging,
Harvard University, Charlestown, Mass (B.A.B., J.K.C.); Center for Research and
Innovation, American College of Radiology, Philadelphia, Pa (M.A.B.); Department
of Health Technology and Informatics, The Hong Kong Polytechnic University, Hung
Hom, Kowloon, Hong Kong SAR (X.T., J.Z., J.C.); Department of Radiology,
University of Pennsylvania, Philadelphia, Pa (D.K., E.A.C., W.C.M.); Department
of Radiology, Columbia University Medical Center, New York, NY (M.L., R.H.);
Division of Medical Image Computing, German Cancer Research Center, Heidelberg,
Germany (O.J.P.V., K.M.H.); Department of Radiation Oncology, Heidelberg
University Hospital, Heidelberg, Germany (K.M.H.); IBM Research-Israel, Haifa
University Campus, Mount Carmel, Haifa, Israel (S.R.C., T.T., M.O.F.);
University of Maryland Medical Intelligent Imaging (UM2ii) Center and Department
of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of
Medicine, Baltimore, Md (V.S.P.); The Russell H. Morgan Department of Radiology
and Radiological Science, The Johns Hopkins School of Medicine, Sidney Kimmel
Comprehensive Cancer Center, The Johns Hopkins School of Medicine, Baltimore, Md
(V.S.P., M.A.J.); Department of Diagnostic and Interventional Imaging, UT Health
at Houston, Houston, Tex (M.A.J.); Department of Radiological Sciences, David
Geffen School of Medicine, University of California, Los Angeles, Calif (R.Y.,
K.S.); Department of Bioengineering, Henry Samueli School of Engineering,
University of California, Los Angeles, Calif (R.Y., K.S.); Livestrong Cancer
Institutes (J.C.D., T.E.Y.), Departments of Biomedical Engineering, Diagnostic
Medicine, and Oncology (T.E.Y.), and The Oden Institute for Computational
Engineering and Sciences, The University of Texas at Austin, Austin, Tex
(J.C.D., T.E.Y.); Department of Imaging Physics, The University of Texas MD
Anderson Cancer Center, Houston, Tex (T.E.Y.); and Department of Radiology,
University of Michigan, Ann Arbor, Mich (T.L.C.)
| | - Michal Ozery-Flato
- From the Department of Radiology & Biomedical Imaging,
University of California San Francisco, San Francisco, Calif (W.L., D.C.N.,
N.M.H.); Department of Radiology, University of Washington, Fred Hutchinson
Cancer Center, 1100 Fairview Ave N, Seattle, WA 98109 (S.C.P., M.H., A.S.K.);
Center for Statistical Sciences, Brown University, Providence, RI (J.S.,
H.S.M.); Center for Magnetic Resonance Research, University of Minnesota,
Minneapolis, Minn (P.J.B.); Athinoula A. Martinos Center for Biomedical Imaging,
Harvard University, Charlestown, Mass (B.A.B., J.K.C.); Center for Research and
Innovation, American College of Radiology, Philadelphia, Pa (M.A.B.); Department
of Health Technology and Informatics, The Hong Kong Polytechnic University, Hung
Hom, Kowloon, Hong Kong SAR (X.T., J.Z., J.C.); Department of Radiology,
University of Pennsylvania, Philadelphia, Pa (D.K., E.A.C., W.C.M.); Department
of Radiology, Columbia University Medical Center, New York, NY (M.L., R.H.);
Division of Medical Image Computing, German Cancer Research Center, Heidelberg,
Germany (O.J.P.V., K.M.H.); Department of Radiation Oncology, Heidelberg
University Hospital, Heidelberg, Germany (K.M.H.); IBM Research-Israel, Haifa
University Campus, Mount Carmel, Haifa, Israel (S.R.C., T.T., M.O.F.);
University of Maryland Medical Intelligent Imaging (UM2ii) Center and Department
of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of
Medicine, Baltimore, Md (V.S.P.); The Russell H. Morgan Department of Radiology
and Radiological Science, The Johns Hopkins School of Medicine, Sidney Kimmel
Comprehensive Cancer Center, The Johns Hopkins School of Medicine, Baltimore, Md
(V.S.P., M.A.J.); Department of Diagnostic and Interventional Imaging, UT Health
at Houston, Houston, Tex (M.A.J.); Department of Radiological Sciences, David
Geffen School of Medicine, University of California, Los Angeles, Calif (R.Y.,
K.S.); Department of Bioengineering, Henry Samueli School of Engineering,
University of California, Los Angeles, Calif (R.Y., K.S.); Livestrong Cancer
Institutes (J.C.D., T.E.Y.), Departments of Biomedical Engineering, Diagnostic
Medicine, and Oncology (T.E.Y.), and The Oden Institute for Computational
Engineering and Sciences, The University of Texas at Austin, Austin, Tex
(J.C.D., T.E.Y.); Department of Imaging Physics, The University of Texas MD
Anderson Cancer Center, Houston, Tex (T.E.Y.); and Department of Radiology,
University of Michigan, Ann Arbor, Mich (T.L.C.)
| | - Vishwa S. Parekh
- From the Department of Radiology & Biomedical Imaging,
University of California San Francisco, San Francisco, Calif (W.L., D.C.N.,
N.M.H.); Department of Radiology, University of Washington, Fred Hutchinson
Cancer Center, 1100 Fairview Ave N, Seattle, WA 98109 (S.C.P., M.H., A.S.K.);
Center for Statistical Sciences, Brown University, Providence, RI (J.S.,
H.S.M.); Center for Magnetic Resonance Research, University of Minnesota,
Minneapolis, Minn (P.J.B.); Athinoula A. Martinos Center for Biomedical Imaging,
Harvard University, Charlestown, Mass (B.A.B., J.K.C.); Center for Research and
Innovation, American College of Radiology, Philadelphia, Pa (M.A.B.); Department
of Health Technology and Informatics, The Hong Kong Polytechnic University, Hung
Hom, Kowloon, Hong Kong SAR (X.T., J.Z., J.C.); Department of Radiology,
University of Pennsylvania, Philadelphia, Pa (D.K., E.A.C., W.C.M.); Department
of Radiology, Columbia University Medical Center, New York, NY (M.L., R.H.);
Division of Medical Image Computing, German Cancer Research Center, Heidelberg,
Germany (O.J.P.V., K.M.H.); Department of Radiation Oncology, Heidelberg
University Hospital, Heidelberg, Germany (K.M.H.); IBM Research-Israel, Haifa
University Campus, Mount Carmel, Haifa, Israel (S.R.C., T.T., M.O.F.);
University of Maryland Medical Intelligent Imaging (UM2ii) Center and Department
of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of
Medicine, Baltimore, Md (V.S.P.); The Russell H. Morgan Department of Radiology
and Radiological Science, The Johns Hopkins School of Medicine, Sidney Kimmel
Comprehensive Cancer Center, The Johns Hopkins School of Medicine, Baltimore, Md
(V.S.P., M.A.J.); Department of Diagnostic and Interventional Imaging, UT Health
at Houston, Houston, Tex (M.A.J.); Department of Radiological Sciences, David
Geffen School of Medicine, University of California, Los Angeles, Calif (R.Y.,
K.S.); Department of Bioengineering, Henry Samueli School of Engineering,
University of California, Los Angeles, Calif (R.Y., K.S.); Livestrong Cancer
Institutes (J.C.D., T.E.Y.), Departments of Biomedical Engineering, Diagnostic
Medicine, and Oncology (T.E.Y.), and The Oden Institute for Computational
Engineering and Sciences, The University of Texas at Austin, Austin, Tex
(J.C.D., T.E.Y.); Department of Imaging Physics, The University of Texas MD
Anderson Cancer Center, Houston, Tex (T.E.Y.); and Department of Radiology,
University of Michigan, Ann Arbor, Mich (T.L.C.)
| | - Michael A. Jacobs
- From the Department of Radiology & Biomedical Imaging,
University of California San Francisco, San Francisco, Calif (W.L., D.C.N.,
N.M.H.); Department of Radiology, University of Washington, Fred Hutchinson
Cancer Center, 1100 Fairview Ave N, Seattle, WA 98109 (S.C.P., M.H., A.S.K.);
Center for Statistical Sciences, Brown University, Providence, RI (J.S.,
H.S.M.); Center for Magnetic Resonance Research, University of Minnesota,
Minneapolis, Minn (P.J.B.); Athinoula A. Martinos Center for Biomedical Imaging,
Harvard University, Charlestown, Mass (B.A.B., J.K.C.); Center for Research and
Innovation, American College of Radiology, Philadelphia, Pa (M.A.B.); Department
of Health Technology and Informatics, The Hong Kong Polytechnic University, Hung
Hom, Kowloon, Hong Kong SAR (X.T., J.Z., J.C.); Department of Radiology,
University of Pennsylvania, Philadelphia, Pa (D.K., E.A.C., W.C.M.); Department
of Radiology, Columbia University Medical Center, New York, NY (M.L., R.H.);
Division of Medical Image Computing, German Cancer Research Center, Heidelberg,
Germany (O.J.P.V., K.M.H.); Department of Radiation Oncology, Heidelberg
University Hospital, Heidelberg, Germany (K.M.H.); IBM Research-Israel, Haifa
University Campus, Mount Carmel, Haifa, Israel (S.R.C., T.T., M.O.F.);
University of Maryland Medical Intelligent Imaging (UM2ii) Center and Department
of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of
Medicine, Baltimore, Md (V.S.P.); The Russell H. Morgan Department of Radiology
and Radiological Science, The Johns Hopkins School of Medicine, Sidney Kimmel
Comprehensive Cancer Center, The Johns Hopkins School of Medicine, Baltimore, Md
(V.S.P., M.A.J.); Department of Diagnostic and Interventional Imaging, UT Health
at Houston, Houston, Tex (M.A.J.); Department of Radiological Sciences, David
Geffen School of Medicine, University of California, Los Angeles, Calif (R.Y.,
K.S.); Department of Bioengineering, Henry Samueli School of Engineering,
University of California, Los Angeles, Calif (R.Y., K.S.); Livestrong Cancer
Institutes (J.C.D., T.E.Y.), Departments of Biomedical Engineering, Diagnostic
Medicine, and Oncology (T.E.Y.), and The Oden Institute for Computational
Engineering and Sciences, The University of Texas at Austin, Austin, Tex
(J.C.D., T.E.Y.); Department of Imaging Physics, The University of Texas MD
Anderson Cancer Center, Houston, Tex (T.E.Y.); and Department of Radiology,
University of Michigan, Ann Arbor, Mich (T.L.C.)
| | - Ran Yan
- From the Department of Radiology & Biomedical Imaging,
University of California San Francisco, San Francisco, Calif (W.L., D.C.N.,
N.M.H.); Department of Radiology, University of Washington, Fred Hutchinson
Cancer Center, 1100 Fairview Ave N, Seattle, WA 98109 (S.C.P., M.H., A.S.K.);
Center for Statistical Sciences, Brown University, Providence, RI (J.S.,
H.S.M.); Center for Magnetic Resonance Research, University of Minnesota,
Minneapolis, Minn (P.J.B.); Athinoula A. Martinos Center for Biomedical Imaging,
Harvard University, Charlestown, Mass (B.A.B., J.K.C.); Center for Research and
Innovation, American College of Radiology, Philadelphia, Pa (M.A.B.); Department
of Health Technology and Informatics, The Hong Kong Polytechnic University, Hung
Hom, Kowloon, Hong Kong SAR (X.T., J.Z., J.C.); Department of Radiology,
University of Pennsylvania, Philadelphia, Pa (D.K., E.A.C., W.C.M.); Department
of Radiology, Columbia University Medical Center, New York, NY (M.L., R.H.);
Division of Medical Image Computing, German Cancer Research Center, Heidelberg,
Germany (O.J.P.V., K.M.H.); Department of Radiation Oncology, Heidelberg
University Hospital, Heidelberg, Germany (K.M.H.); IBM Research-Israel, Haifa
University Campus, Mount Carmel, Haifa, Israel (S.R.C., T.T., M.O.F.);
University of Maryland Medical Intelligent Imaging (UM2ii) Center and Department
of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of
Medicine, Baltimore, Md (V.S.P.); The Russell H. Morgan Department of Radiology
and Radiological Science, The Johns Hopkins School of Medicine, Sidney Kimmel
Comprehensive Cancer Center, The Johns Hopkins School of Medicine, Baltimore, Md
(V.S.P., M.A.J.); Department of Diagnostic and Interventional Imaging, UT Health
at Houston, Houston, Tex (M.A.J.); Department of Radiological Sciences, David
Geffen School of Medicine, University of California, Los Angeles, Calif (R.Y.,
K.S.); Department of Bioengineering, Henry Samueli School of Engineering,
University of California, Los Angeles, Calif (R.Y., K.S.); Livestrong Cancer
Institutes (J.C.D., T.E.Y.), Departments of Biomedical Engineering, Diagnostic
Medicine, and Oncology (T.E.Y.), and The Oden Institute for Computational
Engineering and Sciences, The University of Texas at Austin, Austin, Tex
(J.C.D., T.E.Y.); Department of Imaging Physics, The University of Texas MD
Anderson Cancer Center, Houston, Tex (T.E.Y.); and Department of Radiology,
University of Michigan, Ann Arbor, Mich (T.L.C.)
| | - Kyunghyun Sung
- From the Department of Radiology & Biomedical Imaging,
University of California San Francisco, San Francisco, Calif (W.L., D.C.N.,
N.M.H.); Department of Radiology, University of Washington, Fred Hutchinson
Cancer Center, 1100 Fairview Ave N, Seattle, WA 98109 (S.C.P., M.H., A.S.K.);
Center for Statistical Sciences, Brown University, Providence, RI (J.S.,
H.S.M.); Center for Magnetic Resonance Research, University of Minnesota,
Minneapolis, Minn (P.J.B.); Athinoula A. Martinos Center for Biomedical Imaging,
Harvard University, Charlestown, Mass (B.A.B., J.K.C.); Center for Research and
Innovation, American College of Radiology, Philadelphia, Pa (M.A.B.); Department
of Health Technology and Informatics, The Hong Kong Polytechnic University, Hung
Hom, Kowloon, Hong Kong SAR (X.T., J.Z., J.C.); Department of Radiology,
University of Pennsylvania, Philadelphia, Pa (D.K., E.A.C., W.C.M.); Department
of Radiology, Columbia University Medical Center, New York, NY (M.L., R.H.);
Division of Medical Image Computing, German Cancer Research Center, Heidelberg,
Germany (O.J.P.V., K.M.H.); Department of Radiation Oncology, Heidelberg
University Hospital, Heidelberg, Germany (K.M.H.); IBM Research-Israel, Haifa
University Campus, Mount Carmel, Haifa, Israel (S.R.C., T.T., M.O.F.);
University of Maryland Medical Intelligent Imaging (UM2ii) Center and Department
of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of
Medicine, Baltimore, Md (V.S.P.); The Russell H. Morgan Department of Radiology
and Radiological Science, The Johns Hopkins School of Medicine, Sidney Kimmel
Comprehensive Cancer Center, The Johns Hopkins School of Medicine, Baltimore, Md
(V.S.P., M.A.J.); Department of Diagnostic and Interventional Imaging, UT Health
at Houston, Houston, Tex (M.A.J.); Department of Radiological Sciences, David
Geffen School of Medicine, University of California, Los Angeles, Calif (R.Y.,
K.S.); Department of Bioengineering, Henry Samueli School of Engineering,
University of California, Los Angeles, Calif (R.Y., K.S.); Livestrong Cancer
Institutes (J.C.D., T.E.Y.), Departments of Biomedical Engineering, Diagnostic
Medicine, and Oncology (T.E.Y.), and The Oden Institute for Computational
Engineering and Sciences, The University of Texas at Austin, Austin, Tex
(J.C.D., T.E.Y.); Department of Imaging Physics, The University of Texas MD
Anderson Cancer Center, Houston, Tex (T.E.Y.); and Department of Radiology,
University of Michigan, Ann Arbor, Mich (T.L.C.)
| | - Anum S. Kazerouni
- From the Department of Radiology & Biomedical Imaging,
University of California San Francisco, San Francisco, Calif (W.L., D.C.N.,
N.M.H.); Department of Radiology, University of Washington, Fred Hutchinson
Cancer Center, 1100 Fairview Ave N, Seattle, WA 98109 (S.C.P., M.H., A.S.K.);
Center for Statistical Sciences, Brown University, Providence, RI (J.S.,
H.S.M.); Center for Magnetic Resonance Research, University of Minnesota,
Minneapolis, Minn (P.J.B.); Athinoula A. Martinos Center for Biomedical Imaging,
Harvard University, Charlestown, Mass (B.A.B., J.K.C.); Center for Research and
Innovation, American College of Radiology, Philadelphia, Pa (M.A.B.); Department
of Health Technology and Informatics, The Hong Kong Polytechnic University, Hung
Hom, Kowloon, Hong Kong SAR (X.T., J.Z., J.C.); Department of Radiology,
University of Pennsylvania, Philadelphia, Pa (D.K., E.A.C., W.C.M.); Department
of Radiology, Columbia University Medical Center, New York, NY (M.L., R.H.);
Division of Medical Image Computing, German Cancer Research Center, Heidelberg,
Germany (O.J.P.V., K.M.H.); Department of Radiation Oncology, Heidelberg
University Hospital, Heidelberg, Germany (K.M.H.); IBM Research-Israel, Haifa
University Campus, Mount Carmel, Haifa, Israel (S.R.C., T.T., M.O.F.);
University of Maryland Medical Intelligent Imaging (UM2ii) Center and Department
of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of
Medicine, Baltimore, Md (V.S.P.); The Russell H. Morgan Department of Radiology
and Radiological Science, The Johns Hopkins School of Medicine, Sidney Kimmel
Comprehensive Cancer Center, The Johns Hopkins School of Medicine, Baltimore, Md
(V.S.P., M.A.J.); Department of Diagnostic and Interventional Imaging, UT Health
at Houston, Houston, Tex (M.A.J.); Department of Radiological Sciences, David
Geffen School of Medicine, University of California, Los Angeles, Calif (R.Y.,
K.S.); Department of Bioengineering, Henry Samueli School of Engineering,
University of California, Los Angeles, Calif (R.Y., K.S.); Livestrong Cancer
Institutes (J.C.D., T.E.Y.), Departments of Biomedical Engineering, Diagnostic
Medicine, and Oncology (T.E.Y.), and The Oden Institute for Computational
Engineering and Sciences, The University of Texas at Austin, Austin, Tex
(J.C.D., T.E.Y.); Department of Imaging Physics, The University of Texas MD
Anderson Cancer Center, Houston, Tex (T.E.Y.); and Department of Radiology,
University of Michigan, Ann Arbor, Mich (T.L.C.)
| | - Julie C. DiCarlo
- From the Department of Radiology & Biomedical Imaging,
University of California San Francisco, San Francisco, Calif (W.L., D.C.N.,
N.M.H.); Department of Radiology, University of Washington, Fred Hutchinson
Cancer Center, 1100 Fairview Ave N, Seattle, WA 98109 (S.C.P., M.H., A.S.K.);
Center for Statistical Sciences, Brown University, Providence, RI (J.S.,
H.S.M.); Center for Magnetic Resonance Research, University of Minnesota,
Minneapolis, Minn (P.J.B.); Athinoula A. Martinos Center for Biomedical Imaging,
Harvard University, Charlestown, Mass (B.A.B., J.K.C.); Center for Research and
Innovation, American College of Radiology, Philadelphia, Pa (M.A.B.); Department
of Health Technology and Informatics, The Hong Kong Polytechnic University, Hung
Hom, Kowloon, Hong Kong SAR (X.T., J.Z., J.C.); Department of Radiology,
University of Pennsylvania, Philadelphia, Pa (D.K., E.A.C., W.C.M.); Department
of Radiology, Columbia University Medical Center, New York, NY (M.L., R.H.);
Division of Medical Image Computing, German Cancer Research Center, Heidelberg,
Germany (O.J.P.V., K.M.H.); Department of Radiation Oncology, Heidelberg
University Hospital, Heidelberg, Germany (K.M.H.); IBM Research-Israel, Haifa
University Campus, Mount Carmel, Haifa, Israel (S.R.C., T.T., M.O.F.);
University of Maryland Medical Intelligent Imaging (UM2ii) Center and Department
of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of
Medicine, Baltimore, Md (V.S.P.); The Russell H. Morgan Department of Radiology
and Radiological Science, The Johns Hopkins School of Medicine, Sidney Kimmel
Comprehensive Cancer Center, The Johns Hopkins School of Medicine, Baltimore, Md
(V.S.P., M.A.J.); Department of Diagnostic and Interventional Imaging, UT Health
at Houston, Houston, Tex (M.A.J.); Department of Radiological Sciences, David
Geffen School of Medicine, University of California, Los Angeles, Calif (R.Y.,
K.S.); Department of Bioengineering, Henry Samueli School of Engineering,
University of California, Los Angeles, Calif (R.Y., K.S.); Livestrong Cancer
Institutes (J.C.D., T.E.Y.), Departments of Biomedical Engineering, Diagnostic
Medicine, and Oncology (T.E.Y.), and The Oden Institute for Computational
Engineering and Sciences, The University of Texas at Austin, Austin, Tex
(J.C.D., T.E.Y.); Department of Imaging Physics, The University of Texas MD
Anderson Cancer Center, Houston, Tex (T.E.Y.); and Department of Radiology,
University of Michigan, Ann Arbor, Mich (T.L.C.)
| | - Thomas E. Yankeelov
- From the Department of Radiology & Biomedical Imaging,
University of California San Francisco, San Francisco, Calif (W.L., D.C.N.,
N.M.H.); Department of Radiology, University of Washington, Fred Hutchinson
Cancer Center, 1100 Fairview Ave N, Seattle, WA 98109 (S.C.P., M.H., A.S.K.);
Center for Statistical Sciences, Brown University, Providence, RI (J.S.,
H.S.M.); Center for Magnetic Resonance Research, University of Minnesota,
Minneapolis, Minn (P.J.B.); Athinoula A. Martinos Center for Biomedical Imaging,
Harvard University, Charlestown, Mass (B.A.B., J.K.C.); Center for Research and
Innovation, American College of Radiology, Philadelphia, Pa (M.A.B.); Department
of Health Technology and Informatics, The Hong Kong Polytechnic University, Hung
Hom, Kowloon, Hong Kong SAR (X.T., J.Z., J.C.); Department of Radiology,
University of Pennsylvania, Philadelphia, Pa (D.K., E.A.C., W.C.M.); Department
of Radiology, Columbia University Medical Center, New York, NY (M.L., R.H.);
Division of Medical Image Computing, German Cancer Research Center, Heidelberg,
Germany (O.J.P.V., K.M.H.); Department of Radiation Oncology, Heidelberg
University Hospital, Heidelberg, Germany (K.M.H.); IBM Research-Israel, Haifa
University Campus, Mount Carmel, Haifa, Israel (S.R.C., T.T., M.O.F.);
University of Maryland Medical Intelligent Imaging (UM2ii) Center and Department
of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of
Medicine, Baltimore, Md (V.S.P.); The Russell H. Morgan Department of Radiology
and Radiological Science, The Johns Hopkins School of Medicine, Sidney Kimmel
Comprehensive Cancer Center, The Johns Hopkins School of Medicine, Baltimore, Md
(V.S.P., M.A.J.); Department of Diagnostic and Interventional Imaging, UT Health
at Houston, Houston, Tex (M.A.J.); Department of Radiological Sciences, David
Geffen School of Medicine, University of California, Los Angeles, Calif (R.Y.,
K.S.); Department of Bioengineering, Henry Samueli School of Engineering,
University of California, Los Angeles, Calif (R.Y., K.S.); Livestrong Cancer
Institutes (J.C.D., T.E.Y.), Departments of Biomedical Engineering, Diagnostic
Medicine, and Oncology (T.E.Y.), and The Oden Institute for Computational
Engineering and Sciences, The University of Texas at Austin, Austin, Tex
(J.C.D., T.E.Y.); Department of Imaging Physics, The University of Texas MD
Anderson Cancer Center, Houston, Tex (T.E.Y.); and Department of Radiology,
University of Michigan, Ann Arbor, Mich (T.L.C.)
| | - Thomas L. Chenevert
- From the Department of Radiology & Biomedical Imaging,
University of California San Francisco, San Francisco, Calif (W.L., D.C.N.,
N.M.H.); Department of Radiology, University of Washington, Fred Hutchinson
Cancer Center, 1100 Fairview Ave N, Seattle, WA 98109 (S.C.P., M.H., A.S.K.);
Center for Statistical Sciences, Brown University, Providence, RI (J.S.,
H.S.M.); Center for Magnetic Resonance Research, University of Minnesota,
Minneapolis, Minn (P.J.B.); Athinoula A. Martinos Center for Biomedical Imaging,
Harvard University, Charlestown, Mass (B.A.B., J.K.C.); Center for Research and
Innovation, American College of Radiology, Philadelphia, Pa (M.A.B.); Department
of Health Technology and Informatics, The Hong Kong Polytechnic University, Hung
Hom, Kowloon, Hong Kong SAR (X.T., J.Z., J.C.); Department of Radiology,
University of Pennsylvania, Philadelphia, Pa (D.K., E.A.C., W.C.M.); Department
of Radiology, Columbia University Medical Center, New York, NY (M.L., R.H.);
Division of Medical Image Computing, German Cancer Research Center, Heidelberg,
Germany (O.J.P.V., K.M.H.); Department of Radiation Oncology, Heidelberg
University Hospital, Heidelberg, Germany (K.M.H.); IBM Research-Israel, Haifa
University Campus, Mount Carmel, Haifa, Israel (S.R.C., T.T., M.O.F.);
University of Maryland Medical Intelligent Imaging (UM2ii) Center and Department
of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of
Medicine, Baltimore, Md (V.S.P.); The Russell H. Morgan Department of Radiology
and Radiological Science, The Johns Hopkins School of Medicine, Sidney Kimmel
Comprehensive Cancer Center, The Johns Hopkins School of Medicine, Baltimore, Md
(V.S.P., M.A.J.); Department of Diagnostic and Interventional Imaging, UT Health
at Houston, Houston, Tex (M.A.J.); Department of Radiological Sciences, David
Geffen School of Medicine, University of California, Los Angeles, Calif (R.Y.,
K.S.); Department of Bioengineering, Henry Samueli School of Engineering,
University of California, Los Angeles, Calif (R.Y., K.S.); Livestrong Cancer
Institutes (J.C.D., T.E.Y.), Departments of Biomedical Engineering, Diagnostic
Medicine, and Oncology (T.E.Y.), and The Oden Institute for Computational
Engineering and Sciences, The University of Texas at Austin, Austin, Tex
(J.C.D., T.E.Y.); Department of Imaging Physics, The University of Texas MD
Anderson Cancer Center, Houston, Tex (T.E.Y.); and Department of Radiology,
University of Michigan, Ann Arbor, Mich (T.L.C.)
| | - Nola M. Hylton
- From the Department of Radiology & Biomedical Imaging,
University of California San Francisco, San Francisco, Calif (W.L., D.C.N.,
N.M.H.); Department of Radiology, University of Washington, Fred Hutchinson
Cancer Center, 1100 Fairview Ave N, Seattle, WA 98109 (S.C.P., M.H., A.S.K.);
Center for Statistical Sciences, Brown University, Providence, RI (J.S.,
H.S.M.); Center for Magnetic Resonance Research, University of Minnesota,
Minneapolis, Minn (P.J.B.); Athinoula A. Martinos Center for Biomedical Imaging,
Harvard University, Charlestown, Mass (B.A.B., J.K.C.); Center for Research and
Innovation, American College of Radiology, Philadelphia, Pa (M.A.B.); Department
of Health Technology and Informatics, The Hong Kong Polytechnic University, Hung
Hom, Kowloon, Hong Kong SAR (X.T., J.Z., J.C.); Department of Radiology,
University of Pennsylvania, Philadelphia, Pa (D.K., E.A.C., W.C.M.); Department
of Radiology, Columbia University Medical Center, New York, NY (M.L., R.H.);
Division of Medical Image Computing, German Cancer Research Center, Heidelberg,
Germany (O.J.P.V., K.M.H.); Department of Radiation Oncology, Heidelberg
University Hospital, Heidelberg, Germany (K.M.H.); IBM Research-Israel, Haifa
University Campus, Mount Carmel, Haifa, Israel (S.R.C., T.T., M.O.F.);
University of Maryland Medical Intelligent Imaging (UM2ii) Center and Department
of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of
Medicine, Baltimore, Md (V.S.P.); The Russell H. Morgan Department of Radiology
and Radiological Science, The Johns Hopkins School of Medicine, Sidney Kimmel
Comprehensive Cancer Center, The Johns Hopkins School of Medicine, Baltimore, Md
(V.S.P., M.A.J.); Department of Diagnostic and Interventional Imaging, UT Health
at Houston, Houston, Tex (M.A.J.); Department of Radiological Sciences, David
Geffen School of Medicine, University of California, Los Angeles, Calif (R.Y.,
K.S.); Department of Bioengineering, Henry Samueli School of Engineering,
University of California, Los Angeles, Calif (R.Y., K.S.); Livestrong Cancer
Institutes (J.C.D., T.E.Y.), Departments of Biomedical Engineering, Diagnostic
Medicine, and Oncology (T.E.Y.), and The Oden Institute for Computational
Engineering and Sciences, The University of Texas at Austin, Austin, Tex
(J.C.D., T.E.Y.); Department of Imaging Physics, The University of Texas MD
Anderson Cancer Center, Houston, Tex (T.E.Y.); and Department of Radiology,
University of Michigan, Ann Arbor, Mich (T.L.C.)
| |
Collapse
|
47
|
Staplin N, Haynes R, Judge PK, Wanner C, Green JB, Emberson J, Preiss D, Mayne KJ, Ng SYA, Sammons E, Zhu D, Hill M, Stevens W, Wallendszus K, Brenner S, Cheung AK, Liu ZH, Li J, Hooi LS, Liu WJ, Kadowaki T, Nangaku M, Levin A, Cherney D, Maggioni AP, Pontremoli R, Deo R, Goto S, Rossello X, Tuttle KR, Steubl D, Petrini M, Seidi S, Landray MJ, Baigent C, Herrington WG, Abat S, Abd Rahman R, Abdul Cader R, Abdul Hafidz MI, Abdul Wahab MZ, Abdullah NK, Abdul-Samad T, Abe M, Abraham N, Acheampong S, Achiri P, Acosta JA, Adeleke A, Adell V, Adewuyi-Dalton R, Adnan N, Africano A, Agharazii M, Aguilar F, Aguilera A, Ahmad M, Ahmad MK, Ahmad NA, Ahmad NH, Ahmad NI, Ahmad Miswan N, Ahmad Rosdi H, Ahmed I, Ahmed S, Ahmed S, Aiello J, Aitken A, AitSadi R, Aker S, Akimoto S, Akinfolarin A, Akram S, Alberici F, Albert C, Aldrich L, Alegata M, Alexander L, Alfaress S, Alhadj Ali M, Ali A, Ali A, Alicic R, Aliu A, Almaraz R, Almasarwah R, Almeida J, Aloisi A, Al-Rabadi L, Alscher D, Alvarez P, Al-Zeer B, Amat M, Ambrose C, Ammar H, An Y, Andriaccio L, Ansu K, Apostolidi A, Arai N, Araki H, Araki S, Arbi A, Arechiga O, Armstrong S, Arnold T, Aronoff S, Arriaga W, Arroyo J, Arteaga D, Asahara S, Asai A, Asai N, Asano S, Asawa M, Asmee MF, Aucella F, Augustin M, Avery A, Awad A, Awang IY, Awazawa M, Axler A, Ayub W, Azhari Z, Baccaro R, Badin C, Bagwell B, Bahlmann-Kroll E, Bahtar AZ, Baigent C, Bains D, Bajaj H, Baker R, Baldini E, Banas B, Banerjee D, Banno S, Bansal S, Barberi S, Barnes S, Barnini C, Barot C, Barrett K, Barrios R, Bartolomei Mecatti B, Barton I, Barton J, Basily W, Bavanandan S, Baxter A, Becker L, Beddhu S, Beige J, Beigh S, Bell S, Benck U, Beneat A, Bennett A, Bennett D, Benyon S, Berdeprado J, Bergler T, Bergner A, Berry M, Bevilacqua M, Bhairoo J, Bhandari S, Bhandary N, Bhatt A, Bhattarai M, Bhavsar M, Bian W, Bianchini F, Bianco S, Bilous R, Bilton J, Bilucaglia D, Bird C, Birudaraju D, Biscoveanu M, Blake C, Bleakley N, Bocchicchia K, Bodine S, Bodington R, Boedecker S, Bolduc M, Bolton S, Bond C, Boreky F, Boren K, Bouchi R, Bough L, Bovan D, Bowler C, Bowman L, Brar N, Braun C, Breach A, Breitenfeldt M, Brenner S, Brettschneider B, Brewer A, Brewer G, Brindle V, Brioni E, Brown C, Brown H, Brown L, Brown R, Brown S, Browne D, Bruce K, Brueckmann M, Brunskill N, Bryant M, Brzoska M, Bu Y, Buckman C, Budoff M, Bullen M, Burke A, Burnette S, Burston C, Busch M, Bushnell J, Butler S, Büttner C, Byrne C, Caamano A, Cadorna J, Cafiero C, Cagle M, Cai J, Calabrese K, Calvi C, Camilleri B, Camp S, Campbell D, Campbell R, Cao H, Capelli I, Caple M, Caplin B, Cardone A, Carle J, Carnall V, Caroppo M, Carr S, Carraro G, Carson M, Casares P, Castillo C, Castro C, Caudill B, Cejka V, Ceseri M, Cham L, Chamberlain A, Chambers J, Chan CBT, Chan JYM, Chan YC, Chang E, Chang E, Chant T, Chavagnon T, Chellamuthu P, Chen F, Chen J, Chen P, Chen TM, Chen Y, Chen Y, Cheng C, Cheng H, Cheng MC, Cherney D, Cheung AK, Ching CH, Chitalia N, Choksi R, Chukwu C, Chung K, Cianciolo G, Cipressa L, Clark S, Clarke H, Clarke R, Clarke S, Cleveland B, Cole E, Coles H, Condurache L, Connor A, Convery K, Cooper A, Cooper N, Cooper Z, Cooperman L, Cosgrove L, Coutts P, Cowley A, Craik R, Cui G, Cummins T, Dahl N, Dai H, Dajani L, D'Amelio A, Damian E, Damianik K, Danel L, Daniels C, Daniels T, Darbeau S, Darius H, Dasgupta T, Davies J, Davies L, Davis A, Davis J, Davis L, Dayanandan R, Dayi S, Dayrell R, De Nicola L, Debnath S, Deeb W, Degenhardt S, DeGoursey K, Delaney M, Deo R, DeRaad R, Derebail V, Dev D, Devaux M, Dhall P, Dhillon G, Dienes J, Dobre M, Doctolero E, Dodds V, Domingo D, Donaldson D, Donaldson P, Donhauser C, Donley V, Dorestin S, Dorey S, Doulton T, Draganova D, Draxlbauer K, Driver F, Du H, Dube F, Duck T, Dugal T, Dugas J, Dukka H, Dumann H, Durham W, Dursch M, Dykas R, Easow R, Eckrich E, Eden G, Edmerson E, Edwards H, Ee LW, Eguchi J, Ehrl Y, Eichstadt K, Eid W, Eilerman B, Ejima Y, Eldon H, Ellam T, Elliott L, Ellison R, Emberson J, Epp R, Er A, Espino-Obrero M, Estcourt S, Estienne L, Evans G, Evans J, Evans S, Fabbri G, Fajardo-Moser M, Falcone C, Fani F, Faria-Shayler P, Farnia F, Farrugia D, Fechter M, Fellowes D, Feng F, Fernandez J, Ferraro P, Field A, Fikry S, Finch J, Finn H, Fioretto P, Fish R, Fleischer A, Fleming-Brown D, Fletcher L, Flora R, Foellinger C, Foligno N, Forest S, Forghani Z, Forsyth K, Fottrell-Gould D, Fox P, Frankel A, Fraser D, Frazier R, Frederick K, Freking N, French H, Froment A, Fuchs B, Fuessl L, Fujii H, Fujimoto A, Fujita A, Fujita K, Fujita Y, Fukagawa M, Fukao Y, Fukasawa A, Fuller T, Funayama T, Fung E, Furukawa M, Furukawa Y, Furusho M, Gabel S, Gaidu J, Gaiser S, Gallo K, Galloway C, Gambaro G, Gan CC, Gangemi C, Gao M, Garcia K, Garcia M, Garofalo C, Garrity M, Garza A, Gasko S, Gavrila M, Gebeyehu B, Geddes A, Gentile G, George A, George J, Gesualdo L, Ghalli F, Ghanem A, Ghate T, Ghavampour S, Ghazi A, Gherman A, Giebeln-Hudnell U, Gill B, Gillham S, Girakossyan I, Girndt M, Giuffrida A, Glenwright M, Glider T, Gloria R, Glowski D, Goh BL, Goh CB, Gohda T, Goldenberg R, Goldfaden R, Goldsmith C, Golson B, Gonce V, Gong Q, Goodenough B, Goodwin N, Goonasekera M, Gordon A, Gordon J, Gore A, Goto H, Goto S, Goto S, Gowen D, Grace A, Graham J, Grandaliano G, Gray M, Green JB, Greene T, Greenwood G, Grewal B, Grifa R, Griffin D, Griffin S, Grimmer P, Grobovaite E, Grotjahn S, Guerini A, Guest C, Gunda S, Guo B, Guo Q, Haack S, Haase M, Haaser K, Habuki K, Hadley A, Hagan S, Hagge S, Haller H, Ham S, Hamal S, Hamamoto Y, Hamano N, Hamm M, Hanburry A, Haneda M, Hanf C, Hanif W, Hansen J, Hanson L, Hantel S, Haraguchi T, Harding E, Harding T, Hardy C, Hartner C, Harun Z, Harvill L, Hasan A, Hase H, Hasegawa F, Hasegawa T, Hashimoto A, Hashimoto C, Hashimoto M, Hashimoto S, Haskett S, Hauske SJ, Hawfield A, Hayami T, Hayashi M, Hayashi S, Haynes R, Hazara A, Healy C, Hecktman J, Heine G, Henderson H, Henschel R, Hepditch A, Herfurth K, Hernandez G, Hernandez Pena A, Hernandez-Cassis C, Herrington WG, Herzog C, Hewins S, Hewitt D, Hichkad L, Higashi S, Higuchi C, Hill C, Hill L, Hill M, Himeno T, Hing A, Hirakawa Y, Hirata K, Hirota Y, Hisatake T, Hitchcock S, Hodakowski A, Hodge W, Hogan R, Hohenstatt U, Hohenstein B, Hooi L, Hope S, Hopley M, Horikawa S, Hosein D, Hosooka T, Hou L, Hou W, Howie L, Howson A, Hozak M, Htet Z, Hu X, Hu Y, Huang J, Huda N, Hudig L, Hudson A, Hugo C, Hull R, Hume L, Hundei W, Hunt N, Hunter A, Hurley S, Hurst A, Hutchinson C, Hyo T, Ibrahim FH, Ibrahim S, Ihana N, Ikeda T, Imai A, Imamine R, Inamori A, Inazawa H, Ingell J, Inomata K, Inukai Y, Ioka M, Irtiza-Ali A, Isakova T, Isari W, Iselt M, Ishiguro A, Ishihara K, Ishikawa T, Ishimoto T, Ishizuka K, Ismail R, Itano S, Ito H, Ito K, Ito M, Ito Y, Iwagaitsu S, Iwaita Y, Iwakura T, Iwamoto M, Iwasa M, Iwasaki H, Iwasaki S, Izumi K, Izumi K, Izumi T, Jaafar SM, Jackson C, Jackson Y, Jafari G, Jahangiriesmaili M, Jain N, Jansson K, Jasim H, Jeffers L, Jenkins A, Jesky M, Jesus-Silva J, Jeyarajah D, Jiang Y, Jiao X, Jimenez G, Jin B, Jin Q, Jochims J, Johns B, Johnson C, Johnson T, Jolly S, Jones L, Jones L, Jones S, Jones T, Jones V, Joseph M, Joshi S, Judge P, Junejo N, Junus S, Kachele M, Kadowaki T, Kadoya H, Kaga H, Kai H, Kajio H, Kaluza-Schilling W, Kamaruzaman L, Kamarzarian A, Kamimura Y, Kamiya H, Kamundi C, Kan T, Kanaguchi Y, Kanazawa A, Kanda E, Kanegae S, Kaneko K, Kaneko K, Kang HY, Kano T, Karim M, Karounos D, Karsan W, Kasagi R, Kashihara N, Katagiri H, Katanosaka A, Katayama A, Katayama M, Katiman E, Kato K, Kato M, Kato N, Kato S, Kato T, Kato Y, Katsuda Y, Katsuno T, Kaufeld J, Kavak Y, Kawai I, Kawai M, Kawai M, Kawase A, Kawashima S, Kazory A, Kearney J, Keith B, Kellett J, Kelley S, Kershaw M, Ketteler M, Khai Q, Khairullah Q, Khandwala H, Khoo KKL, Khwaja A, Kidokoro K, Kielstein J, Kihara M, Kimber C, Kimura S, Kinashi H, Kingston H, Kinomura M, Kinsella-Perks E, Kitagawa M, Kitajima M, Kitamura S, Kiyosue A, Kiyota M, Klauser F, Klausmann G, Kmietschak W, Knapp K, Knight C, Knoppe A, Knott C, Kobayashi M, Kobayashi R, Kobayashi T, Koch M, Kodama S, Kodani N, Kogure E, Koizumi M, Kojima H, Kojo T, Kolhe N, Komaba H, Komiya T, Komori H, Kon SP, Kondo M, Kondo M, Kong W, Konishi M, Kono K, Koshino M, Kosugi T, Kothapalli B, Kozlowski T, Kraemer B, Kraemer-Guth A, Krappe J, Kraus D, Kriatselis C, Krieger C, Krish P, Kruger B, Ku Md Razi KR, Kuan Y, Kubota S, Kuhn S, Kumar P, Kume S, Kummer I, Kumuji R, Küpper A, Kuramae T, Kurian L, Kuribayashi C, Kurien R, Kuroda E, Kurose T, Kutschat A, Kuwabara N, Kuwata H, La Manna G, Lacey M, Lafferty K, LaFleur P, Lai V, Laity E, Lambert A, Landray MJ, Langlois M, Latif F, Latore E, Laundy E, Laurienti D, Lawson A, Lay M, Leal I, Leal I, Lee AK, Lee J, Lee KQ, Lee R, Lee SA, Lee YY, Lee-Barkey Y, Leonard N, Leoncini G, Leong CM, Lerario S, Leslie A, Levin A, Lewington A, Li J, Li N, Li X, Li Y, Liberti L, Liberti ME, Liew A, Liew YF, Lilavivat U, Lim SK, Lim YS, Limon E, Lin H, Lioudaki E, Liu H, Liu J, Liu L, Liu Q, Liu WJ, Liu X, Liu Z, Loader D, Lochhead H, Loh CL, Lorimer A, Loudermilk L, Loutan J, Low CK, Low CL, Low YM, Lozon Z, Lu Y, Lucci D, Ludwig U, Luker N, Lund D, Lustig R, Lyle S, Macdonald C, MacDougall I, Machicado R, MacLean D, Macleod P, Madera A, Madore F, Maeda K, Maegawa H, Maeno S, Mafham M, Magee J, Maggioni AP, Mah DY, Mahabadi V, Maiguma M, Makita Y, Makos G, Manco L, Mangiacapra R, Manley J, Mann P, Mano S, Marcotte G, Maris J, Mark P, Markau S, Markovic M, Marshall C, Martin M, Martinez C, Martinez S, Martins G, Maruyama K, Maruyama S, Marx K, Maselli A, Masengu A, Maskill A, Masumoto S, Masutani K, Matsumoto M, Matsunaga T, Matsuoka N, Matsushita M, Matthews M, Matthias S, Matvienko E, Maurer M, Maxwell P, Mayne KJ, Mazlan N, Mazlan SA, Mbuyisa A, McCafferty K, McCarroll F, McCarthy T, McClary-Wright C, McCray K, McDermott P, McDonald C, McDougall R, McHaffie E, McIntosh K, McKinley T, McLaughlin S, McLean N, McNeil L, Measor A, Meek J, Mehta A, Mehta R, Melandri M, Mené P, Meng T, Menne J, Merritt K, Merscher S, Meshykhi C, Messa P, Messinger L, Miftari N, Miller R, Miller Y, Miller-Hodges E, Minatoguchi M, Miners M, Minutolo R, Mita T, Miura Y, Miyaji M, Miyamoto S, Miyatsuka T, Miyazaki M, Miyazawa I, Mizumachi R, Mizuno M, Moffat S, Mohamad Nor FS, Mohamad Zaini SN, Mohamed Affandi FA, Mohandas C, Mohd R, Mohd Fauzi NA, Mohd Sharif NH, Mohd Yusoff Y, Moist L, Moncada A, Montasser M, Moon A, Moran C, Morgan N, Moriarty J, Morig G, Morinaga H, Morino K, Morisaki T, Morishita Y, Morlok S, Morris A, Morris F, Mostafa S, Mostefai Y, Motegi M, Motherwell N, Motta D, Mottl A, Moys R, Mozaffari S, Muir J, Mulhern J, Mulligan S, Munakata Y, Murakami C, Murakoshi M, Murawska A, Murphy K, Murphy L, Murray S, Murtagh H, Musa MA, Mushahar L, Mustafa R, Mustafar R, Muto M, Nadar E, Nagano R, Nagasawa T, Nagashima E, Nagasu H, Nagelberg S, Nair H, Nakagawa Y, Nakahara M, Nakamura J, Nakamura R, Nakamura T, Nakaoka M, Nakashima E, Nakata J, Nakata M, Nakatani S, Nakatsuka A, Nakayama Y, Nakhoul G, Nangaku M, Naverrete G, Navivala A, Nazeer I, Negrea L, Nethaji C, Newman E, Ng SYA, Ng TJ, Ngu LLS, Nimbkar T, Nishi H, Nishi M, Nishi S, Nishida Y, Nishiyama A, Niu J, Niu P, Nobili G, Nohara N, Nojima I, Nolan J, Nosseir H, Nozawa M, Nunn M, Nunokawa S, Oda M, Oe M, Oe Y, Ogane K, Ogawa W, Ogihara T, Oguchi G, Ohsugi M, Oishi K, Okada Y, Okajyo J, Okamoto S, Okamura K, Olufuwa O, Oluyombo R, Omata A, Omori Y, Ong LM, Ong YC, Onyema J, Oomatia A, Oommen A, Oremus R, Orimo Y, Ortalda V, Osaki Y, Osawa Y, Osmond Foster J, O'Sullivan A, Otani T, Othman N, Otomo S, O'Toole J, Owen L, Ozawa T, Padiyar A, Page N, Pajak S, Paliege A, Pandey A, Pandey R, Pariani H, Park J, Parrigon M, Passauer J, Patecki M, Patel M, Patel R, Patel T, Patel Z, Paul R, Paul R, Paulsen L, Pavone L, Peixoto A, Peji J, Peng BC, Peng K, Pennino L, Pereira E, Perez E, Pergola P, Pesce F, Pessolano G, Petchey W, Petr EJ, Pfab T, Phelan P, Phillips R, Phillips T, Phipps M, Piccinni G, Pickett T, Pickworth S, Piemontese M, Pinto D, Piper J, Plummer-Morgan J, Poehler D, Polese L, Poma V, Pontremoli R, Postal A, Pötz C, Power A, Pradhan N, Pradhan R, Preiss D, Preiss E, Preston K, Prib N, Price L, Provenzano C, Pugay C, Pulido R, Putz F, Qiao Y, Quartagno R, Quashie-Akponeware M, Rabara R, Rabasa-Lhoret R, Radhakrishnan D, Radley M, Raff R, Raguwaran S, Rahbari-Oskoui F, Rahman M, Rahmat K, Ramadoss S, Ramanaidu S, Ramasamy S, Ramli R, Ramli S, Ramsey T, Rankin A, Rashidi A, Raymond L, Razali WAFA, Read K, Reiner H, Reisler A, Reith C, Renner J, Rettenmaier B, Richmond L, Rijos D, Rivera R, Rivers V, Robinson H, Rocco M, Rodriguez-Bachiller I, Rodriquez R, Roesch C, Roesch J, Rogers J, Rohnstock M, Rolfsmeier S, Roman M, Romo A, Rosati A, Rosenberg S, Ross T, Rossello X, Roura M, Roussel M, Rovner S, Roy S, Rucker S, Rump L, Ruocco M, Ruse S, Russo F, Russo M, Ryder M, Sabarai A, Saccà C, Sachson R, Sadler E, Safiee NS, Sahani M, Saillant A, Saini J, Saito C, Saito S, Sakaguchi K, Sakai M, Salim H, Salviani C, Sammons E, Sampson A, Samson F, Sandercock P, Sanguila S, Santorelli G, Santoro D, Sarabu N, Saram T, Sardell R, Sasajima H, Sasaki T, Satko S, Sato A, Sato D, Sato H, Sato H, Sato J, Sato T, Sato Y, Satoh M, Sawada K, Schanz M, Scheidemantel F, Schemmelmann M, Schettler E, Schettler V, Schlieper GR, Schmidt C, Schmidt G, Schmidt U, Schmidt-Gurtler H, Schmude M, Schneider A, Schneider I, Schneider-Danwitz C, Schomig M, Schramm T, Schreiber A, Schricker S, Schroppel B, Schulte-Kemna L, Schulz E, Schumacher B, Schuster A, Schwab A, Scolari F, Scott A, Seeger W, Seeger W, Segal M, Seifert L, Seifert M, Sekiya M, Sellars R, Seman MR, Shah S, Shah S, Shainberg L, Shanmuganathan M, Shao F, Sharma K, Sharpe C, Sheikh-Ali M, Sheldon J, Shenton C, Shepherd A, Shepperd M, Sheridan R, Sheriff Z, Shibata Y, Shigehara T, Shikata K, Shimamura K, Shimano H, Shimizu Y, Shimoda H, Shin K, Shivashankar G, Shojima N, Silva R, Sim CSB, Simmons K, Sinha S, Sitter T, Sivanandam S, Skipper M, Sloan K, Sloan L, Smith R, Smyth J, Sobande T, Sobata M, Somalanka S, Song X, Sonntag F, Sood B, Sor SY, Soufer J, Sparks H, Spatoliatore G, Spinola T, Squyres S, Srivastava A, Stanfield J, Staplin N, Staylor K, Steele A, Steen O, Steffl D, Stegbauer J, Stellbrink C, Stellbrink E, Stevens W, Stevenson A, Stewart-Ray V, Stickley J, Stoffler D, Stratmann B, Streitenberger S, Strutz F, Stubbs J, Stumpf J, Suazo N, Suchinda P, Suckling R, Sudin A, Sugamori K, Sugawara H, Sugawara K, Sugimoto D, Sugiyama H, Sugiyama H, Sugiyama T, Sullivan M, Sumi M, Suresh N, Sutton D, Suzuki H, Suzuki R, Suzuki Y, Suzuki Y, Suzuki Y, Swanson E, Swift P, Syed S, Szerlip H, Taal M, Taddeo M, Tailor C, Tajima K, Takagi M, Takahashi K, Takahashi K, Takahashi M, Takahashi T, Takahira E, Takai T, Takaoka M, Takeoka J, Takesada A, Takezawa M, Talbot M, Taliercio J, Talsania T, Tamori Y, Tamura R, Tamura Y, Tan CHH, Tan EZZ, Tanabe A, Tanabe K, Tanaka A, Tanaka A, Tanaka N, Tang S, Tang Z, Tanigaki K, Tarlac M, Tatsuzawa A, Tay JF, Tay LL, Taylor J, Taylor K, Taylor K, Te A, Tenbusch L, Teng KS, Terakawa A, Terry J, Tham ZD, Tholl S, Thomas G, Thong KM, Tietjen D, Timadjer A, Tindall H, Tipper S, Tobin K, Toda N, Tokuyama A, Tolibas M, Tomita A, Tomita T, Tomlinson J, Tonks L, Topf J, Topping S, Torp A, Torres A, Totaro F, Toth P, Toyonaga Y, Tripodi F, Trivedi K, Tropman E, Tschope D, Tse J, Tsuji K, Tsunekawa S, Tsunoda R, Tucky B, Tufail S, Tuffaha A, Turan E, Turner H, Turner J, Turner M, Tuttle KR, Tye YL, Tyler A, Tyler J, Uchi H, Uchida H, Uchida T, Uchida T, Udagawa T, Ueda S, Ueda Y, Ueki K, Ugni S, Ugwu E, Umeno R, Unekawa C, Uozumi K, Urquia K, Valleteau A, Valletta C, van Erp R, Vanhoy C, Varad V, Varma R, Varughese A, Vasquez P, Vasseur A, Veelken R, Velagapudi C, Verdel K, Vettoretti S, Vezzoli G, Vielhauer V, Viera R, Vilar E, Villaruel S, Vinall L, Vinathan J, Visnjic M, Voigt E, von-Eynatten M, Vourvou M, Wada J, Wada J, Wada T, Wada Y, Wakayama K, Wakita Y, Wallendszus K, Walters T, Wan Mohamad WH, Wang L, Wang W, Wang X, Wang X, Wang Y, Wanner C, Wanninayake S, Watada H, Watanabe K, Watanabe K, Watanabe M, Waterfall H, Watkins D, Watson S, Weaving L, Weber B, Webley Y, Webster A, Webster M, Weetman M, Wei W, Weihprecht H, Weiland L, Weinmann-Menke J, Weinreich T, Wendt R, Weng Y, Whalen M, Whalley G, Wheatley R, Wheeler A, Wheeler J, Whelton P, White K, Whitmore B, Whittaker S, Wiebel J, Wiley J, Wilkinson L, Willett M, Williams A, Williams E, Williams K, Williams T, Wilson A, Wilson P, Wincott L, Wines E, Winkelmann B, Winkler M, Winter-Goodwin B, Witczak J, Wittes J, Wittmann M, Wolf G, Wolf L, Wolfling R, Wong C, Wong E, Wong HS, Wong LW, Wong YH, Wonnacott A, Wood A, Wood L, Woodhouse H, Wooding N, Woodman A, Wren K, Wu J, Wu P, Xia S, Xiao H, Xiao X, Xie Y, Xu C, Xu Y, Xue H, Yahaya H, Yalamanchili H, Yamada A, Yamada N, Yamagata K, Yamaguchi M, Yamaji Y, Yamamoto A, Yamamoto S, Yamamoto S, Yamamoto T, Yamanaka A, Yamano T, Yamanouchi Y, Yamasaki N, Yamasaki Y, Yamasaki Y, Yamashita C, Yamauchi T, Yan Q, Yanagisawa E, Yang F, Yang L, Yano S, Yao S, Yao Y, Yarlagadda S, Yasuda Y, Yiu V, Yokoyama T, Yoshida S, Yoshidome E, Yoshikawa H, Young A, Young T, Yousif V, Yu H, Yu Y, Yuasa K, Yusof N, Zalunardo N, Zander B, Zani R, Zappulo F, Zayed M, Zemann B, Zettergren P, Zhang H, Zhang L, Zhang L, Zhang N, Zhang X, Zhao J, Zhao L, Zhao S, Zhao Z, Zhong H, Zhou N, Zhou S, Zhu D, Zhu L, Zhu S, Zietz M, Zippo M, Zirino F, Zulkipli FH. Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial. Lancet Diabetes Endocrinol 2024; 12:39-50. [PMID: 38061371 PMCID: PMC7615591 DOI: 10.1016/s2213-8587(23)00321-2] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/05/2023] [Revised: 10/24/2023] [Accepted: 10/25/2023] [Indexed: 12/23/2023]
Abstract
BACKGROUND Sodium-glucose co-transporter-2 (SGLT2) inhibitors reduce progression of chronic kidney disease and the risk of cardiovascular morbidity and mortality in a wide range of patients. However, their effects on kidney disease progression in some patients with chronic kidney disease are unclear because few clinical kidney outcomes occurred among such patients in the completed trials. In particular, some guidelines stratify their level of recommendation about who should be treated with SGLT2 inhibitors based on diabetes status and albuminuria. We aimed to assess the effects of empagliflozin on progression of chronic kidney disease both overall and among specific types of participants in the EMPA-KIDNEY trial. METHODS EMPA-KIDNEY, a randomised, controlled, phase 3 trial, was conducted at 241 centres in eight countries (Canada, China, Germany, Italy, Japan, Malaysia, the UK, and the USA), and included individuals aged 18 years or older with an estimated glomerular filtration rate (eGFR) of 20 to less than 45 mL/min per 1·73 m2, or with an eGFR of 45 to less than 90 mL/min per 1·73 m2 with a urinary albumin-to-creatinine ratio (uACR) of 200 mg/g or higher. We explored the effects of 10 mg oral empagliflozin once daily versus placebo on the annualised rate of change in estimated glomerular filtration rate (eGFR slope), a tertiary outcome. We studied the acute slope (from randomisation to 2 months) and chronic slope (from 2 months onwards) separately, using shared parameter models to estimate the latter. Analyses were done in all randomly assigned participants by intention to treat. EMPA-KIDNEY is registered at ClinicalTrials.gov, NCT03594110. FINDINGS Between May 15, 2019, and April 16, 2021, 6609 participants were randomly assigned and then followed up for a median of 2·0 years (IQR 1·5-2·4). Prespecified subgroups of eGFR included 2282 (34·5%) participants with an eGFR of less than 30 mL/min per 1·73 m2, 2928 (44·3%) with an eGFR of 30 to less than 45 mL/min per 1·73 m2, and 1399 (21·2%) with an eGFR 45 mL/min per 1·73 m2 or higher. Prespecified subgroups of uACR included 1328 (20·1%) with a uACR of less than 30 mg/g, 1864 (28·2%) with a uACR of 30 to 300 mg/g, and 3417 (51·7%) with a uACR of more than 300 mg/g. Overall, allocation to empagliflozin caused an acute 2·12 mL/min per 1·73 m2 (95% CI 1·83-2·41) reduction in eGFR, equivalent to a 6% (5-6) dip in the first 2 months. After this, it halved the chronic slope from -2·75 to -1·37 mL/min per 1·73 m2 per year (relative difference 50%, 95% CI 42-58). The absolute and relative benefits of empagliflozin on the magnitude of the chronic slope varied significantly depending on diabetes status and baseline levels of eGFR and uACR. In particular, the absolute difference in chronic slopes was lower in patients with lower baseline uACR, but because this group progressed more slowly than those with higher uACR, this translated to a larger relative difference in chronic slopes in this group (86% [36-136] reduction in the chronic slope among those with baseline uACR <30 mg/g compared with a 29% [19-38] reduction for those with baseline uACR ≥2000 mg/g; ptrend<0·0001). INTERPRETATION Empagliflozin slowed the rate of progression of chronic kidney disease among all types of participant in the EMPA-KIDNEY trial, including those with little albuminuria. Albuminuria alone should not be used to determine whether to treat with an SGLT2 inhibitor. FUNDING Boehringer Ingelheim and Eli Lilly.
Collapse
|
48
|
Cai J, Liu P, Lei J, Zhang Y, Xiang Y, Wang X, Wu Q, Hu Z. Solution-Processed 1D Wurtzite ZnS Nanostructures with Controlled Crystallographic Orientation and Tunable Band-Edge Emission. Small 2024; 20:e2303560. [PMID: 37726249 DOI: 10.1002/smll.202303560] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/27/2023] [Revised: 09/04/2023] [Indexed: 09/21/2023]
Abstract
1D compound semiconductor nanomaterials possess unique physicochemical properties that strongly depend on their size, composition, and structures. ZnS has been widely investigated as one of the most important semiconductors, and the control of crystallographic orientation of 1D ZnS nanostructures is still challenging and crucial to exploring their anisotropic properties. Herein, a solution-processed strategy is developed to synthesize 1D wurtzite (w-)ZnS nanostructures with the specific <002> and <210> orientations by co-decomposing the copper dibutyldithiocarbamate {[(C4 H9 )2 NCS2 ]2 Cu, i.e., R2 Cu} and zinc dibutyldithiocarbamate (R2 Zn) precursors in the mixed solvents of oleylamine and 1-dodecanethoil. A solution-solid-solid (SSS)-Oriented growth mechanism is proposed, which includes oriented nucleation dominated and SSS growth dominated stages. The crystallographic orientation mainly depends on the interfacial energy and ligand effect. The 1D w-ZnS nanostructures with controlled crystallographic orientation display unique morphologies, i.e., <002>-oriented w-ZnS nanorod enclosed with {110} facets while <210>-oriented w-ZnS nanobelt enclosed with wide (002) and narrow (110) facets. The bandgap of 1D w-ZnS nanostructures can be tuned from 3.94 to 3.82 eV with the crystallographic growth direction varied from <002> to <210>, thus leading to the tunable band-edge emission from ≈338 to ≈345 nm.
Collapse
Affiliation(s)
- Jing Cai
- School of Materials Science and Engineering, Hefei University of Technology, Hefei, 230009, P. R. China
| | - Peifeng Liu
- School of Materials Science and Engineering, Hefei University of Technology, Hefei, 230009, P. R. China
| | - Junyu Lei
- School of Materials Science and Engineering, Hefei University of Technology, Hefei, 230009, P. R. China
| | - Yongliang Zhang
- Anhui Province Key Laboratory of Advanced Catalytic Materials and Reaction Engineering, School of Chemistry and Chemical Engineering, Hefei University of Technology, Hefei, 230009, P. R. China
| | - Yu Xiang
- Anhui Province Key Laboratory of Advanced Catalytic Materials and Reaction Engineering, School of Chemistry and Chemical Engineering, Hefei University of Technology, Hefei, 230009, P. R. China
| | - Xizhang Wang
- Key Laboratory of Mesoscopic Chemistry of MOE, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing, 210093, P. R. China
| | - Qiang Wu
- Key Laboratory of Mesoscopic Chemistry of MOE, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing, 210093, P. R. China
| | - Zheng Hu
- Key Laboratory of Mesoscopic Chemistry of MOE, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing, 210093, P. R. China
| |
Collapse
|
49
|
Cai J, Xu X, Saw PE. Nanomedicine targeting ferroptosis to overcome anticancer therapeutic resistance. Sci China Life Sci 2024; 67:19-40. [PMID: 37728804 DOI: 10.1007/s11427-022-2340-4] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/17/2023] [Accepted: 03/30/2023] [Indexed: 09/21/2023]
Abstract
A potential reason for the failure of tumor therapies is treatment resistance. Resistance to chemotherapy, radiotherapy, and immunotherapy continues to be a major obstacle in clinic, resulting in tumor recurrence and metastasis. The major mechanisms of therapy resistance are inhibitions of cell deaths, like apoptosis and necrosis, through drug inactivation and excretion, repair of DNA damage, tumor heterogeneity, or changes in tumor microenvironment, etc. Recent studies have shown that ferroptosis play a major role in therapies resistance by inducing phospholipid peroxidation and iron-dependent cell death. Some ferroptosis inducers in combination with clinical treatment techniques have been used to enhance the effect in tumor therapy. Notably, versatile ferroptosis nanoinducers exhibit an extensive range of functions in reversing therapy resistance, including directly triggering ferroptosis and feedback regulation. Herein, we provide a detailed description of the design, mechanism, and therapeutic application of ferroptosis-mediated synergistic tumor therapeutics. We also discuss the prospect and challenge of nanomedicine in tumor therapy resistance by regulating ferroptosis and combination therapy.
Collapse
Affiliation(s)
- Jing Cai
- Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Medical Research Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China
- Nanhai Translational Innovation Center of Precision Immunology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Foshan, 528200, China
| | - Xiaoding Xu
- Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Medical Research Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China
- Nanhai Translational Innovation Center of Precision Immunology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Foshan, 528200, China
| | - Phei Er Saw
- Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Medical Research Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China.
- Nanhai Translational Innovation Center of Precision Immunology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Foshan, 528200, China.
| |
Collapse
|
50
|
Sheng J, Lam S, Zhang J, Zhang Y, Cai J. Multi-omics fusion with soft labeling for enhanced prediction of distant metastasis in nasopharyngeal carcinoma patients after radiotherapy. Comput Biol Med 2024; 168:107684. [PMID: 38039891 DOI: 10.1016/j.compbiomed.2023.107684] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/07/2023] [Revised: 10/06/2023] [Accepted: 11/06/2023] [Indexed: 12/03/2023]
Abstract
Omics fusion has emerged as a crucial preprocessing approach in medical image processing, significantly assisting several studies. One of the challenges encountered in integrating omics data is the unpredictability arising from disparities in data sources and medical imaging equipment. Due to these differences, the distribution of omics futures exhibits spatial heterogeneity, diminishing their capacity to enhance subsequent tasks. To overcome this challenge and facilitate the integration of their joint application to specific medical objectives, this study aims to develop a fusion methodology for nasopharyngeal carcinoma (NPC) distant metastasis prediction to mitigate the disparities inherent in omics data. The multi-kernel late-fusion method can reduce the impact of these differences by mapping the features using the most suiTable single-kernel function and then combining them in a high-dimensional space that can effectively represent the data. The proposed approach in this study employs a distinctive framework incorporating a label-softening technique alongside a multi-kernel-based Radial basis function (RBF) neural network to address these limitations. An efficient representation of the data may be achieved by utilizing the multi-kernel to map the inherent features and then merging them in a space with many dimensions. However, the inflexibility of label fitting poses a constraint on using multi-kernel late-fusion methods in complex NPC datasets, hence affecting the efficacy of general classifiers in dealing with high-dimensional characteristics. The label softening increases the disparity between the two cohorts, providing a more flexible structure for allocating labels. The proposed model is evaluated on multi-omics datasets, and the results demonstrate its strength and effectiveness in predicting distant metastasis of NPC patients.
Collapse
Affiliation(s)
- Jiabao Sheng
- Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong Special Administrative Region, China; Research Institute for Smart Ageing, The Hong Kong Polytechnic University, Hong Kong Special Administrative Region, China.
| | - SaiKit Lam
- Research Institute for Smart Ageing, The Hong Kong Polytechnic University, Hong Kong Special Administrative Region, China; Department of Biomedical Engineering, The Hong Kong Polytechnic University, Hong Kong Special Administrative Region, China.
| | - Jiang Zhang
- Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong Special Administrative Region, China.
| | - Yuanpeng Zhang
- Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong Special Administrative Region, China; The Hong Kong Polytechnic University Shenzhen Research Institute, Shenzhen, China.
| | - Jing Cai
- Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong Special Administrative Region, China; Research Institute for Smart Ageing, The Hong Kong Polytechnic University, Hong Kong Special Administrative Region, China; The Hong Kong Polytechnic University Shenzhen Research Institute, Shenzhen, China.
| |
Collapse
|